Datasets:
ChatDOC
/
OCRFlux-pubtabnet-single

Dataset card Data Studio Files Community
image_name
stringlengths
68
68
type
stringclasses
2 values
gt_table
stringlengths
116
12.6k
deb42789550559f981a032884195522ebc52af753abfd46fd7e5d8a4f801dd4d.png
simple
<table><tr><td></td><td>A MSC</td><td>BM MSC</td><td>COMMON</td></tr><tr><td>INHIBITION OF MMP</td><td>A2M, MMP2, TIMP1, TIMP2</td><td>A2M, MMP2, TIMP2</td><td>A2M, MMP2, TIMP2</td></tr><tr><td>EPITHELIAL ADHERENS JUNCTION</td><td>ACTN1, ACTN4, ACTR2, MYH9, TUBA1C, TUBB, VCL</td><td>ACTN1, ACTN4, ACTR2, ARPC3, IQGAP1, MYH9, TUBB, VCL</td><td>ACTN1, ACTN4, ACTR2, MYH9, TUBB, VCL</td></tr><tr><td>REMODELING OF EPITHELIAL ADHERENS JUNCTION</td><td>ACTN1, ACTN4, ACTR2, TUBA1C, TUBB, VCL</td><td>ACTN1, ACTN4, ACTR2, IQGAP1, NME1, TUBB, VCL</td><td>ACTNI, ACTN4, ACTR2, TUBB, VCL</td></tr><tr><td>GERM CELL SERTOLI JUNCTION</td><td>A2M, ACTN1, ACTN4, TUB1AC, TUBB, VCL</td><td>A2M, ACTN1, ACTN4, CFL1, IQGAP1, TUBB, VCL</td><td>A2M, ACTN1, ACTN4, TUBB, VCL</td></tr><tr><td>ACTIN CYTOSKELETON</td><td>ACTN1, ACTN4, ACTR2, EZR, MSN, MYH9, PFN1, TLN1, VCL</td><td>ACTN1, ACTN4, ARPC3, CFL1, FN1, IQGAP1, MSN, PFN1, RDX, VCL</td><td>ACTN1, ACTN4, MSN, PFN1, VCL</td></tr><tr><td>HEPATIC FIBROSIS</td><td>A2M, COL1A1, COL1A2, COL3A1, COL6A2, FN1, IGFBP3, MMP2, MYH9, SERPINE1, TIMP1, TIMP2</td><td>A2M, COL1A1, COL1A2, COL3A1, FN1, IGFBP3, MMP2, MYH9, SERPINE1, TIMP2</td><td>A2M, COL1A1, COL1A2, COL3A1, FN1, IGFBP3, MMP2, MYH9, SERPINE1, TIMP2</td></tr><tr><td>PROTEIN UBIQUITINATION</td><td>HSP90AA1, HSP90AB1, HSP90B1, HSPA5, HSPA8, HSPB1, HSPD1, PSMA1, PSMA3, PSMA5, PSMA6</td><td>HSP90AA1, HSP90AB1, HSP90B1, HSPA4, HSPA5, HSPA8, HSPB1, HSPD1, PSMA5, PSMB1, PSMB4, PSMB5, PSMB6</td><td>HSP90AA1, HSP90AB1, HSP90B1, HSPA8, HSPD1, PSMA5</td></tr><tr><td>RHOA SIGNALING</td><td>ACTR2, EZR, MSN, PFN1</td><td>ACRT2, ARPC3, CFL1, MSN, PFN1</td><td>ACTR2, MSN, PFN1</td></tr><tr><td>LEUCOCYTE EXTRAVASATION</td><td>ACTN1, ACTN4, EZR, GNAI2, MMP2, MSN, TIMP1, TIMP2, VCL</td><td>ACTN1, ACTN4, MMP2, MSN, RDX, TIMP2, VCL</td><td>ACTN1, ACTN4, MMP2, MSN, TIMP2, VCL</td></tr></table>
affaba5fe790896184457c4d521c73d789c11d38a2d6dd01f0a087aa47c606c4.png
simple
<table><tr><td>Parameters</td><td>Case report [2]</td><td>Case report [3]</td><td>Our case report</td></tr><tr><td>Age</td><td>76 years</td><td>55 years</td><td>55 years</td></tr><tr><td>Circumcision</td><td>Uncircumcised</td><td>Delayed circumcision</td><td>Infantile circumcision</td></tr><tr><td>Site of stricture</td><td>Bulbar urethral stricture</td><td>Bulbar urethral stricture</td><td>Penile and bulbar urethral strictures</td></tr><tr><td>Time to develop malignancy</td><td>4 months</td><td>3 months</td><td>5 years</td></tr><tr><td>Presentation</td><td>Ulcerative lesion at glans penis</td><td>Penile periurethral mass</td><td>Ventral penile masses involving glans and whole exteriorised urethra, with associated scrotal wall changes</td></tr><tr><td>Treatment</td><td>Partial penectomy</td><td>Total penectomy</td><td>Total penectomy</td></tr></table>
2c3cdf26b25aafee57e9cd9060e275ce67084d88828269fc3a106348f66e0e5c.png
complex
<table><tr><td> </td><td> </td><td colspan="4">O/E ratios</td></tr><tr><td>hospital</td><td>n. deliveries</td><td>Model 1</td><td>Model 2</td><td>Model 3</td><td>Model 4</td></tr><tr><td>1</td><td>3000</td><td>1.23</td><td>1.22</td><td>1.25</td><td>1.25</td></tr><tr><td>2</td><td>1710</td><td>1.22</td><td>1.22</td><td>1.25</td><td>1.24</td></tr><tr><td>3</td><td>1513</td><td>0.98</td><td>0.98</td><td>1.01</td><td>1.00</td></tr><tr><td>4</td><td>473</td><td>1.30</td><td>1.30</td><td>1.40</td><td>1.40</td></tr><tr><td>5</td><td>1869</td><td>0.98</td><td>0.98</td><td>1.09</td><td>1.07</td></tr><tr><td>6</td><td>1914</td><td>0.97</td><td>0.97</td><td>1.02</td><td>1.02</td></tr><tr><td>7</td><td>1558</td><td>1.18</td><td>1.18</td><td>1.25</td><td>1.24</td></tr><tr><td>8</td><td>510</td><td>1.39</td><td>1.38</td><td>1.44</td><td>1.43</td></tr><tr><td>9</td><td>3735</td><td>0.68</td><td>0.68</td><td>0.71</td><td>0.71</td></tr><tr><td>10</td><td>1364</td><td>0.83</td><td>0.83</td><td>0.84</td><td>0.82</td></tr><tr><td>11</td><td>1085</td><td>0.66</td><td>0.66</td><td>0.74</td><td>0.73</td></tr><tr><td>12</td><td>2501</td><td>1.09</td><td>1.08</td><td>1.09</td><td>1.08</td></tr><tr><td>13</td><td>6408</td><td>0.92</td><td>0.92</td><td>0.89</td><td>0.89</td></tr><tr><td>14</td><td>2315</td><td>1.16</td><td>1.16</td><td>1.15</td><td>1.15</td></tr><tr><td>15</td><td>1289</td><td>0.98</td><td>0.99</td><td>0.99</td><td>1.05</td></tr><tr><td>16</td><td>1687</td><td>0.69</td><td>0.69</td><td>0.74</td><td>0.79</td></tr><tr><td>17</td><td>3271</td><td>1.05</td><td>1.05</td><td>1.02</td><td>1.02</td></tr><tr><td>18</td><td>2337</td><td>0.76</td><td>0.76</td><td>0.78</td><td>0.78</td></tr><tr><td>19</td><td>2033</td><td>0.77</td><td>0.77</td><td>0.79</td><td>0.79</td></tr><tr><td>20</td><td>3456</td><td>1.04</td><td>1.04</td><td>1.05</td><td>1.04</td></tr><tr><td>21</td><td>4837</td><td>0.75</td><td>0.75</td><td>0.76</td><td>0.76</td></tr><tr><td>22</td><td>6195</td><td>1.04</td><td>1.04</td><td>0.98</td><td>0.98</td></tr><tr><td>23</td><td>2370</td><td>0.98</td><td>0.98</td><td>1.05</td><td>1.05</td></tr><tr><td>24</td><td>781</td><td>1.41</td><td>1.40</td><td>1.35</td><td>1.34</td></tr><tr><td>25</td><td>5520</td><td>1.17</td><td>1.17</td><td>1.17</td><td>1.17</td></tr><tr><td>26</td><td>5402</td><td>0.89</td><td>0.89</td><td>0.89</td><td>0.88</td></tr><tr><td>27</td><td>7240</td><td>1.03</td><td>1.03</td><td>1.06</td><td>1.06</td></tr><tr><td>28</td><td>7916</td><td>1.18</td><td>1.18</td><td>1.12</td><td>1.13</td></tr><tr><td>29</td><td>3285</td><td>0.91</td><td>0.92</td><td>0.87</td><td>0.87</td></tr></table>
4377c12e18a6de3c83740034481dd7c9e30515d37726c3fa99afac83a3c83794.png
simple
<table><tr><td>Tree</td><td>CT</td><td>CLADHC</td><td>HT</td><td>SbST</td></tr><tr><td>1</td><td><underline>94.8</underline><i> (3.8)</i></td><td>89.1 <i>(3.5)</i></td><td>91.2 <i>(5.6)</i></td><td>89.5 <i>(3.9)</i></td></tr><tr><td>2</td><td>94.0 <i>(3.8)</i></td><td>92.7 <i>(4.1)</i></td><td>87.6 <i>(5.6)</i></td><td><underline>98.5</underline><i> (5.3)</i></td></tr><tr><td>3</td><td>79.3 <i>(3.2)</i></td><td>88.9 <i>(4.7)</i></td><td>86.2 <i>(4.7)</i></td><td><underline>94.2</underline><i> (4.1)</i></td></tr><tr><td>4</td><td>88.7 <i>(2.3)</i></td><td>85.7 <i>(3.1)</i></td><td>87.8 <i>(4.6)</i></td><td><underline>93.6</underline><i> (4.4)</i></td></tr><tr><td>5</td><td>85.6 <i>(4.3)</i></td><td><underline>94.4</underline><i> (4.1)</i></td><td>90.5 <i>(4.5)</i></td><td>94.0 <i>(4.1)</i></td></tr><tr><td>6</td><td>78.6 <i>(3.0)</i></td><td>81.6 <i>(3.3)</i></td><td><underline>88.0</underline><i> (4.2)</i></td><td>67.0 <i>(4.2)</i></td></tr><tr><td>7</td><td>92.4 <i>(3.8)</i></td><td>90.5 <i>(3.7)</i></td><td>87.8 <i>(5.2)</i></td><td><underline>92.7</underline><i> (4.0)</i></td></tr><tr><td>8</td><td><underline>99.7</underline><i> (3.0)</i></td><td>98.6 <i>(2.8)</i></td><td>91.2 <i>(4.7)</i></td><td>99.6 <i>(4.5)</i></td></tr><tr><td>9</td><td><underline>91.9</underline><i> (3.7)</i></td><td>89.2 <i>(4.5)</i></td><td>91.2 <i>(4.8)</i></td><td>89.1 <i>(4.1)</i></td></tr><tr><td>10</td><td><underline>88.8</underline><i> (2.9)</i></td><td>82.8 <i>(3.0)</i></td><td>81.3 <i>(4.1)</i></td><td>79.1 <i>(3.5)</i></td></tr><tr><td>Average</td><td>89,38 <i>(3.4)</i></td><td>89.35 <i>(3.7)</i></td><td>88,28 <i>(4.8)</i></td><td><underline>89,73</underline><i> (4.2)</i></td></tr><tr><td>Std dev.<sup>a</sup></td><td>6.71 <i>(0.6)</i></td><td>5.2 <i>(0.6)</i></td><td>3.06 <i>(0.5)</i></td><td>9.81 <i>(0.5)</i></td></tr></table>
8de54133b3f6958ba675920f847cc29fa24da293540f5c108ba4560a6e044747.png
complex
<table><tr><td>Area</td><td colspan="4">Bj&#248;rndalen</td><td>Sverdrup</td></tr><tr><td>Samples</td><td>Bd1</td><td>Bd2</td><td>Bd3</td><td>Bd4</td><td>Sv1, Sv2</td></tr><tr><td>Type</td><td>Spring water</td><td>Thaw water</td><td>Mix upstream</td><td>Mix downstream</td><td>Mat and sediment</td></tr><tr><td>pH</td><td>2.8</td><td>6.2</td><td>3.5</td><td>3.8</td><td>2.3</td></tr><tr><td>&#176;C (water)</td><td>9</td><td>7</td><td>7</td><td>7</td><td>4</td></tr><tr><td>&#176;C (air)</td><td>6</td><td>6</td><td>6</td><td>6</td><td>4</td></tr><tr><td>Na</td><td>3.1</td><td>2.5</td><td>3</td><td>2.8</td><td>42</td></tr><tr><td>K</td><td>1.1</td><td>0.5</td><td>1.6</td><td>1.3</td><td>0.2</td></tr><tr><td>Zn</td><td>0.3</td><td>Na</td><td>0.1</td><td>0.07</td><td>5.1</td></tr><tr><td>Ni</td><td>0.1</td><td>Na</td><td>0.03</td><td>0.02</td><td>1.3</td></tr><tr><td>Mg</td><td>5.4</td><td>1.3</td><td>2.6</td><td>2.3</td><td>145</td></tr><tr><td>Ca</td><td>Na</td><td>Na</td><td>Na</td><td>Na</td><td>10</td></tr><tr><td>Mn</td><td>0.4</td><td>Na</td><td>0.2</td><td>0.1</td><td>9.7</td></tr><tr><td>Cu</td><td>0.03</td><td>Na</td><td>Na</td><td>Na</td><td>0.8</td></tr><tr><td>Al</td><td>3.4</td><td>Na</td><td>1.8</td><td>0.9</td><td>76</td></tr><tr><td>Fe total</td><td>15</td><td>Na</td><td>2</td><td>2</td><td>883</td></tr><tr><td>Fe<sup>2+</sup></td><td>9</td><td>Na</td><td>1</td><td>1</td><td>183</td></tr><tr><td>Fe<sup>3+</sup></td><td>6</td><td>Na</td><td>1</td><td>1</td><td>700</td></tr><tr><td>SO<sub>4</sub><sup>2&#8722;</sup></td><td>110</td><td>10</td><td>54</td><td>32</td><td>1543</td></tr></table>
82c1a3ce2363446c2cb1542a8becc8af1de965c535b3669039003210e9fc32d6.png
simple
<table><tr><td>Samplelabel</td><td>Addedeuropium(%wt)</td><td>Ca content(at%)</td><td>P content(at%)</td><td>Eu content(at%)</td><td>Ca+Eu/Pratio</td></tr><tr><td>HAP</td><td>0</td><td>6.96</td><td>5.14</td><td>0</td><td>1.35</td></tr><tr><td>HAPEu3%</td><td>3</td><td>9.96</td><td>8.11</td><td>0.16</td><td>1.25</td></tr><tr><td>HAPEu5%</td><td>5</td><td>13.67</td><td>10.61</td><td>0.69</td><td>1.35</td></tr><tr><td>HAPEu10%</td><td>10</td><td>14.44</td><td>11.03</td><td>1.43</td><td>1.44</td></tr><tr><td>HAPEu20%</td><td>20</td><td>10.38</td><td>7.32</td><td>2.60</td><td>1.78</td></tr></table>
34a0bedb86823234faa38123560f4b1b849dfefbed2b2f934e42dae4f8691d18.png
simple
<table><tr><td></td><td>Total types</td><td>Total tokens</td><td>TTR</td></tr><tr><td>Proper nouns (<i>Sem1</i>)</td><td>699</td><td>9,516</td><td>0.073</td></tr><tr><td>Basic level count nouns (<i>Sem2</i>)</td><td>2,675</td><td>25,369</td><td>0.105</td></tr><tr><td>Basic level mass nouns (<i>Sem3</i>)</td><td>288</td><td>2,655</td><td>0.108</td></tr><tr><td>Action words (<i>Sem4a</i>)</td><td>228</td><td>1,419</td><td>0.161</td></tr><tr><td>Non-basic level words (<i>Sem4b</i>)</td><td>1,507</td><td>12,618</td><td>0.119</td></tr></table>
88f0c7d2e73b4e9c755fb3f5cc5485085379046628d04896fc6c9cd733da90e9.png
complex
<table><tr><td></td><td>N</td><td>%</td></tr><tr><td>Mean Age = 37.5 (S.D.11)</td><td></td><td></td></tr><tr><td colspan="3">Citizenship</td></tr><tr><td> Greek</td><td>77</td><td>76.2</td></tr><tr><td> Other</td><td>24</td><td>23.8</td></tr><tr><td>Marital status</td><td></td><td></td></tr><tr><td> Unmarried</td><td>53</td><td>52.5</td></tr><tr><td> Married</td><td>19</td><td>18.8</td></tr><tr><td> Divorced</td><td>21</td><td>20.8</td></tr><tr><td> Widow</td><td>8</td><td>7.9</td></tr><tr><td>Children</td><td></td><td></td></tr><tr><td> Yes</td><td>62</td><td>61.4</td></tr><tr><td> No</td><td>39</td><td>38.6</td></tr><tr><td colspan="3">Occupation before detention</td></tr><tr><td> Employee</td><td>59</td><td>58.4</td></tr><tr><td> Student</td><td>2</td><td>2.0</td></tr><tr><td> Unemployed</td><td>26</td><td>25.7</td></tr><tr><td> Pensioner</td><td>3</td><td>3.0</td></tr><tr><td> Housework</td><td>9</td><td>8.9</td></tr><tr><td> Other</td><td>2</td><td>2.0</td></tr><tr><td colspan="3">Education level</td></tr><tr><td> Compulsory</td><td>36</td><td>35.6</td></tr><tr><td> Secondary</td><td>32</td><td>31.7</td></tr><tr><td> Tertiary</td><td>24</td><td>23.8</td></tr><tr><td> Postgraduate</td><td>9</td><td>8.9</td></tr></table>
61bf3f91bccbb36e8e00e9e3ecca2a3e456f170c63ea258a02ca7d831709190d.png
complex
<table><tr><td>Category</td><td>Clinical attachment level (CAL)</td><td>Probing pocket depth (PD)</td></tr><tr><td>Severe periodontitis</td><td>&#8805; 2 interdental sites with CAL &#8805; 6 mm (not on same tooth) and</td><td>&#8805; 1 interdental site with PD &#8805; 5 mm</td></tr><tr><td>Moderate periodontitis</td><td>&#8805; 2 interdental sites with CAL &#8805; 4 mm (not on same tooth) or</td><td>&#8805; 2 interdental sites with PD &#8805; 5 mm (not on same tooth)</td></tr><tr><td>No-or-mild periodontitis</td><td colspan="2">Neither &#8220;moderate&#8221; nor &#8220;severe&#8221; periodontitis</td></tr></table>
788892dd2e0af80f58c2510b1df7dc286389822cfc5f11e67fa80f02e868ee27.png
complex
<table><tr><td></td><td colspan="2">Rural(<i>N</i> = 2, 799)</td><td colspan="2">Urban(1, 925)</td></tr><tr><td>Socioeconomic variables</td><td>Women(1333) %</td><td>Men(1466) %</td><td>Women(1 044) %</td><td>Men(881) %</td></tr><tr><td>Mean age in years(95 % CI)</td><td>64.9(64.4, 65.5)</td><td>64.1(63.6, 64.7)</td><td>64.7(64.0, 65.4)</td><td>62.65(62.0, 63.3)</td></tr><tr><td>Age group (years)</td><td></td><td></td><td></td><td></td></tr><tr><td> 50&#8211;59</td><td>36.2</td><td>39.0</td><td>39.5</td><td>47.2</td></tr><tr><td> 60&#8211;69</td><td>26.3</td><td>29.8</td><td>26.0</td><td>28.4</td></tr><tr><td> 70&#8211;79</td><td>27.2</td><td>21.1</td><td>23.4</td><td>17.4</td></tr><tr><td> 80+</td><td>10.3</td><td>10.2</td><td>11.2</td><td>7.0</td></tr><tr><td>Educational level</td><td></td><td></td><td></td><td></td></tr><tr><td> No formal education</td><td>78.8</td><td>53.7</td><td>60.4</td><td>35.0</td></tr><tr><td> Primary Education</td><td>14.5</td><td>22.1</td><td>19.4</td><td>19.8</td></tr><tr><td> Secondary education</td><td>5.9</td><td>20.7</td><td>16.8</td><td>36.4</td></tr><tr><td> University/postgraduate</td><td>0.5</td><td>2.7</td><td>3.1</td><td>8.2</td></tr><tr><td> Missing</td><td>0.3</td><td>0.8</td><td>0.3</td><td>0.6</td></tr><tr><td>Marital Status</td><td></td><td></td><td></td><td></td></tr><tr><td> Never Married</td><td>0.9</td><td>1.2</td><td>1.8</td><td>1.1</td></tr><tr><td> Currently married/Cohabiting</td><td>36.0</td><td>84.0</td><td>29.2</td><td>82.1</td></tr><tr><td> Separated/Divorced</td><td>16.4</td><td>7.4</td><td>20.5</td><td>9.3</td></tr><tr><td> Widowed</td><td>46.0</td><td>7.0</td><td>47.8</td><td>6.8</td></tr><tr><td> Missing</td><td>0.6</td><td>0.4</td><td>0.7</td><td>0.7</td></tr><tr><td>Type of Work<sup>a</sup></td><td></td><td></td><td></td><td></td></tr><tr><td> Professional</td><td>0.2</td><td>1.2</td><td>1.3</td><td>5.2</td></tr><tr><td> Skilled agricultural and fishery workers</td><td>67.4</td><td>82.5</td><td>42.4</td><td>61.0</td></tr><tr><td> Technical</td><td>4.6</td><td>5.1</td><td>10.3</td><td>13.5</td></tr><tr><td> Elementary occupation</td><td>10.2</td><td>2.2</td><td>29.1</td><td>10.1</td></tr><tr><td> Missing</td><td>17.7</td><td>9.1</td><td>16.9</td><td>10.2</td></tr><tr><td>Socio-economic status</td><td></td><td></td><td></td><td></td></tr><tr><td> Poorest</td><td>27.5</td><td>27.0</td><td>11.8</td><td>6.0</td></tr><tr><td> Poor</td><td>27.2</td><td>22.9</td><td>14.0</td><td>10.8</td></tr><tr><td> Middle</td><td>23.3</td><td>22.4</td><td>17.1</td><td>15.0</td></tr><tr><td> Upper fifth</td><td>15.3</td><td>17.5</td><td>24.6</td><td>24.4</td></tr><tr><td> Wealthiest</td><td>6.6</td><td>10.2</td><td>32.2</td><td>43.6</td></tr><tr><td> Missing</td><td>0.1</td><td>0.0</td><td>0.4</td><td>0.2</td></tr></table>
05db1e935af9de2917932df9e6ba4aa73361602cca84c83bf104de88223ba9ce.png
complex
<table><tr><td></td><td>Type 45&#176;</td><td>Type 60&#176;</td><td>Type 75&#176;</td><td>Type 90&#176;</td><td><i>p-</i>value</td></tr><tr><td rowspan="3">KVPA,&#176;</td><td rowspan="3">5.1 (0.7)</td><td rowspan="3">5.1 (0.9)</td><td rowspan="3">5.1 (0.9)</td><td rowspan="3">4.4 (1.0)</td><td><i>p1</i>* <i>=</i> 0.017</td></tr><tr><td><i>p2</i>* <i>=</i> 0.004</td></tr><tr><td><i>p3</i>* <i>=</i> 0.001</td></tr><tr><td rowspan="3">mMDFA,&#176;</td><td rowspan="3">94.0 (1.2)</td><td rowspan="3">93.3 (2.1)</td><td rowspan="3">94.3 (2.0)</td><td rowspan="3">95.0 (1.6)</td><td><i>p4</i>* <i>=</i> 0.031</td></tr><tr><td><i>p5</i>* <i>=</i> 0.008</td></tr><tr><td><i>p6</i>* <i>=</i> 0.001</td></tr><tr><td rowspan="3">HKA,&#176;</td><td rowspan="3">179.8 (2.3)</td><td rowspan="3">179.3 (2.1)</td><td rowspan="3">179.6 (2.5)</td><td rowspan="3">181.3 (2.5)</td><td><i>p7</i>* <i>=</i> 0.049</td></tr><tr><td><i>p8</i>* <i>=</i> 0.001</td></tr><tr><td><i>p9</i>* <i>=</i> 0.004</td></tr></table>
a0248753afb763ba39ed045836f65b9d6dd3eaecbfe085e46bde155262413826.png
simple
<table><tr><td>Target</td><td>Accession Number</td><td>Forward Primer</td><td>Reverse Primer</td></tr><tr><td>Cyp2a4</td><td>NM_009997</td><td>GGAAGACGAACGGTGCTTTC</td><td>CCCGAAGACGATTGAGCTAATG</td></tr><tr><td>Cyp3a11</td><td>NM_007818</td><td>CGCCTCTCCTTGCTGTCACA</td><td>CTTTGCCTTCTGCCTCAAGT</td></tr><tr><td>Cyp2c37</td><td>NM_010001</td><td>ATACTCTATATTTGGGCAGG</td><td>GTTCCTCCACAAGGCAAC</td></tr><tr><td>Cyp2c39</td><td>NM_010003</td><td>GGAGACAGAGCTGTGGC</td><td>TAAAAACAATGCCAAGGCCG</td></tr><tr><td>Cyp2d22</td><td>NM_019823</td><td>GGGCCTTTGTTACCATGTTGG</td><td>TACTCGGCGCTGCACATCTG</td></tr><tr><td>&#946;-actin</td><td>NM_007393</td><td>TGTTACCAACTGGGACGACA</td><td>GGGGTGTTGAAGGTCTCAAA</td></tr></table>
5e3aae17c2e0c91e092f78e3af8c65ae65be516ef58958b721cb3e744940bc95.png
complex
<table><tr><td rowspan="3">Surveillance site</td><td colspan="8">Diarrhoea cases</td><td rowspan="2">Total</td></tr><tr><td colspan="2">Non-diarrhoea cases</td><td colspan="2">Rotavirusdiarrhoea</td><td colspan="2">Cholera</td><td colspan="2">Non-rotavirus and non-cholera diarrhoea</td></tr><tr><td>No.</td><td>%</td><td>No.</td><td>%</td><td>No.</td><td>%</td><td>No.</td><td>%</td><td></td></tr><tr><td>Bakerganj</td><td>163</td><td>63.7</td><td>31</td><td>12.1</td><td>27</td><td>10.5</td><td>35</td><td>13.7</td><td>256</td></tr><tr><td>Mathbaria</td><td>163</td><td>60.0</td><td>38</td><td>14.0</td><td>23</td><td>8.5</td><td>48</td><td>17.7</td><td>272</td></tr><tr><td>Total</td><td>326</td><td>61.7</td><td>69</td><td>13.1</td><td>50</td><td>9.5</td><td>83</td><td>15.7</td><td>528</td></tr></table>
032e50712b93da2bad1d1200be9de169adc627258b7ebb2b119363cfdf05751d.png
simple
<table><tr><td>Variables</td><td>OR</td><td>95% CI</td><td>p-value</td></tr><tr><td>Age: &#8804;28</td><td>1.277</td><td>0.489-3.333</td><td>0.617</td></tr><tr><td>Gender: male</td><td>1.237</td><td>0.366-4.183</td><td>0.732</td></tr><tr><td>Smoking: no</td><td>2.717</td><td>1.017-7.257</td><td>0.046</td></tr><tr><td>Lesion: top</td><td>1.531</td><td>0.484-4.844</td><td>0.469</td></tr><tr><td>Comorbidities: yes</td><td>3.413</td><td>1.236-9.433</td><td>0.018</td></tr><tr><td>ISP: yes</td><td>0.862</td><td>0.3615-2.364</td><td>0.773</td></tr><tr><td>CSP: yes</td><td>0.428</td><td>0.129-1.420</td><td>0.166</td></tr><tr><td>Operation for ISP: yes</td><td>4.695</td><td>1.486-14.925</td><td>0.008</td></tr><tr><td>Approach: VATS</td><td>1.802</td><td>0.464-6.999</td><td>0.395</td></tr><tr><td>Buttress stapling: no</td><td>0.724</td><td>0.232-2.262</td><td>0.578</td></tr><tr><td>Covering: no</td><td>0.594</td><td>0.193-1.825</td><td>0.363</td></tr><tr><td>Surgeon: trainee</td><td>0.787</td><td>0.332-1.867</td><td>0.587</td></tr><tr><td>Pleurodesis: yes</td><td>1.420</td><td>0.238-8.475</td><td>0.700</td></tr><tr><td>Complication: yes</td><td>1.763</td><td>0.133-23.255</td><td>0.667</td></tr></table>
c24a69436bd584c92ae274c79da75d88f81294cc4d2475872ee05225e5101ebc.png
simple
<table><tr><td></td><td>12-pNCA</td><td>2PE</td><td>PROP</td><td>11PA</td><td>2A5C</td><td>MDOB</td><td>ALL</td></tr><tr><td>Correlation</td><td>0.32 (0.06)</td><td>0.27 (0.11)</td><td>0.06 (0.71)</td><td>0.12 (0.48)</td><td>0.20 (0.24)</td><td>0.36 (0.04)</td><td>0.22(10<sup>-3</sup>)</td></tr></table>
996e57ad46b2569afe574be932d92f6f6ecc03c2073ebc45a65bf8fe618df5d0.png
complex
<table><tr><td rowspan="2"></td><td colspan="2">Total</td><td colspan="2">Male sex</td><td colspan="2">Female sex</td></tr><tr><td>Normouricemia (<i>n</i> = 1749)</td><td>Hyperuricemia (<i>n</i> = 393)</td><td>Normouricemia (<i>n</i> = 954)</td><td>Hyperuricemia (<i>n</i> = 238)</td><td>Normouricemia (<i>n</i> = 795)</td><td>Hyperuricemia (<i>n</i> = 155)</td></tr><tr><td>At 1-year</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>CAD</td><td>15</td><td>5</td><td>10</td><td>3</td><td>5</td><td>2</td></tr><tr><td>Congestive heart failure</td><td>4</td><td>2</td><td>2</td><td>1</td><td>2</td><td>1</td></tr><tr><td>Stroke</td><td>6</td><td>2</td><td>3</td><td>1</td><td>3</td><td>1</td></tr><tr><td>Peripheral vascular disease</td><td>0</td><td>1</td><td>0</td><td>0</td><td>0</td><td>1</td></tr><tr><td>At 2-year</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>CAD</td><td>25</td><td>8</td><td>16</td><td>5</td><td>9</td><td>3</td></tr><tr><td>Congestive heart failure</td><td>6</td><td>3</td><td>3</td><td>2</td><td>3</td><td>1</td></tr><tr><td>Stroke</td><td>11</td><td>2</td><td>6</td><td>1</td><td>5</td><td>1</td></tr><tr><td>Peripheral vascular disease</td><td>2</td><td>2</td><td>1</td><td>1</td><td>1</td><td>1</td></tr><tr><td>At 3-year</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>CAD</td><td>31</td><td>13</td><td>18</td><td>8</td><td>13</td><td>5</td></tr><tr><td>Congestive heart failure</td><td>15</td><td>5</td><td>9</td><td>3</td><td>6</td><td>2</td></tr><tr><td>Stroke</td><td>13</td><td>6</td><td>8</td><td>4</td><td>5</td><td>2</td></tr><tr><td>peripheral vascular disease</td><td>8</td><td>3</td><td>5</td><td>2</td><td>3</td><td>1</td></tr><tr><td>At 4-year</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>CAD</td><td>39</td><td>16</td><td>22</td><td>9</td><td>17</td><td>6</td></tr><tr><td>Congestive heart failure</td><td>16</td><td>6</td><td>10</td><td>4</td><td>6</td><td>2</td></tr><tr><td>Stroke</td><td>18</td><td>9</td><td>11</td><td>6</td><td>7</td><td>3</td></tr><tr><td>Peripheral vascular disease</td><td>11</td><td>5</td><td>7</td><td>4</td><td>4</td><td>1</td></tr><tr><td>At 5-year</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>CAD</td><td>44</td><td>17</td><td>26</td><td>11</td><td>18</td><td>7</td></tr><tr><td>Congestive heart failure</td><td>21</td><td>7</td><td>13</td><td>5</td><td>8</td><td>2</td></tr><tr><td>Stroke</td><td>23</td><td>13</td><td>13</td><td>8</td><td>10</td><td>5</td></tr><tr><td>Peripheral vascular disease</td><td>12</td><td>6</td><td>7</td><td>4</td><td>5</td><td>2</td></tr><tr><td colspan="7">Cumulative Numbers of major CVD events over 5 years</td></tr><tr><td>CAD</td><td>154 (8.8%)</td><td>59 (15.0%)</td><td>92 (9.7 %)</td><td>36 (15.1%)</td><td>62 (7.8%)</td><td>23 (14.8%)</td></tr><tr><td>Congestive heart failure</td><td>62 (3.6%)</td><td>23 (5.9%)</td><td>37 (3.9%)</td><td>15 (6.1%)</td><td>25 (3.2%)</td><td>8 (5.2%)</td></tr><tr><td>Stroke</td><td>73 (4.2%)</td><td>32 (8.1%)</td><td>41 (4.3%)</td><td>20 (8.2%)</td><td>30 (3.8%)</td><td>12 (7.7%)</td></tr><tr><td>Peripheral vascular disease</td><td>33 (1.9%)</td><td>17 (4.6%)</td><td>20 (2.1%)</td><td>11 (4.6%)</td><td>13 (1.6%)</td><td>6 (3.7%)</td></tr></table>
0a7ed016fa9717cbda826640e9047c02793106479f348645a87d3c5f1e2d66b2.png
complex
<table><tr><td></td><td>ASD (<i>n</i> = 24)</td><td>Controls (<i>n</i> = 18)</td><td>Statistics</td></tr><tr><td>Age</td><td>40.54 &#177; 10.279</td><td>37.17 &#177; 10.983</td><td><i>p</i> = 0.313</td></tr><tr><td>Intelligence quotient</td><td>114.29 &#177; 15.213</td><td>113.00 &#177; 13.920</td><td><i>p</i> = 0.779</td></tr><tr><td>Gender</td><td>12 m:12 f</td><td>8 m:10 f</td><td><i>p</i> = 0.721</td></tr><tr><td>Nicotine</td><td>2.292 &#177; 5.894</td><td>2.222 &#177; 6.691</td><td><i>p</i> = 0.972</td></tr><tr><td>Autism-spectrum quotient</td><td>39.08 &#177; 6.386</td><td>12.94 &#177; 5.504</td><td><i>p</i> &lt; 0.001</td></tr><tr><td>Empathy quotient</td><td>17.38 &#177; 9.523</td><td>47.94 &#177; 9.710</td><td><i>p</i> &lt; 0.001</td></tr><tr><td>Wender Utah Rating Scale</td><td>33.75 &#177; 16.690</td><td>8.72 &#177; 7.954</td><td><i>p</i> &lt; 0.001</td></tr><tr><td>Beck Depression Inventory score</td><td>17.25 &#177; 12.365</td><td>3.22 &#177; 4.236</td><td><i>p</i> &lt; 0.001</td></tr><tr><td rowspan="5">Level of education</td><td>Low school degree, 1 (4.2%)</td><td>Low school degree, 0 (0%)</td><td rowspan="5"></td></tr><tr><td>Medium school degree, 3 (12.5%)</td><td>Medium school degree, 3 (16.7%)</td></tr><tr><td>High school degree, 9 (37.5%)</td><td>High school degree, 6 (33.3%)</td></tr><tr><td>University degree, 9 (37.5%)</td><td>University degree, 9 (50%)</td></tr><tr><td>Other, 2 (8.3%)</td><td>Other, 0 (0%)</td></tr><tr><td rowspan="6">Occupational situation</td><td>Full-time employed, 13 (54.2%)</td><td>Full-time employed, 7 (38.9%)</td><td rowspan="6"></td></tr><tr><td>Part-time employment, 4 (16.7%)</td><td>Part-time employment, 4 (22.2%)</td></tr><tr><td>In vocational training/studying, 1 (4.2%)</td><td>In vocational training/studying, 7 (38.9%)</td></tr><tr><td>Pension, 1 (4.2%)</td><td>Pension, 0 (0%)</td></tr><tr><td>Unemployed, 4 (16.7%)</td><td>Unemployed, 0 (0%)</td></tr><tr><td>Other, 1 (4.2%)</td><td>Other, 0 (0%)</td></tr><tr><td rowspan="5">Psychiatric medication (in the last 3 months)</td><td>No, 11</td><td>No, 18</td><td rowspan="5"></td></tr><tr><td>AD, 6</td><td>AD, 0</td></tr><tr><td>NL, 1</td><td>NL, 0</td></tr><tr><td>AD + NL, 5</td><td>AD + NL, 0</td></tr><tr><td>AD + MPH, 1</td><td>AD + MPH, 0</td></tr></table>
c910cdc766d3d76bd21d924006ac5561f193c486f0e5b2c292da0586236eed29.png
simple
<table><tr><td>Cytological diagnosis</td><td>Frequency (n)</td><td>Percentage (%)</td></tr><tr><td>Chronic granulomatous inflammation</td><td>20</td><td>27.0%</td></tr><tr><td>Chronic sialadenitis</td><td>25</td><td>33.7%</td></tr><tr><td>Acute on chronic sialdenitis</td><td>22</td><td>29.7%</td></tr><tr><td>Benign cystic lesion</td><td>7</td><td>9.4%</td></tr><tr><td>Total</td><td>74</td><td>39.5%</td></tr></table>
d2b00a7885ed32740e52b3bd095474678d628fe54f7e0cc745c5b513d358a1fd.png
simple
<table><tr><td>Plasmid</td><td>Properties</td><td>Source/Reference</td></tr><tr><td>pRS316</td><td>Yeast centromeric plasmid. <i>URA3</i> marker.</td><td>[52]</td></tr><tr><td>pRS316[P<sub>PHO84</sub>-GFP-T<sub>PHO84</sub>] (pRUL1336)</td><td>pRS316 containing the <i>PHO84</i> promoter (600 bp), GFP and the <i>PHO84</i> terminator (436 bp)</td><td>This study</td></tr><tr><td>pRS316[P<sub>CYC1</sub>-GFP-T<sub>CYC1</sub>] (pRUL1339)</td><td>pRS316 containing the <i>CYC1</i> promoter (300 bp), GFP and the <i>CYC1</i> terminator (220 bp)</td><td>This study</td></tr><tr><td>pRS316[P<sub>SPL2</sub>-GFP-T<sub>SPL2</sub>] (pRUL1354)</td><td>pRS316 containing the <i>SPL2</i> promoter (647 bp), GFP and the <i>SPL2</i> terminator (324 bp)</td><td>This study</td></tr><tr><td>pUG6</td><td>Plasmid containing the KAN.MX casette for gene disruptions</td><td>[53]</td></tr><tr><td>pUG36</td><td>Centromeric plasmid to make N-terminal GFP fusions.</td><td>Gu&#776;ldener and Hegemann, unpublished</td></tr><tr><td>pRS305</td><td>Yeast integration plasmid. <i>LEU2</i> marker.</td><td>[52]</td></tr><tr><td>pRS305[P<sub>PHO84</sub>-GFP-T<sub>PHO84</sub>] (pRUL1359)</td><td>pRS305 containing the <i>PHO84</i> promoter (600 bp), GFP and the <i>PHO84</i> terminator (436 bp)</td><td>This study</td></tr><tr><td>pRS305[P<sub>CYC1</sub>-GFP-T<sub>CYC1</sub>] (pRUL1360)</td><td>pRS305 containing the <i>CYC1</i> promoter (300 bp), GFP and the <i>CYC1</i> terminator (220 bp)</td><td>This study</td></tr><tr><td>pRS313</td><td>Yeast centromeric plasmid. <i>HIS3</i> selection marker.</td><td>[52]</td></tr><tr><td>pRS313[PHO4](pRUL1334)</td><td>pRS313 containing <i>PHO4</i></td><td>[7]</td></tr><tr><td>pRS313[BMH1] (pRUL1330)</td><td>pRS313 containing a 3.2 kb genomic DNA fragment with <i>BMH1</i></td><td>I.G. Anemaet, unpublished results</td></tr><tr><td>pRS305[PHO4] (pRUL1358)</td><td>pRS305 containing <i>PHO4</i></td><td>This study</td></tr><tr><td>YCplac33</td><td>Yeast centromeric plasmid. <i>URA3</i> marker</td><td>[54]</td></tr><tr><td>YCplac33[BMH1]</td><td>YCplac33 with a 3.2 kb genomic DNA fragment with <i>BMH1</i></td><td>[55]</td></tr></table>
19f0a829f8912952abc185954f07da79595b5973060e7fb359eaad5269a62ff8.png
complex
<table><tr><td colspan="9">Down-regulated genes</td></tr><tr><td></td><td>mst<sup>1ts</sup></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Gene</td><td>Log2 change</td><td>p-value</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>SPAC1039.02</td><td>-2.66</td><td>0.000635869</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>SPBC29A3.05</td><td>-2.18</td><td>5.55E-05</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>SPCC757.06</td><td>-2.08</td><td>1.87E-07</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="9">Up-regulated genes</td></tr><tr><td></td><td>mst1<sup>ts</sup></td><td></td><td></td><td>mst1<sup>ts</sup></td><td></td><td></td><td>mst1<sup><i>ts</i></sup></td><td></td></tr><tr><td>Gene</td><td>Log 2 change</td><td>p-value</td><td>Gene</td><td>Log 2 change</td><td>p-value</td><td>Gene</td><td>Log2 change</td><td>p-value</td></tr><tr><td>SPBC1348.09</td><td>1.89</td><td>3.69E-11</td><td>SPAC977.17</td><td>2.40</td><td>1.80E-08</td><td>map2</td><td>3.52</td><td>2.50E-12</td></tr><tr><td>SPAC22F8.05</td><td>1.90</td><td>0.001560473</td><td>SPBC1348.14c</td><td>2.41</td><td>2.14E-15</td><td>SPAPJ695.01c</td><td>3.52</td><td>2.00E-09</td></tr><tr><td>SPAC3C7.13c</td><td>1.92</td><td>3.23E-10</td><td>SPAC5H10.02c</td><td>2.46</td><td>3.89E-11</td><td>SPBC1198.01</td><td>3.55</td><td>7.19E-16</td></tr><tr><td>SPBPB2B2.06c</td><td>1.93</td><td>0.000987078</td><td>SPCC663.08c</td><td>2.54</td><td>0.009807792</td><td>SPAC22A12.17c</td><td>3.57</td><td>1.96E-11</td></tr><tr><td>SPBPB2B2.07c</td><td>1.93</td><td>9.41E-10</td><td>SPBC725.10</td><td>2.57</td><td>9.52E-05</td><td>SPAPB1A11.03</td><td>3.59</td><td>1.50E-13</td></tr><tr><td>nta1</td><td>1.94</td><td>3.20E-06</td><td>SPBC83.19c</td><td>2.58</td><td>3.49E-12</td><td>SPAC1F8.04c</td><td>3.59</td><td>5.41E-07</td></tr><tr><td>SPCC191.01</td><td>1.94</td><td>5.61E-06</td><td>SPCC1393.12</td><td>2.58</td><td>4.35E-11</td><td>SPAC11D3.01c</td><td>3.61</td><td>1.72E-07</td></tr><tr><td>SPCC70.04c</td><td>1.95</td><td>2.09E-06</td><td>SPBPB2B2.08</td><td>2.60</td><td>0.007868315</td><td>SPBPB8B6.03</td><td>3.64</td><td>2.07E-12</td></tr><tr><td>meu7</td><td>1.96</td><td>2.81E-05</td><td>SPCC777.04</td><td>2.63</td><td>3.77E-05</td><td>SPBP4G3.03</td><td>3.65</td><td>2.74E-13</td></tr><tr><td>SPAC9.10</td><td>1.98</td><td>8.57E-09</td><td>SPAC26F1.05</td><td>2.64</td><td>1.00E-07</td><td>SPCC663.06c</td><td>3.66</td><td>3.28E-05</td></tr><tr><td>map1</td><td>1.98</td><td>0.000618909</td><td>pma2</td><td>2.64</td><td>6.19E-07</td><td>SPBPB21E7.04c</td><td>3.67</td><td>3.08E-06</td></tr><tr><td>SPBC8E4.05c</td><td>1.99</td><td>1.54E-08</td><td>SPAC32A11.02c</td><td>2.65</td><td>4.69E-09</td><td>frp1</td><td>3.69</td><td>3.37E-05</td></tr><tr><td>SPAC637.03</td><td>2.03</td><td>0.000132799</td><td>SPBC2G2.17c</td><td>2.66</td><td>2.11E-07</td><td>SPCC737.04</td><td>3.85</td><td>3.10E-07</td></tr><tr><td>SPBC4C3.08</td><td>2.04</td><td>6.23E-08</td><td>SPAC56F8.15</td><td>2.68</td><td>0.001276426</td><td>SPBC359.06</td><td>3.91</td><td>0.000499938</td></tr><tr><td>meu10</td><td>2.05</td><td>4.69E-07</td><td>SPAPJ691.02</td><td>2.72</td><td>1.52E-05</td><td>apc10</td><td>3.96</td><td>4.49E-12</td></tr><tr><td>SPCC1840.12</td><td>2.05</td><td>4.17E-06</td><td>SPBC1773.06c</td><td>2.76</td><td>0.000469242</td><td>SPAPB8E5.10</td><td>3.98</td><td>1.31E-12</td></tr><tr><td>SPBPB2B2.02</td><td>2.06</td><td>0.000305555</td><td>SPBC1685.05</td><td>2.86</td><td>1.62E-11</td><td>SPBC16E9.16c</td><td>4.00</td><td>6.07E-13</td></tr><tr><td>SPBC19C7.04c</td><td>2.09</td><td>0.001283597</td><td>SPAC4F10.17</td><td>2.88</td><td>6.57E-09</td><td>SPAC29A4.12c</td><td>4.06</td><td>1.45E-09</td></tr><tr><td>SPAC5H10.04</td><td>2.10</td><td>1.33E-06</td><td>SPCC16A11.15c</td><td>2.94</td><td>5.09E-11</td><td>SPAC869.08</td><td>4.08</td><td>1.01E-15</td></tr><tr><td>SPBC947.05c</td><td>2.11</td><td>5.62E-08</td><td>SPCC1739.08c</td><td>2.96</td><td>0.021512753</td><td>SPBC3H7.08c</td><td>4.09</td><td>9.33E-14</td></tr><tr><td>SPAC3H8.09c</td><td>2.11</td><td>1.77E-10</td><td>SPAC23C11.06c</td><td>2.99</td><td>1.15E-07</td><td>SPBCPT2R1.08c</td><td>4.16</td><td>0.000258571</td></tr><tr><td>ish1</td><td>2.11</td><td>9.95E-06</td><td>SPAC15E1.02c</td><td>3.00</td><td>8.68E-09</td><td>fbp1</td><td>4.32</td><td>3.57E-14</td></tr><tr><td>SPAC513.02</td><td>2.12</td><td>1.94E-06</td><td>SPBC1105.13c</td><td>3.02</td><td>1.10E-07</td><td>SPBC56F2.06</td><td>4.36</td><td>2.99E-07</td></tr><tr><td>SPAC4H3.03c</td><td>2.14</td><td>0.000486057</td><td>grt1</td><td>3.04</td><td>7.61E-08</td><td>mel1</td><td>4.43</td><td>2.62E-15</td></tr><tr><td>SPAPB15E9.02c</td><td>2.17</td><td>3.00E-08</td><td>SPCC338.18</td><td>3.04</td><td>7.26E-07</td><td>SPAC139.05</td><td>4.49</td><td>1.53E-09</td></tr><tr><td>SPCC794.01c</td><td>2.18</td><td>0.042343035</td><td>SPBPB2B2.18</td><td>3.05</td><td>1.46E-05</td><td>SPCPB16A4.06c</td><td>4.53</td><td>1.21E-11</td></tr><tr><td>SPAC1F8.02c</td><td>2.18</td><td>3.57E-07</td><td>SPCC1322.07c</td><td>3.10</td><td>9.51E-09</td><td>SPBC1289.14</td><td>4.61</td><td>8.12E-16</td></tr><tr><td>SPBC4.01</td><td>2.20</td><td>9.35E-05</td><td>SPCC757.03c</td><td>3.11</td><td>2.10E-09</td><td>ght3</td><td>4.72</td><td>0.001973142</td></tr><tr><td>SPBPB8B6.02c</td><td>2.23</td><td>1.43E-12</td><td>SPAC4H3.08</td><td>3.16</td><td>4.98E-12</td><td>zym1</td><td>4.85</td><td>1.83E-08</td></tr><tr><td>SPBC36.02c</td><td>2.23</td><td>0.000135759</td><td>SPBPB2B2.12c</td><td>3.16</td><td>0.00706426</td><td>SPBC24C6.09c</td><td>4.94</td><td>1.55E-13</td></tr><tr><td>SPCC1393.07c</td><td>2.23</td><td>4.88E-10</td><td>spk1</td><td>3.17</td><td>0.000216514</td><td>dak2</td><td>5.02</td><td>4.45E-12</td></tr><tr><td>SPAC513.06c</td><td>2.24</td><td>1.52E-09</td><td>mei2</td><td>3.25</td><td>0.000888516</td><td>SPAC186.02c</td><td>5.11</td><td>6.43E-15</td></tr><tr><td>SPCPB1C11.02</td><td>2.25</td><td>7.04E-07</td><td>SPAC977.05c</td><td>3.29</td><td>2.46E-05</td><td>eno102</td><td>5.11</td><td>3.01E-13</td></tr><tr><td>ste11</td><td>2.27</td><td>0.000335259</td><td>SPAC1F8.08</td><td>3.32</td><td>2.20E-09</td><td>SPAC3G9.11c</td><td>5.13</td><td>5.88E-11</td></tr><tr><td>wtf20</td><td>2.28</td><td>4.37E-06</td><td>SPAC3G6.07</td><td>3.33</td><td>1.53E-05</td><td>SPAC22G7.11c</td><td>5.22</td><td>4.34E-14</td></tr><tr><td>ppk33</td><td>2.28</td><td>0.000119009</td><td>SPACUNK4.17</td><td>3.33</td><td>3.64E-07</td><td>SPBC23G7.10c</td><td>5.25</td><td>4.94E-06</td></tr><tr><td>SPAC1F7.06</td><td>2.33</td><td>5.44E-12</td><td>SPAC23H3.15c</td><td>3.42</td><td>1.03E-05</td><td>isp3</td><td>5.36</td><td>1.87E-11</td></tr><tr><td>ssa1</td><td>2.34</td><td>0.000834021</td><td>caf5</td><td>3.44</td><td>4.99E-07</td><td>SPAC869.06c</td><td>6.61</td><td>2.79E-13</td></tr><tr><td>cta3</td><td>2.36</td><td>6.88E-11</td><td>str3</td><td>3.48</td><td>2.47E-05</td><td>SPAC869.09</td><td>6.68</td><td>2.91E-12</td></tr><tr><td>agl1</td><td>2.37</td><td>0.026304809</td><td></td><td></td><td></td><td></td><td></td><td></td></tr></table>
6b76373d886ffd28d751c37a78fe08fbbb438d4c221c7664fe429ac58b9bb3ba.png
simple
<table><tr><td></td><td><i>N</i></td><td>%</td></tr><tr><td>Clinic location</td><td></td><td></td></tr><tr><td> Rural</td><td>18</td><td>60</td></tr><tr><td> Urban</td><td>5</td><td>17</td></tr><tr><td> Peri-urban</td><td>7</td><td>23</td></tr><tr><td>Clinic type</td><td></td><td></td></tr><tr><td> Quaternary/tertiary</td><td>1</td><td>3</td></tr><tr><td> Secondary</td><td>1</td><td>3</td></tr><tr><td> Primary</td><td>28</td><td>93</td></tr><tr><td>Public/private</td><td></td><td></td></tr><tr><td> Public</td><td>27</td><td>90</td></tr><tr><td> Private</td><td>0</td><td>0</td></tr><tr><td> Mixed</td><td>3</td><td>10</td></tr><tr><td>NGO support</td><td></td><td></td></tr><tr><td> None</td><td>17</td><td>57</td></tr><tr><td> One</td><td>5</td><td>17</td></tr><tr><td> Multiple</td><td>8</td><td>26</td></tr><tr><td>Year of pMTCT initiation</td><td></td><td></td></tr><tr><td> Before 2005</td><td>5</td><td>17</td></tr><tr><td> Between 2006 and 2008</td><td>21</td><td>70</td></tr><tr><td> After 2008</td><td>4</td><td>13</td></tr><tr><td>Other characteristics</td><td>Mean</td><td>Median</td></tr><tr><td> Distance to reference laboratory (km)</td><td>22</td><td>16</td></tr><tr><td> Catchment population (people)</td><td>27,774</td><td>19,644</td></tr><tr><td> No. 1st ANC visits in the last 6 months</td><td>674</td><td>468</td></tr><tr><td> No. institutional births in the last 6 months</td><td>482</td><td>257</td></tr><tr><td> No. post-partum visits in the last 6 months</td><td>418</td><td>189</td></tr></table>
1b357d3df36d7125bed00fe4279f1e4de6dedc46cff093eb89fd2a4081df2363.png
simple
<table><tr><td>Exposure</td><td>Study groups</td><td></td><td></td></tr><tr><td>Serum<sup>b</sup></td><td>Infections</td><td>White blood cells</td><td>Lymphocyte subsets</td></tr><tr><td>CB 28+52+101</td><td>4 (3&#8211;427)</td><td>4 (3&#8211;427)</td><td>4 (3&#8211;19)</td></tr><tr><td>CB-153</td><td>60 (23&#8211;179)</td><td>57 (23&#8211;158)</td><td>59 (23&#8211;158)</td></tr><tr><td>Di-<i>ortho </i>PCB</td><td>131 (44&#8211;362)</td><td>127 (44&#8211;342)</td><td>129 (44&#8211;342)</td></tr><tr><td>Mono-<i>ortho </i>PCB TEQ</td><td>4 (1&#8211;20)</td><td>4 (1&#8211;11)</td><td>4 (1&#8211;9)</td></tr><tr><td><i>p,p'</i>-DDE</td><td>88 (21&#8211;622)</td><td>85 (24&#8211;622)</td><td>83 (29&#8211;622)</td></tr><tr><td>Mother's milk exposure<sup>c</sup></td><td></td><td></td><td></td></tr><tr><td>CB 28+52+101</td><td>8 (0&#8211;155)</td><td>8 (0&#8211;76)</td><td>9 (0&#8211;39)</td></tr><tr><td>CB-153</td><td>187 (0&#8211;853)</td><td>174 (0&#8211;396)</td><td>186 (0&#8211;396)</td></tr><tr><td>Di-<i>ortho </i>PCB</td><td>364 (0&#8211;1666)</td><td>351 (0&#8211;830)</td><td>372 (0&#8211;830)</td></tr><tr><td>Mono-<i>ortho </i>PCB TEQ</td><td>11 (0&#8211;54)</td><td>11 (0&#8211;26)</td><td>11 (0&#8211;26)</td></tr><tr><td><i>p,p'</i>-DDE</td><td>311 (0&#8211;2199)</td><td>289 (0&#8211;2199)</td><td>306 (0&#8211;2199)</td></tr></table>
98c1011578002bc1b0b4b555445477896756dab34803dbfd2f76e8b421d1950a.png
simple
<table><tr><td>Variable</td><td>Category</td><td>C<sub>m</sub></td><td>C<sub>c</sub></td><td>C<sub>i</sub></td><td>C<sub>a</sub></td><td>TFR</td></tr><tr><td>Religion</td><td>Catholic</td><td>0.756688</td><td>0.81124</td><td>0.72359</td><td>1.0</td><td>6.8</td></tr><tr><td></td><td>Protestant</td><td>0.688570</td><td>0.76740</td><td>0.74156</td><td>1.0</td><td>6.0</td></tr><tr><td></td><td>Moslem</td><td>0.723129</td><td>0.71102</td><td>0.75700</td><td>1.0</td><td>6.0</td></tr><tr><td></td><td>Other</td><td>0.677555</td><td>0.78402</td><td>0.73206</td><td>1.0</td><td>5.9</td></tr><tr><td>Region</td><td>Kampala</td><td>0.532694</td><td>0.52907</td><td>0.81400</td><td>1.0</td><td>3.5</td></tr><tr><td></td><td>Central</td><td>0.680401</td><td>0.66009</td><td>0.76805</td><td>1.0</td><td>5.3</td></tr><tr><td></td><td>Eastern</td><td>0.776696</td><td>0.79588</td><td>0.74267</td><td>1.0</td><td>7.0</td></tr><tr><td></td><td>Northern</td><td>0.773491</td><td>0.90037</td><td>0.69493</td><td>1.0</td><td>7.4</td></tr><tr><td></td><td>Western</td><td>0.749218</td><td>0.77022</td><td>0.73475</td><td>1.0</td><td>6.5</td></tr><tr><td>Residence</td><td>Rural</td><td>0.761407</td><td>0.81240</td><td>0.72966</td><td>1.0</td><td>6.9</td></tr><tr><td></td><td>Urban</td><td>0.562910</td><td>0.56882</td><td>0.79239</td><td>1.0</td><td>3.9</td></tr><tr><td>Wealth Index</td><td>Poorest</td><td>0.815166</td><td>0.92263</td><td>0.71200</td><td>1.0</td><td>8.2</td></tr><tr><td></td><td>Poor</td><td>0.767808</td><td>0.85478</td><td>0.71023</td><td>1.0</td><td>7.1</td></tr><tr><td></td><td>Middle</td><td>0.739220</td><td>0.81104</td><td>0.71968</td><td>1.0</td><td>6.6</td></tr><tr><td></td><td>Richer</td><td>0.759015</td><td>0.73921</td><td>0.75614</td><td>1.0</td><td>6.5</td></tr><tr><td></td><td>Richest</td><td>0.577128</td><td>0.53849</td><td>0.79618</td><td>1.0</td><td>3.8</td></tr><tr><td>Education</td><td>None</td><td>0.830933</td><td>0.89279</td><td>0.70547</td><td>1.0</td><td>8.0</td></tr><tr><td></td><td>Primary</td><td>0.748226</td><td>0.78791</td><td>0.73233</td><td>1.0</td><td>6.6</td></tr><tr><td></td><td>Secondary +</td><td>0.611473</td><td>0.56484</td><td>0.79904</td><td>1.0</td><td>4.2</td></tr><tr><td>TOTAL</td><td>UGANDA</td><td>0.722717</td><td>0.78179</td><td>0.73502</td><td>1.0</td><td>6.4</td></tr></table>
13d306ca145b950da438fc5c35c7dc0c928a43b1c5054c72293a46c2e9542a25.png
simple
<table><tr><td>Profession</td><td>Round 1</td><td>Round 2</td><td>Round 3</td></tr><tr><td>P-HEMS doctors</td><td>21</td><td>16</td><td>15</td></tr><tr><td>P-HEMS nurses</td><td>14</td><td>12</td><td>12</td></tr><tr><td>EMS nurses</td><td>28</td><td>27</td><td>26</td></tr><tr><td>Dispatch centre operators</td><td>14</td><td>12</td><td>11</td></tr><tr><td>Trauma surgeons</td><td>22</td><td>24</td><td>21</td></tr><tr><td>Total respondents</td><td>83</td><td>79</td><td>71</td></tr></table>
43a616e7a1f36fd5fee5d75cfc4c15e127c4a7dcd45b291ee09b8f4123c6309c.png
simple
<table><tr><td></td><td></td><td>Hierarchical clustering</td><td>CCA</td><td>TribeMCL</td><td>Spectral clustering</td></tr><tr><td>Cluster count</td><td>Significant</td><td>243</td><td>243</td><td>245</td><td>235</td></tr><tr><td></td><td>All</td><td>293</td><td>307</td><td>332</td><td>308</td></tr><tr><td></td><td>Ratio</td><td>0.829</td><td>0.792</td><td>0.738</td><td>0.763</td></tr><tr><td>Total cluster size</td><td>Significant</td><td>1,166</td><td>1,858</td><td>3,600</td><td>4,863</td></tr><tr><td></td><td>All</td><td>1,396</td><td>2,144</td><td>4,047</td><td>5,380</td></tr><tr><td></td><td>Ratio</td><td>0.835</td><td>0.866</td><td>0.889</td><td>0.903</td></tr></table>
40ede6d239b80006a1046ef017783831a632be6b4e10cf6bd7c55edbe797cc31.png
simple
<table><tr><td>missing rate(%)</td><td>KNN</td><td>SKNN</td><td>EM-SKNN</td><td>MI</td><td>MLE</td></tr><tr><td>10</td><td>0.2171</td><td>0.2247</td><td>0.2239</td><td>0.1573</td><td>0.2112</td></tr><tr><td>20</td><td>0.2233</td><td>0.2223</td><td>0.2175</td><td>0.2171</td><td>0.2602</td></tr><tr><td>30</td><td>0.2422</td><td>0.2285</td><td>0.2224</td><td>0.2277</td><td>0.2907</td></tr><tr><td>40</td><td>0.2778</td><td>0.2369</td><td>0.2288</td><td>0.2380</td><td>0.3079</td></tr><tr><td>50</td><td>0.3155</td><td>0.2450</td><td>0.2349</td><td>0.2495</td><td>0.3237</td></tr><tr><td>60</td><td>0.3210</td><td>0.2487</td><td>0.2476</td><td>0.2627</td><td>0.3381</td></tr></table>
3df8330162e4eb55b76a2a26cc0825cf2e223732d63445d52ae053497de8d2de.png
simple
<table><tr><td>Primer name</td><td>Primer sequence (5&#8242;&#8211;3&#8242;)</td></tr><tr><td>Block-E1</td><td>CTACAAATCTTGTTACGCGGTATTA</td></tr><tr><td><i>argX-hisR</i> 5&#8242; intergenic region</td><td>CAGCTCAAGCGCCGGGACTA</td></tr><tr><td><i>argX-hisR</i> centre intergenic region</td><td>TATTACTACCACCGCAGC</td></tr><tr><td>Block-E2</td><td>TTGTCACAACTTCTAATAA</td></tr><tr><td>Block-E3</td><td>TTTTAGTTCAATTCTTTAAAGTCG</td></tr><tr><td>Block-E4</td><td>AATACTGCTTTTTGAATTTTTAG</td></tr></table>
b202fa9cc678ccce76b46557928da832d8961da221290c0bae0157e25500c9b8.png
simple
<table><tr><td>Sample</td><td>Average Coverage after 1 s of SP</td><td>Coverage Standard Deviation after 1 s of SP</td><td>AR Coeff.</td><td><i>t</i> (98%) [s]</td></tr><tr><td>CD</td><td>65</td><td>3.0</td><td>1.05</td><td>3.71</td></tr><tr><td>A36</td><td>89</td><td>3.7</td><td>2.18</td><td>1.79</td></tr><tr><td>A72</td><td>67</td><td>2.9</td><td>1.10</td><td>3.57</td></tr><tr><td>A210</td><td>83</td><td>3.9</td><td>1.75</td><td>2.24</td></tr><tr><td>A360</td><td>77</td><td>4.1</td><td>1.45</td><td>2.69</td></tr><tr><td>S1300</td><td>60</td><td>3.3</td><td>0.92</td><td>4.28</td></tr><tr><td>S1400</td><td>73</td><td>2.6</td><td>1.31</td><td>2.98</td></tr></table>
f3e833afdcd1c4474d3c1c495136492ddf7be3f8359689fc6c4a94d0f4a85300.png
complex
<table><tr><td>Characteristic</td><td colspan="2">All women (<i>n = 543</i>)</td><td colspan="2">Subset (<i>n = 147</i>)</td><td><i>p</i> value</td></tr><tr><td>Variables</td><td><i>n</i></td><td>Mean &#177; SD</td><td><i>n</i></td><td>Mean &#177; SD</td><td></td></tr><tr><td>Age (years)</td><td>542</td><td>34.9 &#177; 11.3</td><td>147</td><td>25.5 &#177; 5.0</td><td>&lt;0.001</td></tr><tr><td></td><td></td><td>Median &#177; IQR</td><td></td><td>Median &#177; IQR</td><td></td></tr><tr><td>Water As (&#956;g/L)</td><td>526</td><td>32.9 &#177; 269.4</td><td>146</td><td>17.2 &#177; 120.4</td><td>0.02</td></tr><tr><td>Toenail As (&#956;g/g)</td><td>540</td><td>2.70 &#177; 6.97</td><td>145</td><td>2.12 &#177; 3.65</td><td>0.10</td></tr><tr><td></td><td></td><td>%</td><td></td><td>%</td><td></td></tr><tr><td>Skin Lesions</td><td></td><td></td><td></td><td></td><td>0.80</td></tr><tr><td>No</td><td>272</td><td>50.18</td><td>72</td><td>48.98</td><td></td></tr><tr><td>Yes</td><td>270</td><td>49.82</td><td>75</td><td>51.02</td><td></td></tr><tr><td>Body Mass Index (kg/m<sup>2</sup>)</td><td></td><td></td><td></td><td></td><td>0.70</td></tr><tr><td>&lt;18.5</td><td>158</td><td>29.10</td><td>44</td><td>29.93</td><td></td></tr><tr><td>18.5&#8211;24.9</td><td>332</td><td>61.14</td><td>92</td><td>62.59</td><td></td></tr><tr><td>&#8805;25</td><td>53</td><td>9.76</td><td>11</td><td>7.48</td><td></td></tr><tr><td>Marital Status</td><td></td><td></td><td></td><td></td><td>&lt;0.001</td></tr><tr><td>Not married</td><td>72</td><td>13.33</td><td>37</td><td>25.17</td><td></td></tr><tr><td>Ever married</td><td>468</td><td>86.67</td><td>110</td><td>74.83</td><td></td></tr><tr><td>Education</td><td></td><td></td><td></td><td></td><td>&lt;0.001</td></tr><tr><td>No formal education</td><td>318</td><td>58.56</td><td>53</td><td>36.1</td><td></td></tr><tr><td>Primary</td><td>74</td><td>13.63</td><td>17</td><td>11.56</td><td></td></tr><tr><td>Secondary and above</td><td>150</td><td>27.62</td><td>77</td><td>52.38</td><td></td></tr><tr><td>Chews betel nut</td><td></td><td></td><td></td><td></td><td>&lt;0.001</td></tr><tr><td>No</td><td>385</td><td>71.2</td><td>131</td><td>89.7</td><td></td></tr><tr><td>Yes</td><td>156</td><td>28.8</td><td>15</td><td>10.3</td><td></td></tr><tr><td>Water Arsenic</td><td></td><td></td><td></td><td></td><td>0.16</td></tr><tr><td>&#8804;10 ug/L</td><td>196</td><td>36.10</td><td>65</td><td>44.22</td><td></td></tr><tr><td>10&#8211;50 ug/L</td><td>130</td><td>23.94</td><td>34</td><td>23.13</td><td></td></tr><tr><td>&gt;50 ug/L</td><td>217</td><td>39.96</td><td>48</td><td>32.65</td><td></td></tr><tr><td>Hemoglobin (g/L)</td><td></td><td></td><td></td><td></td><td>0.99</td></tr><tr><td>Normal (Hb &#8805;120 g/L)</td><td>443</td><td>81.58</td><td>120</td><td>81.63</td><td></td></tr><tr><td>Anemia (Hb &lt;120 g/L)</td><td>100</td><td>18.42</td><td>27</td><td>18.37</td><td></td></tr></table>
f4afc5b25196d5967af07a2a750dbfbc6208017f4b2003dc2c9700409c656f7a.png
simple
<table><tr><td>Year Post Op</td><td>Glenoid Loosening</td><td>Bearing failure</td><td>Infection</td><td>Dislocation</td></tr><tr><td>1</td><td>0</td><td>0</td><td>0</td><td>0</td></tr><tr><td>2</td><td>0</td><td>1</td><td>0</td><td>0</td></tr><tr><td>3</td><td>0</td><td>0</td><td>0</td><td>1</td></tr><tr><td>4</td><td>0</td><td>0</td><td>0</td><td>0</td></tr><tr><td>Total</td><td>0</td><td>1</td><td>0</td><td>1</td></tr></table>
a5b2fd70fce589c11b3d55cc88591907e3897dff9451198ae3cbeaa59e062e55.png
simple
<table><tr><td>WHO region</td><td>ILO LABORSTA (farm worker average wage)</td><td>World Bank (average value per agricultural worker)</td><td>ILO (minimum wage)</td><td>US State Department (minimum wage)</td><td>Overall average &#8211; maximum of sources<sup>a</sup></td><td>Overall average &#8211; minimum of sources<sup>a</sup></td></tr><tr><td>AMRO</td><td>$6.90</td><td>$27.36</td><td>$5.27</td><td>$5.17</td><td>$27.36</td><td>$5.11</td></tr><tr><td>AFRO</td><td>$1.92</td><td>$8.18</td><td>$2.06</td><td>$2.16</td><td>$9.05</td><td>$1.01</td></tr><tr><td>EMRO</td><td>$4.84</td><td>$18.26</td><td>$3.19</td><td>$5.00</td><td>$18.26</td><td>$3.00</td></tr><tr><td>WPRO</td><td>$5.36</td><td>$9.06</td><td>$6.81</td><td>$6.74</td><td>$10.70</td><td>$4.98</td></tr><tr><td>SEARO</td><td>$1.80</td><td>$3.47</td><td>$1.77</td><td>$3.75</td><td>$4.04</td><td>$1.47</td></tr><tr><td>Average</td><td>$2.02</td><td>$5.10</td><td>$2.10</td><td>$3.42</td><td>$5.84</td><td>$1.50</td></tr></table>
ec9a5a92ab97f052859117d4dfc3a9f6bf410e3f0cd7663197defdc32fc1a750.png
simple
<table><tr><td>Subject</td><td>Gender</td><td>Age (yrs)</td><td>Etiology</td><td>Deafness (yrs)</td><td>CI side</td><td>CI experience (mos)</td><td>CVC (Ph%)</td><td>Implant</td></tr><tr><td>S1</td><td>Male</td><td>60</td><td>Familial</td><td>46</td><td>Left</td><td>160</td><td>93</td><td>Clarion CII</td></tr><tr><td>S2</td><td>Male</td><td>51</td><td>Progressive</td><td>25</td><td>Right</td><td>124</td><td>76</td><td>HiRes 90K</td></tr><tr><td>S3</td><td>Female</td><td>74</td><td>Familial</td><td>22</td><td>Left</td><td>114</td><td>93</td><td>HiRes 90K</td></tr><tr><td>S4</td><td>Male</td><td>58</td><td>Unknown</td><td>11</td><td>Right</td><td>31</td><td>93</td><td>HiRes 90K</td></tr><tr><td>S5</td><td>Male</td><td>67</td><td>Familial</td><td>67</td><td>Right</td><td>96</td><td>86</td><td>HiRes 90K</td></tr><tr><td>S6</td><td>Male</td><td>57</td><td>Familial</td><td>45</td><td>Right</td><td>174</td><td>96</td><td>Clarion CII</td></tr><tr><td>S7</td><td>Female</td><td>67</td><td>Meningitis</td><td>6</td><td>Left + right</td><td>73</td><td>88</td><td>HiRes 90K</td></tr><tr><td>S8</td><td>Female</td><td>43</td><td>Meningitis</td><td>5</td><td>Left + right</td><td>59</td><td>95</td><td>HiRes 90K</td></tr><tr><td>S9</td><td>Female</td><td>66</td><td>Unknown</td><td>35</td><td>Right</td><td>105</td><td>84</td><td>HiRes 90K</td></tr><tr><td>S10</td><td>Female</td><td>59</td><td>Type II Usher</td><td>4</td><td>Right</td><td>46</td><td>89</td><td>HiRes 90K</td></tr><tr><td>S11</td><td>Female</td><td>65</td><td>Meniere</td><td>25</td><td>Right</td><td>149</td><td>92</td><td>Clarion CII</td></tr></table>
19c1f36d44df02607910e521928ba9f125bf43cdca9a704c7f537fb3ea53fbbf.png
complex
<table><tr><td>Item</td><td colspan="2">Strongly Agree/Agree</td><td>QPCCC Subscale</td></tr><tr><td></td><td><i>n</i></td><td>% <sup>1</sup> (95% CIs)</td><td></td></tr><tr><td>The staff at the hospital showed respect for me</td><td>191</td><td>91.0 (87.1&#8211;94.8)</td><td>Respectful communication</td></tr><tr><td>The staff at the hospital talked to me in a way I could understand</td><td>188</td><td>90.8 (86.9&#8211;94.8)</td><td>Respectful communication</td></tr><tr><td>The staff at the hospital showed respect for my family or friends</td><td>183</td><td>87.6 (83.1&#8211;92.0)</td><td>Respectful communication</td></tr><tr><td>The staff at the hospital gave me information about cancer that was easy to understand</td><td>183</td><td>87.1 (82.6&#8211;91.7)</td><td>Cancer information</td></tr><tr><td>The staff at the hospital gave me information about cancer and treatments to take home (e.g., booklets, websites)</td><td>180</td><td>86.1 (81.4&#8211;90.8)</td><td>Cancer information</td></tr><tr><td>During my treatment, staff at the hospital made sure I received the treatment I was meant to have</td><td>182</td><td>85.8 (81.2&#8211;90.5)</td><td>Treatment delivery</td></tr><tr><td>The doctors at the hospital explained to me the short-term side effects of each treatment option</td><td>175</td><td>84.5 (79.6&#8211;89.5)</td><td>Treatment decision-making</td></tr><tr><td>The doctors at the hospital explained to me all of the treatments I could have</td><td>175</td><td>83.7 (78.7&#8211;88.7)</td><td>Treatment decision-making</td></tr><tr><td>During my treatment, staff at the hospital had up-to-date information about my cancer care</td><td>173</td><td>83.2 (78.1&#8211;88.3)</td><td>Treatment delivery</td></tr><tr><td>During my treatment, staff at the hospital made sure I received treatment that was based on scientific knowledge</td><td>169</td><td>82.0 (76.8&#8211;87.3)</td><td>Treatment delivery</td></tr><tr><td>During my treatment, staff at the hospital gave me consistent information about my treatment</td><td>169</td><td>80.9 (75.5&#8211;86.2)</td><td>Treatment delivery</td></tr><tr><td>During my treatment, staff at the hospital co-ordinated my appointments so that I did not have to go to hospital more than necessary</td><td>168</td><td>80.0 (74.6&#8211;85.4)</td><td>Treatment delivery</td></tr></table>
6e1d4aecae66f6ac94ccb71cd55a85c026837741a963e884d567f5489fce6251.png
complex
<table><tr><td rowspan="3">Place</td><td colspan="2">Age (years)</td><td colspan="2">Level of education (years of study)</td><td colspan="2">Income (R$)</td></tr><tr><td>Average</td><td>95%CI</td><td>Average</td><td>95%CI</td><td>Average</td><td>95%CI</td></tr><tr><td>Supermarket</td><td>29.8</td><td>29.2&#8211;30.3</td><td>8.2</td><td>7.9&#8211;8.5</td><td>871.58</td><td>797.09&#8211;946.07</td></tr><tr><td>Bakery</td><td>35.0</td><td>34.3&#8211;35.8</td><td>9.3</td><td>9.1&#8211;9.6</td><td>1459.60</td><td>1320.05&#8211;1599.16</td></tr><tr><td>Street food</td><td>31.4</td><td>30.9&#8211;32.0</td><td>8.5</td><td>8.2&#8211;8.8</td><td>829.99</td><td>765.29&#8211;894.69</td></tr><tr><td>Snack bar</td><td>32.0</td><td>31.7&#8211;32.3</td><td>9.5</td><td>9.3&#8211;9.6</td><td>1193.18</td><td>1146.81&#8211;1239.55</td></tr><tr><td>Restaurant</td><td>38.2</td><td>37.8&#8211;38.5</td><td>9.9</td><td>9.8&#8211;10.0</td><td>1656.98</td><td>1582.48&#8211;1731.48</td></tr><tr><td>Fruit shop</td><td>32.4</td><td>31.1&#8211;33.7</td><td>7.5</td><td>7.1&#8211;7.9</td><td>678.39</td><td>620.34&#8211;736.45</td></tr><tr><td>Other places</td><td>36.2</td><td>35.7&#8211;36.7</td><td>8.3</td><td>8.1&#8211;8.6</td><td>1035.99</td><td>972.49&#8211;1099.49</td></tr></table>
b73330801196b0b2ae46a49103d4685bbc43ba6c4104f79491352a6059bb1a96.png
complex
<table><tr><td></td><td>Name</td><td colspan="2">Screening</td><td colspan="8">Intervention</td><td>Follow-up</td></tr><tr><td></td><td>Duration</td><td colspan="2">12 months</td><td colspan="8">6 months</td><td>6 months</td></tr><tr><td>Visits</td><td>Time</td><td></td><td>Surgery</td><td>Days 1&#8211;3</td><td>Wk 2</td><td>Wk 4</td><td>Wk 8</td><td>Wk 12</td><td>Wk 16</td><td>Wk 20</td><td>Wk 24</td><td>Wk 48</td></tr><tr><td rowspan="4">Anamnesis</td><td>Anamnesis</td><td>X</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>X</td><td>X</td></tr><tr><td>Body weight</td><td>X</td><td></td><td></td><td>X</td><td>X</td><td>X</td><td>X</td><td>X</td><td>X</td><td>X</td><td>X</td></tr><tr><td>Anthropometry</td><td>X</td><td></td><td></td><td></td><td>X</td><td>X</td><td>X</td><td>X</td><td>X</td><td>X</td><td>X</td></tr><tr><td>Dietary assessment, BDI</td><td>X</td><td></td><td></td><td></td><td>X</td><td></td><td>X</td><td></td><td></td><td>X</td><td>X</td></tr><tr><td>Bone density</td><td>DEXA</td><td>X</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>X</td><td>X</td></tr><tr><td rowspan="2">Liver and microbiota</td><td>FibroScan and CAP<sup>TM</sup></td><td>X</td><td></td><td></td><td></td><td>X</td><td></td><td>X</td><td></td><td></td><td>X</td><td>X</td></tr><tr><td>Stool samples</td><td>X</td><td></td><td></td><td></td><td>X</td><td></td><td>X</td><td></td><td></td><td>X</td><td>X</td></tr><tr><td>Biopsies</td><td>Liver, SAT, VAT</td><td></td><td>X</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td rowspan="2">Supplementation</td><td>Loading dose</td><td></td><td></td><td>X</td><td>X</td><td>X</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Maintenance dose</td><td></td><td></td><td></td><td></td><td>X</td><td>X</td><td>X</td><td>X</td><td>X</td><td>X</td><td>X</td></tr><tr><td rowspan="6">Blood parameter</td><td>Vitamin D</td><td>X</td><td></td><td></td><td>X</td><td>X</td><td>X</td><td>X</td><td>X</td><td>X</td><td>X</td><td>X</td></tr><tr><td>Biochemical</td><td>X</td><td></td><td></td><td>X</td><td>X</td><td>X</td><td>X</td><td>X</td><td>X</td><td>X</td><td>X</td></tr><tr><td>Liver</td><td>X</td><td></td><td></td><td></td><td>X</td><td></td><td>X</td><td></td><td></td><td>X</td><td>X</td></tr><tr><td>Inflammation</td><td>X</td><td></td><td></td><td>X</td><td>X</td><td>X</td><td>X</td><td>X</td><td>X</td><td>X</td><td>X</td></tr><tr><td>Insulin resistance</td><td>X</td><td></td><td></td><td>X</td><td>X</td><td>X</td><td>X</td><td>X</td><td>X</td><td>X</td><td>X</td></tr><tr><td>Bone turnover</td><td>X</td><td></td><td></td><td></td><td>X</td><td></td><td>X</td><td></td><td></td><td>X</td><td>X</td></tr></table>
634964e8214d786ad7cd4256e360560644a751ca7b4958c427e8c8028776c966.png
complex
<table><tr><td rowspan="2">Drug category</td><td rowspan="2">Drug name</td><td colspan="2">Prescribed acutely</td><td colspan="2">Prescribed on discharge</td></tr><tr><td>No.</td><td>%</td><td>No.</td><td>%</td></tr><tr><td rowspan="4">Antiplatelet drugs</td><td>Aspirin</td><td>521</td><td>37.0</td><td>670</td><td>47.7</td></tr><tr><td>Clopidogrel</td><td>50</td><td>3.6</td><td>66</td><td>4.7</td></tr><tr><td>Dipyridamole</td><td>&lt; 10</td><td>&lt; 1</td><td>13</td><td>0.9</td></tr><tr><td>Aggrenox</td><td>&lt; 10</td><td>&lt; 1</td><td>12</td><td>0.9</td></tr><tr><td>Fibrinolytic</td><td>Alteplase</td><td>&lt; 10</td><td>&lt; 1</td><td>n/a</td><td></td></tr><tr><td rowspan="3">Anticoagulants</td><td>Warfarin</td><td>16</td><td>1.1</td><td>49</td><td>3.5</td></tr><tr><td>Heparin (subcutaneous)</td><td>333</td><td>23.7</td><td>n/a</td><td></td></tr><tr><td>Heparin (low molecular weight)</td><td>44</td><td>3.1</td><td>32</td><td>2.3</td></tr><tr><td>Statins</td><td>Simvastatin, Atorvastatin</td><td>304</td><td>21.6</td><td>681</td><td>48.4</td></tr></table>
44d1411477e583e1b57de2de2782a044046524997f3881d3ab2374a3bfef569a.png
simple
<table><tr><td>Boys</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>Special</td><td>New</td><td>Fashionable</td><td>Natural</td><td>Local</td><td>T city</td><td>T countryside</td></tr><tr><td>Biscuits and ice creams</td><td>65.3</td><td>18.7</td><td>44.6</td><td>28.7</td><td>11.2</td><td>35.1</td><td>11.2</td></tr><tr><td>Bread and pasta</td><td>80.0</td><td>8.3</td><td>31.7</td><td>73.3</td><td>16.7</td><td>23.3</td><td>10.0</td></tr><tr><td>Chocolate and snacks</td><td>64.3</td><td>22.6</td><td>49.0</td><td>31.5</td><td>11.1</td><td>38.2</td><td>4.5</td></tr><tr><td>Cold cuts</td><td>60.6</td><td>9.1</td><td>19.7</td><td>74.2</td><td>27.3</td><td>6.1</td><td>36.4</td></tr><tr><td>Dairy products</td><td>55.0</td><td>10.0</td><td>25.0</td><td>85.0</td><td>30.0</td><td>20.0</td><td>35.0</td></tr><tr><td>Eggs</td><td>80.0</td><td>10.0</td><td>20.0</td><td>70.0</td><td>0.0</td><td>10.0</td><td>20.0</td></tr><tr><td>Fat Meat</td><td>68.9</td><td>30.4</td><td>54.1</td><td>38.5</td><td>15.5</td><td>41.2</td><td>11.5</td></tr><tr><td>Filled cakes and sweets</td><td>72.2</td><td>14.8</td><td>50.9</td><td>31.5</td><td>21.3</td><td>35.2</td><td>6.5</td></tr><tr><td>Fish</td><td>75.0</td><td>0.0</td><td>50.0</td><td>75.0</td><td>25.0</td><td>50.0</td><td>25.0</td></tr><tr><td>Fried fish</td><td>50.0</td><td>37.5</td><td>12.5</td><td>50.0</td><td>0.0</td><td>37.5</td><td>37.5</td></tr><tr><td>Fried potatoes</td><td>80.2</td><td>33.7</td><td>60.4</td><td>24.8</td><td>9.9</td><td>48.5</td><td>6.9</td></tr><tr><td>Juices and drinks</td><td>56.3</td><td>34.4</td><td>46.9</td><td>18.8</td><td>15.6</td><td>37.5</td><td>9.4</td></tr><tr><td>Lean meet</td><td>58.0</td><td>4.3</td><td>26.1</td><td>84.1</td><td>11.6</td><td>15.9</td><td>18.8</td></tr><tr><td>Non-sweet fruits and cereals</td><td>69.2</td><td>23.1</td><td>30.8</td><td>69.2</td><td>15.4</td><td>23.1</td><td>30.8</td></tr><tr><td>Oils and condiments</td><td>32.9</td><td>9.2</td><td>26.3</td><td>69.7</td><td>3.9</td><td>22.4</td><td>23.7</td></tr><tr><td>Pizza</td><td>85.5</td><td>21.8</td><td>58.2</td><td>43.6</td><td>30.9</td><td>40.0</td><td>9.1</td></tr><tr><td>Sweet fruit</td><td>100.0</td><td>0.0</td><td>0.0</td><td>100.0</td><td>0.0</td><td>0.0</td><td>0.0</td></tr><tr><td>Vegetables</td><td>50.0</td><td>11.1</td><td>22.2</td><td>88.9</td><td>22.2</td><td>5.6</td><td>22.2</td></tr><tr><td>OVERALL</td><td>65.8</td><td>19.8</td><td>44.1</td><td>42.7</td><td>14.2</td><td>33.2</td><td>12.0</td></tr><tr><td>Girls</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>Special</td><td>New</td><td>Fashionable</td><td>Natural</td><td>Local</td><td>T city</td><td>T countryside</td></tr><tr><td>Biscuits and ice creams</td><td>61.1</td><td>13.7</td><td>35.8</td><td>30.5</td><td>15.0</td><td>24.8</td><td>8.0</td></tr><tr><td>Bread and pasta</td><td>55.5</td><td>7.8</td><td>15.6</td><td>55.5</td><td>18.8</td><td>14.1</td><td>14.8</td></tr><tr><td>Chocolate and snacks</td><td>64.1</td><td>26.4</td><td>47.3</td><td>28.8</td><td>12.0</td><td>30.7</td><td>4.6</td></tr><tr><td>Cold cuts</td><td>58.1</td><td>13.5</td><td>28.4</td><td>66.2</td><td>35.1</td><td>5.4</td><td>20.3</td></tr><tr><td>Dairy products</td><td>56.0</td><td>12.0</td><td>20.0</td><td>76.0</td><td>8.0</td><td>16.0</td><td>40.0</td></tr><tr><td>Eggs</td><td>57.1</td><td>14.3</td><td>28.6</td><td>85.7</td><td>14.3</td><td>42.9</td><td>14.3</td></tr><tr><td>Fat Meat</td><td>44.0</td><td>48.0</td><td>46.7</td><td>29.3</td><td>14.7</td><td>48.0</td><td>8.0</td></tr><tr><td>Filled cakes and sweets</td><td>67.0</td><td>24.7</td><td>37.1</td><td>32.0</td><td>16.5</td><td>30.9</td><td>9.3</td></tr><tr><td>Fish</td><td>20.0</td><td>0.0</td><td>0.0</td><td>80.0</td><td>40.0</td><td>20.0</td><td>40.0</td></tr><tr><td>Fried fish</td><td>25.0</td><td>100.0</td><td>25.0</td><td>50.0</td><td>50.0</td><td>75.0</td><td>0.0</td></tr><tr><td>Fried potatoes</td><td>68.6</td><td>34.3</td><td>50.5</td><td>27.6</td><td>11.4</td><td>41.9</td><td>4.8</td></tr><tr><td>Juices and drinks</td><td>60.0</td><td>42.9</td><td>60.0</td><td>17.1</td><td>17.1</td><td>37.1</td><td>2.9</td></tr><tr><td>Lean meet</td><td>67.8</td><td>11.9</td><td>30.5</td><td>76.3</td><td>22.0</td><td>8.5</td><td>13.6</td></tr><tr><td>Non-sweet fruits and cereals</td><td>35.7</td><td>7.1</td><td>35.7</td><td>71.4</td><td>42.9</td><td>14.3</td><td>35.7</td></tr><tr><td>Oils and condiments</td><td>41.4</td><td>8.1</td><td>25.2</td><td>66.7</td><td>16.2</td><td>7.2</td><td>18.0</td></tr><tr><td>Pizza</td><td>74.3</td><td>11.4</td><td>37.1</td><td>40.0</td><td>34.3</td><td>22.9</td><td>11.4</td></tr><tr><td>Sweet fruit</td><td>77.8</td><td>22.2</td><td>11.1</td><td>77.8</td><td>55.6</td><td>0.0</td><td>44.4</td></tr><tr><td>Vegetables</td><td>69.2</td><td>23.1</td><td>15.4</td><td>100.0</td><td>7.7</td><td>15.4</td><td>0.0</td></tr><tr><td>OVERALL</td><td>59.9</td><td>21.1</td><td>37.1</td><td>41.5</td><td>16.9</td><td>25.2</td><td>10.4</td></tr></table>
6d96c0ebecc34ded0b5b7f1a28e0ace9cb5db316c066f8782b1554dab4be7499.png
complex
<table><tr><td colspan="7">599C&gt;T GPX1 (rs1050450)</td></tr><tr><td></td><td></td><td colspan="2"></td><td></td><td colspan="2">Interaction</td></tr><tr><td></td><td></td><td>CC (<i>n</i> = 36)</td><td>CT + TT (<i>n</i> = 56)</td><td><i>p</i><sup>1</sup></td><td><i>F</i></td><td><i>p</i><sup>2</sup></td></tr><tr><td rowspan="2">BMI (kg/m<sup>2</sup>)</td><td>Before</td><td>33 &#177; 5 31</td><td>35 &#177; 5 33</td><td>0.001</td><td>0.68</td><td>0.412</td></tr><tr><td>After</td><td>30 &#177; 3 30<sup>a**</sup></td><td>33 &#177; 4 32<sup>a**</sup></td><td>0.003</td><td></td><td></td></tr><tr><td rowspan="2">SBP (mgHg)</td><td>Before</td><td>120 &#177; 9120</td><td>124 &#177; 10,120</td><td>0.117</td><td>0.17</td><td>0.684</td></tr><tr><td>After</td><td>114 &#177; 13120<sup>a**</sup></td><td>119 &#177; 13120<sup>a**</sup></td><td>0.049</td><td></td><td></td></tr><tr><td rowspan="2">DBP (mgHg)</td><td>Before</td><td>85 &#177; 14 79</td><td>88 &#177; 8.9 88</td><td>0.375</td><td>21.19</td><td>&lt; 0.001</td></tr><tr><td>After</td><td>77 &#177; 8.4 75</td><td>79 &#177; 7.1 79<sup>a**</sup></td><td>0.011</td><td></td><td></td></tr><tr><td rowspan="2">TBARS (mg/dl)</td><td>Before</td><td>1.61 &#177; 0.61 1.40</td><td>1.34 &#177; 0.61 1.32</td><td>0.031</td><td>2.71</td><td>0.103</td></tr><tr><td>After</td><td>1.08 &#177; 0.42 1.06<sup>a**</sup></td><td>1.01 &#177; 0.45 1.02<sup>a*</sup></td><td>0.611</td><td></td><td></td></tr><tr><td rowspan="2">Glucose (mg/dl)</td><td>Before</td><td>127 &#177; 73,104</td><td>126 &#177; 68,105</td><td>0.600</td><td>0.79</td><td>0.374</td></tr><tr><td>After</td><td>102 &#177; 29 99<sup>a**</sup></td><td>105 &#177; 25 99<sup>a**</sup></td><td>0.990</td><td></td><td></td></tr><tr><td rowspan="2">Total cholesterol (mg/dl)</td><td>Before</td><td>176 &#177; 57,161</td><td>169 &#177; 34,169</td><td>0.489</td><td>1.11</td><td>0.295</td></tr><tr><td>After</td><td>159 &#177; 43,152</td><td>150 &#177; 27 150<sup>b**</sup></td><td>0.384</td><td></td><td></td></tr><tr><td rowspan="2">LDL-C (mg/dl)</td><td>Before</td><td>117.9 &#177; 52.1107</td><td>126.5 &#177; 50.4125</td><td>0.174</td><td>0.01</td><td>0.914</td></tr><tr><td>After</td><td>93.7 &#177; 35.8 89<sup>a**</sup></td><td>102.6 &#177; 38.9 95.5<sup>a**</sup></td><td>0.347</td><td></td><td></td></tr><tr><td>Triglycerides (mg/dl)</td><td>Before</td><td>163.1 &#177; 32.3157</td><td>154.8 &#177; 39.2147</td><td>0.153</td><td>0.05</td><td>0.822</td></tr><tr><td></td><td>After</td><td>161 &#177; 73.5 156<sup>a*</sup></td><td>149 &#177; 48.7138</td><td>0.660</td><td></td><td></td></tr><tr><td rowspan="2">Atherogenic index</td><td>Before</td><td>4.5 &#177; 3.3 4</td><td>4.1 &#177; 1.1 4.3</td><td>0.955</td><td>2.52</td><td>0.116</td></tr><tr><td>After</td><td>3.8 &#177; 1.5 3.5</td><td>3.6 &#177; 1.4 3.3<sup>a*</sup></td><td>0.033</td><td></td><td></td></tr></table>
b207d6a0086aef3df04b9d59da7912a864ccf5a25ec273e4baab06cc982967bf.png
complex
<table><tr><td rowspan="2">EtOH volume (ml)</td><td rowspan="2">Equation (1) diameter (nm)</td><td colspan="2">DLS</td><td colspan="2">SEM</td></tr><tr><td>Diameter (nm)</td><td>PDI</td><td>Diameter (nm)</td><td>SD</td></tr><tr><td>41</td><td>390</td><td>397</td><td>0.041</td><td>391</td><td>54</td></tr><tr><td>45</td><td>360</td><td>400</td><td>0.036</td><td>393</td><td>48</td></tr><tr><td>47</td><td>346</td><td>350</td><td>0.111</td><td>320</td><td>47</td></tr><tr><td>50</td><td>326</td><td>369</td><td>0.028</td><td>343</td><td>27</td></tr><tr><td>53</td><td>307</td><td>282</td><td>0.028</td><td>300</td><td>28</td></tr><tr><td>55</td><td>295</td><td>278</td><td>0.002</td><td>291</td><td>27</td></tr><tr><td>57</td><td>283</td><td>288</td><td>0.040</td><td>307</td><td>28</td></tr><tr><td>60</td><td>267</td><td>270</td><td>0.087</td><td>267</td><td>22</td></tr><tr><td>62</td><td>256</td><td>259</td><td>0.050</td><td>252</td><td>22</td></tr><tr><td>64</td><td>246</td><td>242</td><td>0.007</td><td>254</td><td>35</td></tr><tr><td>67</td><td>232</td><td>249</td><td>0.025</td><td>260</td><td>27</td></tr><tr><td>73</td><td>206</td><td>207</td><td>0.036</td><td>210</td><td>20</td></tr><tr><td>78</td><td>186</td><td>181</td><td>0.016</td><td>187</td><td>24</td></tr><tr><td>83</td><td>168</td><td>159</td><td>0.024</td><td>173</td><td>37</td></tr></table>
a21a4eeda8faa2c99a5196651d96b1da1bc9719bb0771af1a3200bfbe066fd50.png
complex
<table><tr><td rowspan="2" colspan="2">Phenotype</td><td colspan="3">Frequency (<i>n </i>(%))</td><td colspan="2">Genotype concordance (%)</td></tr><tr><td><i>HLA-B27</i>-positive<sup>&#945;</sup></td><td>rs4349859-positive<sup>b</sup></td><td>rs116488202-positive</td><td>rs4349859</td><td>rs116488202</td></tr><tr><td>Controls</td><td>Caucasian</td><td>9/117 (7.7)</td><td>9/117 (7.7)</td><td>9/117 (7.7)</td><td>100.0</td><td>100.0</td></tr><tr><td> </td><td>New Zealand Ma&#772;ori</td><td>7/107 (6.5)</td><td>6/107 (5.6)</td><td>6/107 (5.6)</td><td>85.7</td><td>85.7</td></tr><tr><td>AS</td><td>Overall</td><td>164/176 (93.2)</td><td>159/176 (90.3)</td><td>159/176 (90.3)</td><td>96.9</td><td>97.6</td></tr><tr><td> </td><td>Caucasian</td><td>151/162 (93.2)</td><td>149/162 (91.9)<sup>c</sup></td><td>150/162 (92.6)<sup>d</sup></td><td>98.7</td><td>99.3</td></tr><tr><td> </td><td>New Zealand Ma&#772;ori</td><td>13/14 (92.9)</td><td>10/14 (71.4)</td><td>10/14 (71.4)</td><td>76.9</td><td>76.9</td></tr></table>
25438f0c11f997ca96753f915d1248de6e87fbca7ecba00c84d7257bb1d7de57.png
simple
<table><tr><td>Plant extracts</td><td>IC<sub>50</sub> values (<i>&#956;</i>g/mL) &#177; SD</td><td>Vitamin C equivalents for a 200 mg capsule (in g)</td></tr><tr><td>(1) <i>Rosmarinus officinalis</i> (McConnell's Blue)</td><td>3.48 &#177; 0.22</td><td>0.351</td></tr><tr><td>(2) <i>Rosmarinus officinalis</i> (Tuscan Blue)</td><td>10.84 &#177; 0.12</td><td>1.09</td></tr><tr><td>(3) <i>Lavandula-x-intermedia</i> (Margaret Roberts)</td><td>138.5 &#177; 4.0</td><td>14.0</td></tr><tr><td>(4) <i>Lavandula spica </i></td><td>125.5 &#177; 1.8</td><td>12.67</td></tr><tr><td>(5) <i>Origanum vulgare </i></td><td>26.43 &#177; 1.58</td><td>2.67</td></tr><tr><td>(6) <i>Petroselinum crispum </i></td><td>53.3 &#177; 2.63</td><td>5.38</td></tr><tr><td>(7) <i>Laurus nobilis </i></td><td>30.85 &#177; 0.48</td><td>3.12</td></tr><tr><td>(8) <i>Thymus vulgaris </i></td><td>36.13 &#177; 0.85</td><td>3.65</td></tr><tr><td>(9) <i>Foeniculum vulgaris </i></td><td>38.36 &#177; 0.76</td><td>3.88</td></tr><tr><td>(10) <i>Capsicum annuum</i> (Paprika)</td><td>63.06 &#177; 1.91</td><td>6.27</td></tr><tr><td>(11) Vitamin C<sup>a</sup></td><td>1.98 &#177; 0.01</td><td>&#8212;</td></tr></table>
2f7d31924913c78bcff7b69079171fcf201250717a3e8c31b0a5ebb2de462282.png
complex
<table><tr><td></td><td>Standard low-fat diet</td><td>DHA low-fat diet</td><td>High saturated fat diet</td></tr><tr><td><i>N</i></td><td>18</td><td>20</td><td>19</td></tr><tr><td>Initial body mass (g)</td><td>318 &#177; 7</td><td>323 &#177; 4</td><td>323 &#177; 5</td></tr><tr><td>Final body mass (g)</td><td>488 &#177; 10</td><td>494 &#177; 8</td><td>554 &#177; 111<sup>,</sup>2</td></tr><tr><td>Change in body mass (g)</td><td>170 &#177; 9</td><td>171 &#177; 6</td><td>242 &#177; 151<sup>,</sup>2</td></tr><tr><td>LV mass (g)</td><td>0.98 &#177; 0.02</td><td>0.97 &#177; 0.02</td><td>1.02 &#177; 0.02</td></tr><tr><td>LV/tibia length (mg/mm)</td><td>23.85 &#177; 0.90</td><td>22.93 &#177; 0.51</td><td>24.52 &#177; 0.68</td></tr><tr><td>LV+RV/body weight (mg/g)</td><td>2.45 &#177; 0.03</td><td>2.39 &#177; 0.03</td><td>2.24 &#177; 0.031<sup>,</sup>2</td></tr><tr><td>LV/body weight (mg/g)</td><td>2.01 &#177; 0.03</td><td>1.96 &#177; 0.03</td><td>1.85 &#177; 0.021<sup>,</sup>2</td></tr><tr><td>Epididymal fat mass (g)</td><td>9.24 &#177; 0.85</td><td>7.27 &#177; 0.42</td><td>14.12 &#177; 1.001<sup>,</sup>2</td></tr><tr><td>Retroperitoneal fat mass (g)</td><td>9.66 &#177; 1.23</td><td>7.79 &#177; 0.48</td><td>14.08 &#177; 1.021<sup>,</sup>2</td></tr><tr><td colspan="4">Echocardiography data</td></tr><tr><td> EDD (mm)</td><td>7.5 &#177; 0.3</td><td>7.3 &#177; 0.2</td><td>7.2 &#177; 0.2</td></tr><tr><td> ESD (mm)</td><td>3.7 &#177; 0.2</td><td>3.7 &#177; 0.2</td><td>3.6 &#177; 0.2</td></tr><tr><td> End diastolic volume (mL)</td><td>0.47 &#177; 0.05</td><td>0.43 &#177; 0.03</td><td>0.41 &#177; 0.04</td></tr><tr><td> End systolic volume (mL)</td><td>0.06 &#177; 0.01</td><td>0.06 &#177; 0.01</td><td>0.06 &#177; 0.01</td></tr><tr><td> EF (%)</td><td>88.1 &#177; 1.2</td><td>86.3 &#177; 1.7</td><td>86.9 &#177; 1.5</td></tr><tr><td> Absolute wall thickness (mm)</td><td>4.5 &#177; 0.2</td><td>4.4 &#177; 0.2</td><td>4.3 &#177; 0.2</td></tr><tr><td> Relative wall thickness (mm)</td><td>0.6 &#177; 0.1</td><td>0.6 &#177; 0.0</td><td>0.6 &#177; 0.0</td></tr></table>
3c5d440b87456f423ddabf78bda209c5408e91a9d4bed5330a2df7cd45589a7e.png
simple
<table><tr><td>Patient</td><td>Gender</td><td>Basal CD4<sup>+</sup>(cells/mm<sup>3</sup>)</td><td>HCV VL range (log<sub>10</sub> UI/mL)<sup>&#8224;</sup></td><td>Fibrosis grade (METAVIR score)</td><td>Response to IFN-based therapy</td><td>Sampling times<sup><i>&#8727;</i></sup></td></tr><tr><td>A</td><td>F</td><td>U</td><td>&lt;2.78&#8211;6.5</td><td>0</td><td>R</td><td>0, 24 h, 4 wk, 12 wk, 24 wk, 48 wk, 72 wk</td></tr><tr><td>B</td><td>F</td><td>644</td><td>4.5&#8211;6.7</td><td>4</td><td>NR</td><td>0, 24 h, 4 wk, 12 wk, 24 wk</td></tr><tr><td>C</td><td>M</td><td>304</td><td>5.3&#8211;6.8</td><td>2</td><td>NR</td><td>0, 24 h, 4 wk, 12 wk, 24 wk</td></tr><tr><td>E</td><td>M</td><td>957</td><td>&lt;2.78&#8211;6.1</td><td>3</td><td>NR</td><td>0, 24 h, 3 wk, 12 wk, 24 wk</td></tr><tr><td>G</td><td>M</td><td>376</td><td>&lt;2.78&#8211;6.8</td><td>2</td><td>NR</td><td>0, 24 h, 4 wk, 12 wk, 24 wk, 48 wk, 72 wk</td></tr><tr><td>H</td><td>M</td><td>130</td><td>5.3&#8211;7.1</td><td>0</td><td>NR</td><td>0, 24 h, 4 wk, 24 wk</td></tr><tr><td>J</td><td>M</td><td>817</td><td>3.6&#8211;7.1</td><td>1</td><td>NR</td><td>0, 24 h, 4 wk, 12 wk, 24 wk</td></tr><tr><td>K</td><td>M</td><td>400</td><td>6.4&#8211;6.7</td><td>4</td><td>NR</td><td>0, 24 h, 4 wk, 12 wk</td></tr><tr><td>L</td><td>M</td><td>625</td><td>5.9&#8211;7.4</td><td>3</td><td>NR</td><td>0, 24 h, 4 wk, 12 wk</td></tr><tr><td>M</td><td>M</td><td>414</td><td>4.2&#8211;6.3</td><td>3</td><td>NR</td><td>0, 24 h, 4 wk, 12 wk, 24 wk</td></tr><tr><td>N</td><td>M</td><td>303</td><td>6.0&#8211;6.6</td><td>2</td><td>NR</td><td>0, 24 h, 4 wk, 12 wk, 24 wk</td></tr><tr><td>P</td><td>M</td><td>622</td><td>&lt;2.78&#8211;7.0</td><td>1</td><td>NR</td><td>0, 24 h, 4 wk, 12 wk, 24 wk</td></tr><tr><td>Q</td><td>M</td><td>468</td><td>&lt;2.78&#8211;6.2</td><td>4</td><td>NR</td><td>0, 24 h, 4 wk, 12 wk, 24 wk, 48 wk, 72 wk</td></tr><tr><td>R</td><td>M</td><td>U</td><td>&lt;2.78&#8211;7.5</td><td>0.5</td><td>R</td><td>0, 24 h, 4 wk, 12 wk, 24 wk, 48 wk, 72 wk</td></tr><tr><td>S</td><td>M</td><td>262</td><td>5.8&#8211;7.2</td><td>1</td><td>NR</td><td>0, 24 h, 4 wk, 12 wk, 24 wk</td></tr><tr><td>U</td><td>M</td><td>842</td><td>&lt;2.78&#8211;6.7</td><td>4</td><td>R</td><td>0, 24 h, 4 wk, 12 wk, 24 wk, 48 wk</td></tr><tr><td>X</td><td>M</td><td>483</td><td>&lt;2.78&#8211;6.1</td><td>1</td><td>NR</td><td>0, 24 h, 4 wk, 12 wk, 24 wk</td></tr><tr><td>Z</td><td>M</td><td>U</td><td>&lt;2.78</td><td>4</td><td>R</td><td>0, 24 h, 4 wk, 12 wk, 24 wk, 48 wk, 72 wk</td></tr></table>
fd1ee683b23db2a301c10f9ce5f2a4fbe514dc7e913fbd5ea957524bcfde8ee1.png
simple
<table><tr><td>Disease location</td><td>Cases(<i>n</i> = 94)</td><td>Sensitivity(%)</td><td>Specificity(%)</td><td>PPV(%)</td><td>NPV(%)</td><td>Accuracy(%)</td></tr><tr><td>Endometriomas</td><td>57 (60.6%)</td><td>100</td><td>100</td><td>100</td><td>100</td><td>100</td></tr><tr><td>Bladder nodules</td><td>11 (11.7%)</td><td>90.9</td><td>100</td><td>100</td><td>98.8</td><td>98.9</td></tr><tr><td>Vaginal nodules</td><td>39 (41.5%)</td><td>92.3</td><td>98.2</td><td>97.3</td><td>94.7</td><td>95.7</td></tr><tr><td>Pouch of Douglas obliteration</td><td>48 (51.1%)</td><td>93.8</td><td>91.3</td><td>91.8</td><td>93.3</td><td>92.5</td></tr><tr><td>Bowel lesions (rectum, sigma, POD)</td><td>20 (21.3%)</td><td>80</td><td>98.6</td><td>94.1</td><td>94.8</td><td>94.7</td></tr><tr><td>Uterosacral ligaments</td><td>50 (53.2%)</td><td>60</td><td>70.5</td><td>69.8</td><td>60.8</td><td>64.9</td></tr></table>
b89877003aa202921b9bac11669ef1252ee7cc802ca350338ccb57a155710203.png
complex
<table><tr><td rowspan="2"></td><td colspan="4">Phenolic Acid Intake</td><td rowspan="2"><i>p</i></td></tr><tr><td>Q1 (Median = 120.36)</td><td>Q2 (Median = 205.39)</td><td>Q3 (Median = 307.70)</td><td>Q4 (Median = 522.26)</td></tr><tr><td>Sex, <i>n</i> (%)</td><td></td><td></td><td></td><td></td><td>0.919</td></tr><tr><td>Male</td><td>186 (41.1)</td><td>197 (40.5)</td><td>215 (42.3)</td><td>206 (42.2)</td><td></td></tr><tr><td>Female</td><td>267 (58.9)</td><td>290 (59.5)</td><td>293 (57.7)</td><td>282 (57.8)</td><td></td></tr><tr><td>Educational level, <i>n</i> (%)</td><td></td><td></td><td></td><td></td><td>&lt;0.001</td></tr><tr><td>Low</td><td>150 (33.1)</td><td>161 (33.1)</td><td>198 (39.0)</td><td>188 (38.5)</td><td></td></tr><tr><td>Medium</td><td>141 (31.1)</td><td>218 (44.8)</td><td>177 (34.8)</td><td>184 (37.7)</td><td></td></tr><tr><td>High</td><td>162 (35.8)</td><td>108 (22.2)</td><td>133 (26.2)</td><td>116 (23.8)</td><td></td></tr><tr><td>Occupational level, <i>n</i> (%)</td><td></td><td></td><td></td><td></td><td>0.046</td></tr><tr><td>Unemployed</td><td>94 (22.8)</td><td>110 (27.0)</td><td>134 (29.7)</td><td>123 (31.9)</td><td></td></tr><tr><td>Low</td><td>69 (16.7)</td><td>75 (18.4)</td><td>67 (14.9)</td><td>55 (14.2)</td><td></td></tr><tr><td>Medium</td><td>111 (26.9)</td><td>95 (23.3)</td><td>131 (29.0)</td><td>103 (26.7)</td><td></td></tr><tr><td>High</td><td>139 (33.7)</td><td>128 (31.4)</td><td>119 (26.4)</td><td>105 (27.2)</td><td></td></tr><tr><td>Smoking status, <i>n</i> (%)</td><td></td><td></td><td></td><td></td><td>0.034</td></tr><tr><td>Non smoker</td><td>298 (65.8)</td><td>289 (59.3)</td><td>316 (62.2)</td><td>292 (59.8)</td><td></td></tr><tr><td>Ex-smoker</td><td>85 (18.8)</td><td>131 (26.9)</td><td>132 (26.0)</td><td>117 (24.0)</td><td></td></tr><tr><td>Current smoker</td><td>70 (15.5)</td><td>67 (13.8)</td><td>60 (11.8)</td><td>79 (16.2)</td><td></td></tr><tr><td>Physical activity, <i>n</i> (%)</td><td></td><td></td><td></td><td></td><td>0.585</td></tr><tr><td>Low</td><td>85 (21.5)</td><td>87 (19.1)</td><td>75 (16.4)</td><td>82 (19.5)</td><td></td></tr><tr><td>Medium</td><td>190 (48.0)</td><td>218 (47.9)</td><td>234 (51.3)</td><td>214 (50.8)</td><td></td></tr><tr><td>High</td><td>121 (30.6)</td><td>150 (33.0)</td><td>147 (32.2)</td><td>125 (29.7)</td><td></td></tr><tr><td>Alcohol intake, <i>n</i> (%)</td><td></td><td></td><td></td><td></td><td>&lt;0.001</td></tr><tr><td>No</td><td>110 (24.2)</td><td>108 (22.2)</td><td>97 (19.1)</td><td>60 (12.3)</td><td></td></tr><tr><td>Moderate</td><td>324 (71.4)</td><td>319 (65.5)</td><td>290 (57.1)</td><td>273 (55.9)</td><td></td></tr><tr><td>Regular</td><td>20 (4.4)</td><td>60 (12.3)</td><td>121 (23.8)</td><td>155 (31.8)</td><td></td></tr><tr><td>Age (years), mean (SD)</td><td>47.4 (19.3)</td><td>48.7 (18.2)</td><td>48.0 (16.0)</td><td>49.5 (16.9)</td><td>0.296</td></tr><tr><td>Sodium (mg/day), mean (SD)</td><td>2669 (864.2)</td><td>2868 (1074.2)</td><td>2793.2 (1174.3)</td><td>3093.8 (1224.1)</td><td>&lt;0.001</td></tr><tr><td>Potassium(mg/day), mean (SD)</td><td>2892 (848.8)</td><td>3471 (1027.1)</td><td>3892.1(1306.1)</td><td>4392.4 (1713.6)</td><td>&lt;0.001</td></tr><tr><td>Magnesium (mg/day), mean (SD)</td><td>311.1 (87.9)</td><td>382.5 (109.5)</td><td>416.2 (128.6)</td><td>467.5 (172.7)</td><td>&lt;0.001</td></tr><tr><td>Calcium (mg/day), mean (SD)</td><td>690.5 (258.3)</td><td>755.6 (264.7)</td><td>808.3 (331.0)</td><td>951.6 (400.5)</td><td>&lt;0.001</td></tr><tr><td>High adherence to the Mediterranean diet (high)</td><td>40 (14.5)</td><td>102 (37.1)</td><td>82 (29.8)</td><td>51 (18.5)</td><td>&lt;0.001</td></tr></table>
e9b1d32d2546852fdd1799c4ed94727402f6e7cd14f3632b890a5c60de346d12.png
complex
<table><tr><td colspan="2">Item</td><td>Number of Patients</td><td>Percentage (%)</td></tr><tr><td rowspan="2">Gender</td><td>Male</td><td>127</td><td>59.1</td></tr><tr><td>Female</td><td>88</td><td>40.9</td></tr><tr><td rowspan="2">Age</td><td>&lt;60</td><td>108</td><td>50.2</td></tr><tr><td>&#8805;60</td><td>107</td><td>49.8</td></tr><tr><td rowspan="2">Smoking history</td><td>Yes</td><td>95</td><td>44.2</td></tr><tr><td>No</td><td>120</td><td>55.8</td></tr><tr><td rowspan="2">Disease staging</td><td>Stage IIIB</td><td>36</td><td>16.7</td></tr><tr><td>Stage IV</td><td>179</td><td>83.3</td></tr><tr><td rowspan="2">Therapy received</td><td>Chemotherapy</td><td>181</td><td>84.2</td></tr><tr><td>EGFR-TKI treatment</td><td>114</td><td>53.0</td></tr></table>
37e7e452440fa4576ef24d2370509cc5a9e2cf0d7a36ec91495e347ba5112eab.png
complex
<table><tr><td>Name<sup>a</sup></td><td>Age</td><td>Regular medication prior to trial</td><td>Trial completion</td><td>Result of trial</td><td>Treatment decision</td></tr><tr><td colspan="6"><i>Standard vs heat retaining knee support &#8211; trials commencing December 2001 to February 2002</i></td></tr><tr><td>Ann</td><td>67</td><td>solpadol, meloxicam, amitryptiline</td><td>Completed</td><td>Heat retaining support beneficial</td><td>Continued use of heat retaining support</td></tr><tr><td>Mel</td><td>54</td><td>dihydrocodeine, co-dydramol, amitryptiline</td><td colspan="2">Withdrew after 6 weeks &#8211; intolerance to supports</td><td>No further use of supports</td></tr><tr><td>Amber</td><td>49</td><td>no regular medication, occasional paracetamol</td><td>Completed</td><td>Heat retaining support beneficial</td><td>Continued use of heat retaining support</td></tr><tr><td>Lyn</td><td>54</td><td>rofecoxib, dihydrocodeine, paracetamol</td><td>Completed</td><td>No benefit from either support</td><td>No further use of supports</td></tr><tr><td>Pansy<sup>b</sup></td><td>51</td><td>rofecoxib</td><td>Completed</td><td>No benefit from either support</td><td>No further use of supports</td></tr><tr><td colspan="6"><i>Diclofenac vs paracetamol &#8211; trials commencing September 2003 to October 2003</i></td></tr><tr><td>Pansy<sup>b</sup></td><td>53</td><td>Rofecoxib</td><td colspan="2">Withdrew after 6 weeks &#8211; diclofenac side-effect (stomach pains)</td><td>Returned to previous treatment</td></tr><tr><td>Rosie</td><td>31</td><td>Paracetamol</td><td colspan="2">Withdrew after 2 weeks &#8211; diclofenac side-effect (mouth ulcers)</td><td>Returned to previous treatment</td></tr><tr><td>Jack</td><td>59</td><td>no regular medication</td><td>Completed</td><td>No benefit from either drug</td><td>No regular medication (paracetamol when necessary)</td></tr><tr><td>George</td><td>61</td><td>cod liver oil only</td><td>Completed</td><td>Diclofenac superior</td><td>Continued with diclofenac</td></tr></table>
d452c2e639f6584c49ad158e264ab73e336ee2f963c0a2dcb723ac3d2acfd5dc.png
simple
<table><tr><td>Skin cancer</td><td>TGF-<i>&#946;</i></td><td>uPA/uPAR</td></tr><tr><td>BCC</td><td>&#8722;/+</td><td>?</td></tr><tr><td>SCC</td><td>++</td><td>++</td></tr><tr><td>Melanoma</td><td>&#8722;/+</td><td>++</td></tr></table>
c7ea0b4a6d566244ba4a306bbbebcf58588d3053cac2f0437fc6a6bc11ca7f6a.png
simple
<table><tr><td>Motif family</td><td>Heart</td><td>Sperm</td></tr><tr><td>E2F<sup>1</sup></td><td>Hypo-methylated</td><td>Hypo-methylated</td></tr><tr><td>NFY<sup>1</sup></td><td>Hypo-methylated</td><td>Hypo-methylated</td></tr><tr><td>YY1<sup>1</sup></td><td>Hypo-methylated</td><td>Hypo-methylated</td></tr><tr><td>MYCMAX<sup>1</sup></td><td>Hypo-methylated</td><td>Hyper-methylated</td></tr><tr><td>NFKB<sup>1</sup></td><td>Hypo-methylated</td><td>Hyper-methylated</td></tr><tr><td>AP<sup>1</sup></td><td>Hypo-methylated</td><td>Hyper-methylated</td></tr><tr><td>NRSF<sup>2</sup></td><td>Hypo-methylated</td><td>Neutral</td></tr><tr><td>SREBP<sup>3</sup></td><td>Hypo-methylated</td><td>Neutral</td></tr><tr><td>SRF<sup>2</sup></td><td>Hypo-methylated</td><td>Neutral</td></tr><tr><td>STAT<sup>4</sup></td><td>Hypo-methylated</td><td>Neutral</td></tr><tr><td>TCF<sup>1</sup></td><td>Hypo-methylated</td><td>Neutral</td></tr><tr><td>GATA<sup>1</sup></td><td>Neutral</td><td>Hyper-methylated</td></tr><tr><td>NFE2<sup>1</sup></td><td>Neutral</td><td>Neutral</td></tr><tr><td>OCT<sup>5</sup></td><td>Neutral</td><td>Neutral</td></tr><tr><td>SOX<sup>5</sup></td><td>Neutral</td><td>Neutral</td></tr><tr><td>EP300<sup>5</sup></td><td>Neutral</td><td>Neutral</td></tr><tr><td>TP53<sup>6</sup></td><td>Neutral</td><td>Neutral</td></tr></table>
ae51bc2edcabfd61e89161ac169356e6c4a59982b5b728110e7d7b3cdb44cc6c.png
complex
<table><tr><td> </td><td>Features or characteristics</td><td>Total</td></tr><tr><td rowspan="2">Diagnosed with infection in pregnancy</td><td>Infant with CRI but no CRS features at birth</td><td>3</td></tr><tr><td>Infant with CRI resulting in CRS</td><td>5</td></tr><tr><td>Diagnosed after birth</td><td>Infant with CRI resulting in CRS</td><td>7</td></tr><tr><td rowspan="3">Acquisition of rubella infection</td><td>Maternal infection acquired abroad</td><td>8</td></tr><tr><td>Maternal infection UK acquired</td><td>6</td></tr><tr><td>Place of infection not known</td><td>1</td></tr><tr><td rowspan="2">Maternal place of birth</td><td>Mother born abroad</td><td>14</td></tr><tr><td>Maternal place of birth not known</td><td>1</td></tr><tr><td rowspan="7">Reported features of 11 of 12 CRS cases<sup>b</sup> (more than one feature may be reported for each infant)</td><td>Thrombocytopaenia at birth</td><td>2</td></tr><tr><td>Sensorineural hearing loss</td><td>10</td></tr><tr><td>Eye defects</td><td>8</td></tr><tr><td>Failure to thrive</td><td>3</td></tr><tr><td>Heart defects</td><td>10</td></tr><tr><td>Developmental problems</td><td>3</td></tr><tr><td>Microcephaly</td><td>5</td></tr></table>
1941aa1e141d98cca61e1fa85b551158bedbcfaf71ed8b41f09a8cef05c823fa.png
simple
<table><tr><td>Extraction methods</td><td>Abbreviation</td><td>Crude extract (mg/g herb)</td></tr><tr><td>Heat reflux extraction using water</td><td>HRE-W</td><td>297.4 &#177; 28.4</td></tr><tr><td>Microwave-assisted extraction using water</td><td>MAE-W</td><td>390.8 &#177; 16.6***</td></tr><tr><td>Ultrasonic extraction using ethanol (70 % vol/vol)</td><td>UE-E</td><td>327.4 &#177; 19.4</td></tr><tr><td>Ultrasonic extraction using water</td><td>UE-W</td><td>275.0 &#177; 9.0</td></tr></table>
437802043c57c57c02706a38630c9f573b0980e4fa3473f2df1f7bb758d9876c.png
complex
<table><tr><td>Treatment</td><td colspan="3"><i>S. aureus</i> NCTC 13297</td><td colspan="3"><i>P. aeruginosa</i> NCTC 10781</td><td colspan="3">Co-culture</td></tr><tr><td></td><td>Concentration</td><td>Mean OD</td><td>Biofilm</td><td>Concentration</td><td>Mean OD</td><td>Biofilm</td><td>Concentration</td><td>Mean OD</td><td>Biofilm</td></tr><tr><td>Bacteria</td><td></td><td>0.1</td><td>Moderate</td><td></td><td>0.54</td><td>Strong</td><td></td><td>0.14</td><td>Moderate</td></tr><tr><td>Bg<sup>Ag</sup></td><td>0.625%</td><td>0.04</td><td>Non-adherent</td><td>0.625%</td><td>0.08</td><td>Weak</td><td>0.625%</td><td>0.06</td><td>Weak</td></tr><tr><td></td><td>0.15%</td><td>0.1</td><td>Moderate</td><td>0.15%</td><td>0.23</td><td>Strong</td><td>0.15%</td><td>0.09</td><td>Moderate</td></tr><tr><td>Bg</td><td>0.625%</td><td>0.11</td><td>Moderate</td><td>0.625%</td><td>0.07</td><td>Weak</td><td>0.625%</td><td>0.09</td><td>Moderate</td></tr><tr><td></td><td>0.15%</td><td>0.1</td><td>Moderate</td><td>0.15%</td><td>0.5</td><td>Strong</td><td>0.15%</td><td>0.11</td><td>Moderate</td></tr></table>
7a0ebe6c1a67396277db720d5dedefc7d66fd32bb170a16ccc16c7277998348b.png
complex
<table><tr><td rowspan="2">Source of variations</td><td rowspan="2">Degree of freedom</td><td colspan="5">Mean square</td></tr><tr><td>pH</td><td>Exchangeable acidity</td><td>Exchangeable Al</td><td>Exchangeable Fe</td><td>Exchangeable Ca</td></tr><tr><td>Treatments</td><td>4</td><td>3.71&#8727;</td><td>0.23&#8727;</td><td>0.08&#8727;</td><td>9.03&#8727;</td><td>70.70&#8727;</td></tr><tr><td>Time </td><td>2</td><td>0.65&#8727;</td><td>0.15&#8727;</td><td>0.01&#8727;</td><td>0.37&#8727;</td><td>0.52&#8727;</td></tr><tr><td>Treatments &#8727; time</td><td>8</td><td>0.76&#8727;</td><td>0.34&#8727;</td><td>0.01&#8727;</td><td>0.14&#8727;</td><td>0.24&#8727;</td></tr><tr><td>Error</td><td>30</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr></table>
113d7ff2af88eec25e072f2bfff12e74f2f37eec528617aedb4920f7d4b76ec9.png
simple
<table><tr><td>EC identifier</td><td>Enzyme name</td><td>Pathway</td><td>Reference</td></tr><tr><td>2.1.3.3</td><td>Ornithine carbamoyltransferase</td><td>Arginine/Proline</td><td>Cook et al (2007)</td></tr><tr><td>2.3.1.57</td><td>Diamine <i>N</i>-acetyltransferase</td><td>Polyamines</td><td>Cook et al (2007)</td></tr><tr><td>2.6.99.2</td><td>Pyridoxine 5-phosphate synthase</td><td>Misc</td><td>Muller and Kappes (2007)</td></tr><tr><td>2.7.2.2</td><td>Carbamate kinase</td><td>Pyrimidine</td><td>Cook et al (2007)</td></tr><tr><td>3.5.3.6</td><td>Arginine deaminase</td><td>Arginine/Proline</td><td>Cook et al (2007)</td></tr><tr><td>3.5.4.2</td><td>Adenine deaminase</td><td>Purine</td><td>Chaudhary et al (2004)</td></tr><tr><td>4.2.1.60</td><td>3-Hydroxydecanoyl-[acp] dehydratase</td><td>Fatty-acid synthesis</td><td>Dautu et al (2008)</td></tr><tr><td>4.2.1.61</td><td>3-Hydroxydecanoyl-[acp] dehydratase</td><td>Fatty-acid synthesis</td><td>Dautu et al (2008)</td></tr><tr><td>4.2.1.75</td><td>Uroporphyrinogen-III synthase</td><td>Porphyrin</td><td>Seeber et al (2008)</td></tr><tr><td>4.2.1.99</td><td>2-Methylisocitrate dehydratase</td><td>MC cycle</td><td>Seeber et al (2008)</td></tr><tr><td>5.5.1.4</td><td>Inositol-3-phosphate synthase</td><td>Phospholipid</td><td>Smith et al (2007)</td></tr></table>
8da7dcac5e49969d5e15ec914b42a4ad7e77df39e1e03794aa0f128e65a81b09.png
simple
<table><tr><td>Meeting/ Event (Date)</td><td>Alcohol industry</td><td>Tobacco industry</td></tr><tr><td>Informal Discussion meeting for Chairmen &amp; Directors of Large Organisations held at BAT offices (1966)</td><td>Courage, Barclay Simmonds</td><td>BAT, Gallaher</td></tr><tr><td>Practical Skills of Managing People (1981)</td><td>Allied, Bass, Charrington, S&amp;N</td><td>BAT</td></tr><tr><td>Practical Skills of Managing Event (1981)</td><td>Allied, Bass-Charrington, Scottish &amp; Newcastle</td><td>BAT</td></tr><tr><td>Fermenters Symposium (1982)</td><td>Allied, Watney, Grand Met</td><td>BAT</td></tr><tr><td>CBI Conference, Seminar: Employee Involvement (1983)</td><td>Allied, Bass, Brewers&#8217; Society, Grand Met, Lyons Tetley, Truman, Whitbread</td><td>BAT</td></tr><tr><td>Institute of Chemical Engineers (ICHEME) Meeting (1985)</td><td>Guinness, Watney, Nabisco</td><td>BAT</td></tr><tr><td>Minerva Public Relations Group UK Meeting (1988)</td><td>The Alcohol Duty Group</td><td>The Tobacco Duty Free Group</td></tr><tr><td>Statistics for Industry Ltd., Statistical Workshops (1991)</td><td>Allied, Bass, Guinness</td><td>Imperial, Rothmans</td></tr><tr><td>Advertising Association- Performance Monitoring Seminar (1994)</td><td>Carlsberg-Tetley, Allied-Lyons, Hiram Walker Group, United Distillers</td><td>BAT</td></tr><tr><td>Monitoring Advertising Performance Event (1998)</td><td>Guinness, Scottish Courage, IDV</td><td>BAT</td></tr></table>
771da3024860d75f89e671511c1c743cf164eab4bebbde0ff0da4139bc833b09.png
complex
<table><tr><td rowspan="2">Matrix</td><td colspan="4">GlcNAc</td><td colspan="4">GalNAc</td></tr><tr><td>EC<sup>a</sup></td><td>FC<sup>b</sup></td><td>Recovery (%)</td><td>RSD<sup>c</sup></td><td>EC<sup>a</sup></td><td>FC<sup>b</sup></td><td>Recovery (%)</td><td>RSD<sup>c</sup></td></tr><tr><td rowspan="3">Raw milk</td><td rowspan="3">152.3 &#177; 3.4</td><td>30.0</td><td>102.06</td><td>1.94</td><td rowspan="3">189.3 &#177; 12.1</td><td>12.5</td><td>100.50</td><td>2.46</td></tr><tr><td>60.0</td><td>101.41</td><td>1.18</td><td>25.0</td><td>99.92</td><td>1.37</td></tr><tr><td>120.0</td><td>95.12</td><td>0.59</td><td>50.0</td><td>103.30</td><td>2.08</td></tr><tr><td rowspan="3">UHT milk</td><td rowspan="3">150.2 &#177; 5.4</td><td>30.0</td><td>102.39</td><td>3.21</td><td rowspan="3">115.0 &#177; 1.1</td><td>12.5</td><td>103.34</td><td>1.81</td></tr><tr><td>60.0</td><td>97.02</td><td>0.42</td><td>25.0</td><td>105.88</td><td>0.84</td></tr><tr><td>120.0</td><td>101.06</td><td>2.99</td><td>50.0</td><td>102.70</td><td>0.57</td></tr><tr><td rowspan="3">Yoghurt</td><td rowspan="3">151.2 &#177; 11.1</td><td>30.0</td><td>101.20</td><td>0.66</td><td rowspan="3">157.0 &#177; 5.5</td><td>12.5</td><td>99.39</td><td>0.91</td></tr><tr><td>60.0</td><td>100.20</td><td>0.79</td><td>25.0</td><td>100.58</td><td>0.92</td></tr><tr><td>120.0</td><td>100.81</td><td>1.03</td><td>50.0</td><td>99.79</td><td>0.62</td></tr><tr><td rowspan="3">Infant formula</td><td rowspan="3">720.0 &#177; 1.6</td><td>30.0</td><td>105.45</td><td>0.68</td><td rowspan="3">1118.4 &#177; 12.3</td><td>12.5</td><td>100.56</td><td>1.38</td></tr><tr><td>60.0</td><td>103.95</td><td>2.90</td><td>25.0</td><td>102.17</td><td>0.81</td></tr><tr><td>120.0</td><td>103.26</td><td>1.25</td><td>50.0</td><td>99.51</td><td>1.10</td></tr></table>
e665b9bfbd55f55b74d16dd57e2ddb2f12da1072ad1d8dd3b7434b9c21cace6d.png
complex
<table><tr><td>Determinants</td><td>Odds ratio</td><td>Changeability<sup>a</sup></td><td>Category</td><td>Target group<sup>b</sup></td></tr><tr><td colspan="5">Demographic</td></tr><tr><td>Age &gt;40 years</td><td>2.65</td><td>-</td><td>Not applicable</td><td>Not applicable</td></tr><tr><td>Chronic illness</td><td>3.37</td><td>-</td><td>Not applicable</td><td>Not applicable</td></tr><tr><td colspan="5">Behavioural</td></tr><tr><td>Aware of personal risk for influenza infection</td><td>2.80</td><td>+</td><td>Knowledge</td><td>2</td></tr><tr><td>Aware of risk of infecting patients</td><td>2.54</td><td>+</td><td>Knowledge</td><td>2</td></tr><tr><td>&#8216;Vaccination reduces risk of infecting patients&#8217;</td><td>3.68</td><td>+</td><td>Knowledge</td><td>2</td></tr><tr><td>&#8216;Vaccination is useful despite the constant flow of visitors&#8217;</td><td>1.88</td><td>+</td><td>Knowledge</td><td>2</td></tr><tr><td>Aware of the contents of the Health Council&#8217;s Advice</td><td>2.41</td><td>+</td><td>Knowledge</td><td>2</td></tr><tr><td>&#8216;HCWs<sup>c</sup> should get vaccinated to ensure continuity of care&#8217;</td><td>2.15</td><td>+</td><td>Common interest</td><td>3</td></tr><tr><td>&#8216;HCWs should get vaccinated because of their duty to do no harm&#8217;</td><td>2.22</td><td>+</td><td>Common interest</td><td>3</td></tr><tr><td>&#8216;People around me think it is important for me to get vaccinated&#8217;</td><td>1.74</td><td>+/-</td><td>Social impact</td><td>3</td></tr><tr><td>&#8216;I would definitively get vaccinated if it was available at a convenient time&#8217;</td><td>28.91</td><td>+</td><td>Organizational</td><td>1,2,3</td></tr></table>
56ea87a5ecc3b7cd8078c2251c28604cf3edef177e6bce6affcb128fea9247d6.png
simple
<table><tr><td>Rank</td><td>rs ID</td><td>pval</td><td>Gene Sym</td><td>Gene Name</td><td>SNP Function</td></tr><tr><td>1.0</td><td>rs10018625</td><td>0.001536</td><td>TAG ERROR</td><td>TAG ERROR</td><td>unknown, TAG ERROR</td></tr><tr><td>2.0</td><td>rs1047643</td><td>0.001603</td><td>FDFT1</td><td>Farnesyl-diphosphate farnesyltransferase 1</td><td>coding-synon</td></tr><tr><td>3.0</td><td>rs20541</td><td>0.001644</td><td>IL13</td><td>Interleukin 13</td><td>coding-nonsynon</td></tr><tr><td>4.0</td><td>rs2108622</td><td>0.0020374</td><td>CYP4F2</td><td>Cytochrom P450, family 4, subfamily F, polypeptide 2</td><td>coding-nonsynon</td></tr><tr><td>5.0</td><td>rs3759259</td><td>0.002362</td><td>STYK1</td><td>Protein kinase STYK1</td><td>coding-nonsynon</td></tr><tr><td>6.0</td><td>rs1801133</td><td>0.003251</td><td>MTHFR</td><td>5, 10-methylenetetrahydrofolate reductase (NADPH)</td><td>coding-nonsynon</td></tr><tr><td>7.0</td><td>rs2069456</td><td>0.003375</td><td>CDK5</td><td>Cyclin-dependent kinase 5</td><td>intron</td></tr><tr><td>8.0</td><td>rs1131532</td><td>0.005650</td><td>TNFSF10</td><td>Tumor necrosis factor (ligand) superfamily, member 10</td><td>coding-synon</td></tr><tr><td>9.0</td><td>rs882709</td><td>0.005965</td><td>SETX</td><td>senataxin</td><td>coding-nonsynon</td></tr><tr><td>10.0</td><td>rs4646421</td><td>0.007847</td><td>CYP1A1</td><td>Cytochrome P450, family 1, subfamily A, polypeptide 1</td><td>intron</td></tr><tr><td>11.0</td><td>rs1799969</td><td>0.008221</td><td>ICAM1</td><td>Intercellular adhesion molecule 1 (CD54), human rhinovirus receptor</td><td>coding-nonsynon</td></tr><tr><td>12.0</td><td>rs3822430</td><td>0.009157</td><td>SRD5A1</td><td>Steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1)</td><td>coding-synon</td></tr><tr><td>13.0</td><td>rs7903344</td><td>0.009471</td><td>CHUK</td><td>Conserved helix-loop-helix ubiquitous kinase</td><td>coding-nonsynon</td></tr><tr><td>14.0</td><td>rs13926</td><td>0.011531</td><td>TRAP1</td><td>TNF receptor-associated protein 1</td><td>coding-nonsynon</td></tr><tr><td>15.0</td><td>rs3172469</td><td>0.012006</td><td>BCL6</td><td>B-cell CCL/lymphoma 6 (zinc finger protein 51)</td><td>intron</td></tr><tr><td>16.0</td><td>rs215101</td><td>0.012028</td><td>ABCC1</td><td>ATP-binding cassette, sub-family C (CFTR/MRP), member 1</td><td>intron, TagSNP:ABCC1</td></tr><tr><td>17.0</td><td>rs2227564</td><td>0.012246</td><td>PLAU</td><td>Plasminogen activator, urokinase</td><td>coding-nonsynon</td></tr><tr><td>18.0</td><td>rs3096057</td><td>0.012484</td><td>CSF1</td><td>Colony stimulating factor 1 (macrophage)</td><td>Promoter</td></tr><tr><td>19.0</td><td>rs6474491</td><td>0.013935</td><td>STAR</td><td>Steriodogenic acute regulator</td><td>Promoter</td></tr><tr><td>20.0</td><td>rs2066471</td><td>0.015231</td><td>MTHRF</td><td>5, 10-methlyenetetrahydrofolate reductase (NADPH)</td><td>intron</td></tr></table>
11aeb210942d3efbfeb52a8b25ed0d38963de3d34ba22b6c1f78baf2a283d834.png
simple
<table><tr><td>Variable</td><td>All participants<sup>a</sup></td><td>Group 1 (N=21)</td><td>Group 2 (N=21)</td><td>p value<sup>b</sup></td></tr><tr><td>Women N</td><td>39</td><td>19 (90%)</td><td>20 (95%)</td><td>0.55</td></tr><tr><td>College degree or higher N</td><td>40</td><td>20 (95%)</td><td>20 (95%)</td><td>0.32</td></tr><tr><td>White race N</td><td>35</td><td>18 (86%)</td><td>17 (81%)</td><td>0.68</td></tr><tr><td>Hispanic N</td><td>4</td><td>3 (14%)</td><td>1 (5%)</td><td>0.29</td></tr><tr><td>Nonvegetarian N</td><td>37</td><td>18 (86%)</td><td>19 (90%)</td><td>0.63</td></tr><tr><td> </td><td>Mean (SD)</td><td>Mean (SD)</td><td>Mean (SD)</td><td>p value<sup>c</sup></td></tr><tr><td>Age (y)</td><td>45.7 (12.7)</td><td>49 (13.5)</td><td>42.4 (11.1)</td><td>0.09</td></tr><tr><td>Weight (kg)</td><td>76.9 (19.8)</td><td>78.0 (22.6)</td><td>75.7 (17.1)</td><td>0.71</td></tr><tr><td>BMI</td><td>27.6 (6.0)</td><td>27.7 (6.4)</td><td>27.5 (5.8)</td><td>0.90</td></tr><tr><td>Illness duration (y) (N=26)</td><td>23.7 (12.6)</td><td>24.7 (13.8)</td><td>22.7 (11.7)</td><td>0.69</td></tr><tr><td>Total cholesterol (mg/dl)</td><td>191.1 (36.9)</td><td>195.6 (42.5)</td><td>186.9 (31.1)</td><td>0.46</td></tr><tr><td>VAS (cm) (N=41)</td><td>6.4 (2.1)</td><td>6.1 (2.4)</td><td>6.7 (1.9)</td><td>0.38</td></tr><tr><td>Headache number (per wk) (N=40)</td><td>2.3 (1.8)</td><td>2.1 (1.6)</td><td>2.6 (2.1)</td><td>0.50</td></tr><tr><td>Headache intensity, scale 0&#8211;10 (N=37)</td><td>4.2 (1.4)</td><td>3.9 (1.1)</td><td>4.5 (1.7)</td><td>0.20</td></tr><tr><td>Headache duration, hrs (N=38)</td><td>5.8 (3.4)</td><td>6.5 (3.3)</td><td>5.1 (3.5)</td><td>0.19</td></tr><tr><td>Headache days (per wk) (N=40)</td><td>2.2 (1.4)</td><td>2.1 (1.6)</td><td>2.3 (1.2)</td><td>0.64</td></tr></table>
0b4eb3f2986b2ef1fcefc12bc9e82bef8b406af0de6f09d4283a73e4dce55fc0.png
complex
<table><tr><td></td><td colspan="3">Total</td><td colspan="3">Male</td><td colspan="3">Female</td></tr><tr><td></td><td>CAD patients</td><td>Control subjects</td><td><i>P</i> Value</td><td>CAD patients</td><td>Control subjects</td><td><i>P</i> Value</td><td>CAD patients</td><td>Control subjects</td><td><i>P</i> Value</td></tr><tr><td>Number(n)</td><td>506</td><td>351</td><td></td><td>369</td><td>213</td><td></td><td>137</td><td>138</td><td></td></tr><tr><td>Age(years)</td><td>54.44 &#177; 0.407</td><td>53.37 &#177; 0.508</td><td>0.120</td><td>53.94 &#177; 0.502</td><td>53.17 &#177; 0.617</td><td>0.336</td><td>53.52 &#177; 0.710</td><td>53.21 &#177; 0.770</td><td>0.220</td></tr><tr><td>BMI(kg/m<sup>2</sup>)</td><td>27.99 &#177; 0.183</td><td>26.96 &#177; 0.273</td><td>0.001<sup>*</sup></td><td>27.39 &#177; 0.189</td><td>25.39 &#177; 0.321</td><td>0.000<sup>*</sup></td><td>26.63 &#177; 0.413</td><td>25.38 &#177; 0.406</td><td>0.000<sup>*</sup></td></tr><tr><td>Glu(mmol/L)</td><td>6.81 &#177; 0.108</td><td>6.35 &#177; 0.147</td><td>0.001<sup>*</sup></td><td>6.73 &#177; 0.124</td><td>6.45 &#177; 0.159</td><td>0.000<sup>*</sup></td><td>6.89 &#177; 0.218</td><td>6.16 &#177; 0.206</td><td>0.004<sup>*</sup></td></tr><tr><td>BUN(mmol/L)</td><td>5.68 &#177; 0.137</td><td>6.28 &#177; 0.281</td><td>0.030<sup>*</sup></td><td>5.76 &#177; 0.171</td><td>6.36 &#177; 0.242</td><td>0.030<sup>*</sup></td><td>5.48 &#177; 0.185</td><td>6.14 &#177; 0.339</td><td>0.100</td></tr><tr><td>TG(mmol/L)</td><td>2.47 &#177; 0.060</td><td>2.19 &#177; 0.093</td><td>0.009<sup>*</sup></td><td>2.46 &#177; 0.097</td><td>2.43 &#177; 0.080</td><td>0.000<sup>*</sup></td><td>2.49 &#177; 0.133</td><td>1.85 &#177; 0.094</td><td>0.000<sup>*</sup></td></tr><tr><td>TC(mmol/L)</td><td>4.57 &#177; 0.101</td><td>3.82 &#177; 0.088</td><td>0.000<sup>*</sup></td><td>4.61 &#177; 0.111</td><td>3.84 &#177; 0.110</td><td>0.109</td><td>4.51 &#177; 0.191</td><td>3.78 &#177; 0.126</td><td>0.003<sup>*</sup></td></tr><tr><td>LDL-C(mmol/L)</td><td>2.77 &#177; 0.043</td><td>2.62 &#177; 0.050</td><td>0.010<sup>*</sup></td><td>2.81 &#177; 0.048</td><td>2.70 &#177; 0.059</td><td>0.000<sup>*</sup></td><td>2.69 &#177; 0.076</td><td>2.50 &#177; 0.071</td><td>0.040<sup>*</sup></td></tr><tr><td>HDL-C(mmol/L)</td><td>0.92 &#177; 0.019</td><td>1.22 &#177; 0.062</td><td>0.001<sup>*</sup></td><td>0.91 &#177; 0.021</td><td>1.24 &#177; 0.045</td><td>0.000<sup>*</sup></td><td>0.94 &#177; 0.033</td><td>1.20 &#177; 0.043</td><td>0.010<sup>*</sup></td></tr><tr><td>VLDL (mmol/L)</td><td>0.49 &#177; 0.012</td><td>0.44 &#177; 0.019</td><td>0.009<sup>*</sup></td><td>0.49 &#177; 0.012</td><td>0.48 &#177; 0.027</td><td>0.000<sup>*</sup></td><td>0.50 &#177; 0.027</td><td>0.37 &#177; 0.020</td><td>0.000<sup>*</sup></td></tr><tr><td>DM(%)</td><td>174(64.2 %)</td><td>97(35.8 %)</td><td>0.030<sup>*</sup></td><td>119(65.0 %)</td><td>64(35.0 %)</td><td>0.000<sup>*</sup></td><td>55(62.5 %)</td><td>33(37.5 %)</td><td>0.000<sup>*</sup></td></tr><tr><td>EH(%)</td><td>250(54.1 %)</td><td>212(45.9 %)</td><td>0.002<sup>*</sup></td><td>162(55.7 %)</td><td>129(44.3 %)</td><td>0.000<sup>*</sup></td><td>88(51.5 %)</td><td>83(48.5 %)</td><td>0.535</td></tr><tr><td>Hyperlipidemia(%)</td><td>262(67.9 %)</td><td>212(45.9 %)</td><td>0.000<sup>*</sup></td><td>187(68.8 %)</td><td>85(35.0 %)</td><td>0.000<sup>*</sup></td><td>75(65.8 %)</td><td>39(34.2 %)</td><td>0.000<sup>*</sup></td></tr><tr><td>Smoking(%)</td><td>385(66.7 %)</td><td>192(33.2 %)</td><td>0.000<sup>*</sup></td><td>309(68.2 %)</td><td>144(31.8 %)</td><td>0.000<sup>*</sup></td><td>76(61.3 %)</td><td>48(38.7 %)</td><td>0.001<sup>*</sup></td></tr></table>
93c1a1d92e85b1c30f80ae10111863301a0ebed7403dfec1adf0dd600d46cb87.png
simple
<table><tr><td> </td><td>AA-MF</td><td>GMP-MF</td><td><i>p</i></td></tr><tr><td><i>Energy</i></td><td> </td><td> </td><td> </td></tr><tr><td> kcal/d</td><td>2,266 &#177; 263</td><td>2,566 &#177; 204</td><td>0.26</td></tr><tr><td>kcal from MF/d</td><td>544 &#177; 100</td><td>763 &#177; 118</td><td>0.049</td></tr><tr><td>kcal from NF/d</td><td>1,722 &#177; 229</td><td>1,802 &#177; 127</td><td>0.77</td></tr><tr><td><i>Protein</i></td><td> </td><td> </td><td> </td></tr><tr><td> g protein/d</td><td>79 &#177; 4</td><td>81 &#177; 6</td><td>0.70</td></tr><tr><td>g protein from MF/d</td><td>57 &#177; 5</td><td>55 &#177; 7</td><td>0.72</td></tr><tr><td>g protein from NF/d</td><td>21 &#177; 2</td><td>26 &#177; 4</td><td>0.32</td></tr><tr><td><i>Calcium : phosphorus ratio</i><sup><i>3</i></sup></td><td> </td><td> </td><td> </td></tr><tr><td> Ca : P ratio/d</td><td>1.06 &#177; 0.14</td><td>1.19 &#177; 0.17</td><td>0.13</td></tr><tr><td>Ca : P ratio from MF/d</td><td>0.96 &#177; 0.14</td><td>1.22 &#177; 0.04</td><td>0.03</td></tr><tr><td>Ca : P ratio from NF/d</td><td>0.90 &#177; 0.27</td><td>1.38 &#177; 0.66</td><td>0.28</td></tr><tr><td><i>Vitamin D</i><sup><i>2</i></sup></td><td> </td><td> </td><td> </td></tr><tr><td> IU vitamin D/d</td><td>630 &#177; 230</td><td>680 &#177; 167</td><td>0.75</td></tr><tr><td>IU vitamin D from MF/d</td><td>623 &#177; 182</td><td>593 &#177; 131</td><td>0.82</td></tr><tr><td>IU vitamin D from NF/d</td><td>54 &#177; 30</td><td>60 &#177; 26</td><td>0.81</td></tr><tr><td><i>Calcium</i><sup><i>2</i></sup></td><td> </td><td> </td><td> </td></tr><tr><td> mg calcium/d</td><td>1,745 &#177; 274</td><td>1,898 &#177; 270</td><td>0.69</td></tr><tr><td>mg calcium from MF/d</td><td>1,282 &#177; 240</td><td>1,408 &#177; 264</td><td>0.58</td></tr><tr><td>mg calcium from NF/d<sup>3</sup></td><td>416 &#177; 78</td><td>484 &#177; 76</td><td>0.39</td></tr><tr><td><i>Magnesium</i></td><td> </td><td> </td><td> </td></tr><tr><td> mg magnesium/d</td><td>568 &#177; 62</td><td>684 &#177; 113</td><td>0.27</td></tr><tr><td>mg magnesium from MF/d</td><td>362 &#177; 68</td><td>400 &#177; 68</td><td>0.43</td></tr><tr><td>mg magnesium from NF/d</td><td>206 &#177; 30</td><td>284 &#177; 77</td><td>0.37</td></tr><tr><td><i>Phosphorus</i></td><td> </td><td> </td><td> </td></tr><tr><td> mg phosphorus/d</td><td>1,836 &#177; 228</td><td>1,749 &#177; 161</td><td>0.62</td></tr><tr><td>mg phosphorus from MF/d</td><td>1,183 &#177; 229</td><td>1,131 &#177; 195</td><td>0.80</td></tr><tr><td>mg phosphorus from NF/d</td><td>653 &#177; 58</td><td>618 &#177; 69</td><td>0.70</td></tr><tr><td><i>Potassium</i></td><td> </td><td> </td><td> </td></tr><tr><td> mg potassium/d</td><td>3,249 &#177; 403</td><td>3,699 &#177; 383</td><td>0.40</td></tr><tr><td>mg potassium from MF/d</td><td>1,100 &#177; 307</td><td>1,388 &#177; 175</td><td>0.39</td></tr><tr><td>mg potassium from NF/d</td><td>2,149 &#177; 324</td><td>2,311 &#177; 302</td><td>0.70</td></tr><tr><td><i>Sodium</i></td><td> </td><td> </td><td> </td></tr><tr><td> mg sodium/d<sup>2</sup></td><td>2,559 &#177; 298</td><td>3,487 &#177; 334</td><td>0.006</td></tr><tr><td>mg sodium from MF/d</td><td>499 &#177; 123</td><td>1,251 &#177; 176</td><td>0.017</td></tr><tr><td>mg sodium from NF/d<sup>2</sup></td><td>2,060 &#177; 271</td><td>2,236 &#177; 270</td><td>0.48</td></tr></table>
5426c25300c3dc36fdeb2ca4854efc5846d5c27c66458ebe1b471c173a4456cc.png
complex
<table><tr><td rowspan="2">Category</td><td>Male (<i>n</i> = 129)</td><td>Female (<i>n</i> = 108)</td><td rowspan="2"><i>P</i>-value</td></tr><tr><td>Mean (sd)</td><td>Mean (sd)</td></tr><tr><td>Confidence to undertake endodontic treatment</td><td>11.34 (2.65)</td><td>09.87 (2.83)</td><td>0.001*</td></tr><tr><td>Training/Support for undertaking more endodontic treatment in NHS primary dental care</td><td>11.33 (2.48)</td><td>11.12 (2.41)</td><td>0.51</td></tr><tr><td>Dissatisfaction with endodontic service access</td><td>11.72 (2.25)</td><td>12.05 (2.19)</td><td>0.051</td></tr><tr><td>Acceptability/Support for DwSI services</td><td>15.09 (2.05)</td><td>15.58 (1.68)</td><td>0.047</td></tr><tr><td>Interest in training as an endodontic DwSI</td><td>3.48 (1.36)</td><td>3.51 (1.41)</td><td>0.82</td></tr></table>
69152c463b6e3d824aa41cf90ae880edfd54f22357ff6cca72c3b244da6d37ec.png
simple
<table><tr><td>Characteristic</td><td>Full Cohort(n = 309) &#8224;</td><td>Excluded(n = 199) &#8224;</td><td>One Month Analysis Sample(n = 110) &#8225;</td><td>P-value&#8224;&#8224;</td></tr><tr><td></td><td>Mean (SD) or n (%)</td><td>Mean (SD) or n (%)</td><td>Mean (SD) or n (%)</td><td></td></tr><tr><td>Age in years</td><td>74.7 (8.5)</td><td>75.9 (8.3)</td><td>72.5 (8.3)</td><td>0.001</td></tr><tr><td>Male</td><td>145 (47)</td><td>96 (48)</td><td>49 (45)</td><td>0.53</td></tr><tr><td>Education in years</td><td>12.5 (2.8)</td><td>12.4 (2.9)</td><td>12.5 (2.6)</td><td>0.75</td></tr><tr><td>Non-white race</td><td>51 (16)</td><td>35 (18)</td><td>16 (14)</td><td>0.49</td></tr><tr><td>APACHE II score</td><td>23.5 (6.4)</td><td>24.6 (6.3)</td><td>21.4 (6.1)</td><td>&lt;0.0001</td></tr><tr><td>Charlson Co-Morbidity Index</td><td>1.8 (1.9)</td><td>1.9 (2.0)</td><td>1.7 (1.6)</td><td>0.99</td></tr><tr><td>Admitted from home*</td><td>241 (78)</td><td>143 (72)</td><td>98 (89)</td><td>0.0005</td></tr><tr><td>Baseline Medical Status</td><td></td><td></td><td></td><td></td></tr><tr><td>Evidence of depression**</td><td>85 (28)</td><td>63 (32)</td><td>22 (20)</td><td>0.03</td></tr><tr><td>Dementia</td><td>95 (31)</td><td>75 (38)</td><td>20 (18)</td><td>0.0004</td></tr><tr><td>Any Impairment in Activities of Daily Living</td><td>115 (37)</td><td>94 (47)</td><td>21 (19)</td><td>&lt;0.0001</td></tr><tr><td> Bathing impairment</td><td>104 (34)</td><td>88 (44)</td><td>16 (14)</td><td>&lt;0.0001</td></tr><tr><td> Grooming impairment</td><td>42 (14)</td><td>37 (19)</td><td>5 (5)</td><td>0.0005</td></tr><tr><td> Transfer bed to chair impairment</td><td>54 (17)</td><td>48 (24)</td><td>6 (5)</td><td>&lt;0.0001</td></tr><tr><td> Walk across room impairment</td><td>56 (18)</td><td>49 (25)</td><td>7 (7)</td><td>&lt;0.0001</td></tr><tr><td> Ability to dress impairment</td><td>44 (14)</td><td>34 (17)</td><td>10 (9)</td><td>0.05</td></tr><tr><td> Ability to eat impairment</td><td>10 (3)</td><td>10 (5)</td><td>0 (0)</td><td>0.02</td></tr><tr><td> Ability to toilet impairment</td><td>41 (13)</td><td>38 (19)</td><td>3 (3)</td><td>&lt;0.0001</td></tr><tr><td>Admitting Diagnosis</td><td></td><td></td><td></td><td></td></tr><tr><td> Sepsis</td><td>51 (16)</td><td>39 (20)</td><td>12 (11)</td><td>0.049</td></tr><tr><td> Respiratory</td><td>156 (51)</td><td>104 (52)</td><td>52 (47)</td><td>0.40</td></tr><tr><td> Neurologic</td><td>5 (2)</td><td>5 (3)</td><td>0 (0)</td><td>0.16</td></tr><tr><td> Gastrointestinal hemorrhage</td><td>52 (17)</td><td>24 (12)</td><td>28 (25)</td><td>0.003</td></tr><tr><td> Other</td><td>45 (15)</td><td>27 (14)</td><td>18 (16)</td><td>0.50</td></tr><tr><td>ICU Factors</td><td></td><td></td><td></td><td></td></tr><tr><td>Delirium during ICU Stay***</td><td>239 (79)</td><td>177 (92)</td><td>61 (55)</td><td>&lt;0.0001</td></tr><tr><td>Intubated</td><td>167 (54)</td><td>126 (63)</td><td>41 (37)</td><td>&lt;0.0001</td></tr><tr><td>Days of ventilation, Median (IQR)****</td><td>6 (8)</td><td>6 (10)</td><td>4 (3)</td><td>0.006</td></tr><tr><td>Length of stay, Median (IQR)****</td><td>5 (6)</td><td>6 (9)</td><td>3 (3)</td><td>&lt;0.0001</td></tr><tr><td>Total days of delirium (IQR)****</td><td>5 (6)</td><td>6 (9)</td><td>1 (3)</td><td>&lt;0.0001</td></tr></table>
70b825cc5507e452f3740b8f7d7c06a1c4483c152ab309c446b114be58989e5a.png
complex
<table><tr><td colspan="2">PM/DM-ILD (n = 116)</td><td>Infection (n = 38)</td><td>Non-infection (n = 78)</td><td><i>P</i> value</td></tr><tr><td colspan="2">Women (<i>n</i> (%))</td><td>24/38 (63.2%)</td><td>59/78 (75.6%)</td><td>0.16</td></tr><tr><td colspan="2">Type (<i>n</i>)</td><td>PM 7, DM 24, CADM 7</td><td>PM 15, DM 27, CADM 36</td><td>0.007**</td></tr><tr><td colspan="2">Age (years)</td><td>58.9 &#177; 13.9<sup>c</sup></td><td>54.7 &#177; 15.2<sup>c</sup></td><td>0.15</td></tr><tr><td rowspan="6">Baseline data</td><td>LDH (U/l)</td><td>420 (335&#8211;574)<sup>d</sup></td><td>343 (258&#8211;486)<sup>d</sup></td><td>0.005**</td></tr><tr><td>KL-6 (U/ml)</td><td>848 (605&#8211;1231)<sup>d</sup></td><td>572 (405&#8211;978)<sup>d</sup></td><td>0.014*</td></tr><tr><td>CRP (mg/dl)</td><td>0.9 (0.34&#8211;1.99)<sup>d</sup></td><td>0.30 (0.10&#8211;1.51)<sup>d</sup></td><td>0.032*</td></tr><tr><td>Lymphocyte (/&#956;l)</td><td>848 (552&#8211;1177)<sup>d</sup></td><td>1,008 (735&#8211;1435)<sup>d</sup></td><td>0.040*</td></tr><tr><td>Albumin (g/dl)</td><td>3.18 &#177; 0.52<sup>c</sup></td><td>3.53 &#177; 0.55<sup>c</sup></td><td>0.003**</td></tr><tr><td>PaCO<sub>2</sub> (mmHg)</td><td>36.0 (31.5&#8211;38.8)<sup>d</sup></td><td>38.0 (35.5&#8211;41.5)<sup>d</sup></td><td>0.016*</td></tr><tr><td rowspan="5">HRCT</td><td>Zone A</td><td>1.0 (0&#8211;2.0)<sup>d</sup></td><td>1.0 (0&#8211;1.0)<sup>d</sup></td><td>0.054</td></tr><tr><td>Zone B</td><td>1.0 (1.0&#8211;2.0)<sup>d</sup></td><td>1.0 (0&#8211;1.0)<sup>d</sup></td><td>0.049*</td></tr><tr><td>Zone C</td><td>2.0 (1.0&#8211;3.0)<sup>d</sup></td><td>1.0 (1.0&#8211;2.0)<sup>d</sup></td><td>0.036*</td></tr><tr><td>Zone D</td><td>3.0 (2.0&#8211;4.0)<sup>d</sup></td><td>3.0 (2.0&#8211;4.0)<sup>d</sup></td><td>0.068</td></tr><tr><td>Zone total</td><td>7.0 (4.0&#8211;11.0)<sup>d</sup></td><td>6.0 (4.0&#8211;8.0)<sup>d</sup></td><td>0.031*</td></tr><tr><td rowspan="5">Treatment (<i>n</i> (%))</td><td>Initial PSL dose (mg/kg/day)</td><td>0.94 &#177; 0.30<sup>c</sup></td><td>0.76 &#177; 0.29<sup>c</sup></td><td>0.005**</td></tr><tr><td>mPSL pulse (<i>n</i> (%))</td><td>31/38 (81.6%)</td><td>46/78 (59.0%)</td><td>0.016*</td></tr><tr><td>IVCY (<i>n</i> (%))</td><td>25/38 (65.8%)</td><td>23/78 (29.5%)</td><td>&lt;0.001**</td></tr><tr><td>Calcineurin inhibitor</td><td>34/38 (89.5%)</td><td>47/77 (61.0%)</td><td>0.002**</td></tr><tr><td>Combination therapy<sup>e</sup></td><td>23/38 (60.5%)</td><td>17/78 (21.8%)</td><td>&lt;0.001**</td></tr><tr><td>Outcome (<i>n</i> (%))</td><td>Death</td><td>11/38 (28.9%)</td><td>3/78 (3.8%)</td><td>&lt;0.001**</td></tr></table>
22e1078af499c940c190780fd6807d288e1815a191ee4dba3828fd5298a4a05c.png
complex
<table><tr><td></td><td></td><td></td><td colspan="2">MF (<i>&#949; </i>= 10)</td><td colspan="2">PHIA (<i>&#949; </i>= 14)</td></tr><tr><td>PDB code</td><td>Name</td><td>length</td><td>low energy</td><td>high score</td><td>low energy</td><td>high scoring</td></tr><tr><td>1gcq(B)</td><td>Grb2</td><td>57</td><td>37.2</td><td>49.5</td><td>36.1</td><td>47.0</td></tr><tr><td>1gcq(C)</td><td>Vav</td><td>69</td><td>45.6</td><td>55.0</td><td>45.1</td><td>52.4</td></tr><tr><td>1cka</td><td>c-Crk</td><td>56</td><td>39.8</td><td>52.1</td><td>35.9</td><td>49.9</td></tr><tr><td>1shg</td><td>alpha-spec.</td><td>57</td><td>26.9</td><td>37.6</td><td>26.5</td><td>39.5</td></tr><tr><td>1abo</td><td>Abl kinase</td><td>58</td><td>37.7</td><td>48.5</td><td>34.7</td><td>45.8</td></tr><tr><td>1ad5</td><td>Hck kinase</td><td>58</td><td>22.6</td><td>38.4</td><td>23.6</td><td>36.1</td></tr><tr><td>1csk</td><td>Csk</td><td>56</td><td>37.3</td><td>48.5</td><td>27.0</td><td>38.5</td></tr><tr><td>1fmk</td><td>c-Src</td><td>60</td><td>32.4</td><td>43.5</td><td>33.8</td><td>45.9</td></tr><tr><td></td><td>average</td><td></td><td>34.9</td><td>46.6</td><td>32.8</td><td>44.4</td></tr></table>
e5abe3d8cf21356b3e8c4bb31f7d6f4d44047e304e7dabf387d8e3e2c30a05be.png
simple
<table><tr><td>Developmental stage</td><td>Water (n)</td><td>Zinc chloride (n)</td><td>Soybean root exudate (n)</td></tr><tr><td>3 cell</td><td>2.67 &#177; 1.15 (3)</td><td>3.24 &#177; 1.25 (4)</td><td>3.20 &#177; 1.3 (6)</td></tr><tr><td>4 cell</td><td>4.67 &#177; 2.08 (3)</td><td>5.33 &#177; 1.53 (3)</td><td>5.25 &#177; 0.96 (7)</td></tr><tr><td>Gastrula</td><td>75.71 &#177; 9.25 (6)</td><td>72.60 &#177; 1.51 (5)</td><td>70.60 &#177; 4.35 (7)</td></tr><tr><td>Tadpole</td><td>100.50 &#177; 8.31 (6)</td><td>97.25 &#177; 4.57 (4)</td><td>93.80 &#177; 5.77 (5)</td></tr><tr><td>J1 stage</td><td>112 &#177; 7.66 (7)</td><td>113.80 &#177; 9.49 (5)</td><td>107.72 &#177; 10.12 (10)</td></tr><tr><td>J2 stage</td><td>168.29 &#177; 7.16 (7)</td><td>165.20 &#177; 9.76 (5)</td><td>166.14 &#177; 10.16 (11)</td></tr></table>
f1c6c919cca07ab54b684d0635b6c222b4270f1c145146d7f8e7490e4636fe57.png
simple
<table><tr><td>Citation</td><td>Mosquito Species</td><td>Diet Components</td><td>Success Rate</td></tr><tr><td>1955. Lea et al. [57]</td><td><i>Aedes aegypti</i>, <i>Ae. quadrimaculatus</i></td><td>Skimmed milk with 10% honey.</td><td>The authors state that skimmed milk can be a substitute for blood to produce eggs. <i>An. quadrimaculatus</i> was also fed proteose-peptone, liver concentrate, and casein hydrolysate.</td></tr><tr><td>1955. Dimond et al. [58]</td><td><i>Aedes aegypti</i></td><td>Mixture of 18 amino acids in 10% honey water.</td><td>A low egg number of 5.2 eggs/female is reported</td></tr><tr><td>1990. Kogan [56]</td><td><i>Aedes aegypti</i></td><td>Porcine albumin (102 mg/mL), &#947;-globulin (15 mg/mL), hemoglobin (8 mg/mL), ATP (1 mM), NaCl (5&#8211;10 mM), and NaHCO<sub>3</sub> (120 mM) in water.</td><td>101 &#177; 6.8 eggs/female</td></tr><tr><td>1996. Cosgrove and Wood [59]</td><td><i>Aedes aegypti</i></td><td>Porcine albumin (100 mg/mL), &#947;-globulin (15 mg/mL), hemoglobin (8 mg/mL), isoleucine (2.5 mg/mL), ATP (1 mM), NaCl (5&#8211;10 mM), and NaHCO<sub>3</sub> (120 mM) in water.</td><td>55.32 &#177; 4.1 eggs/female. 61.9% hatch rate</td></tr><tr><td>1996. Cosgrove and Wood [59]</td><td><i>Aedes aegypti</i></td><td>Bovine serum albumin (100 mg/mL), &#947;-globulin (30 mg/mL), hemoglobin (8 mg/mL), and ATP (1 mM) in Ringer&#8216;s solution.</td><td>64.56 &#177; 5.1 eggs/female. 54.1% hatch rate. A colony of <i>Ae. aegypti</i> was raised on this diet for more than 25 generations</td></tr><tr><td>1996. Griffith and Turner [60]</td><td><i>Culex quinquefasciatus</i></td><td>Soy milk formula (33 mg/mL), &#947;-globulin (11.5 mg/mL), ovalbumin (76.5 mg/mL), ATP (1 mM), NaCl (150 mM), and NaHCO<sub>3</sub> (100 mM) in water. </td><td>116 eggs/female. Colonies were maintained for 6 and 15 generations</td></tr><tr><td>2014. Pitts [61]</td><td><i>Aedes albopictus</i></td><td>Bovine serum albumin (200 mg/mL) and ATP (1 mM) in phosphate buffered saline. </td><td>92.2 &#177; 4.4 eggs/female. 71.8% &#177; 6.1% hatch rate. Colonies were maintained for 6 generations</td></tr><tr><td>2015. Gonzales et al. [32]</td><td><i>Aedes aegypti</i></td><td>Bovine serum albumin (200 mg/mL), ATP (1 mM), and iron (III) chloride (0.5 mg/mL) in <i>Aedes</i> physiological saline. </td><td>66 &#177; 10.8 eggs/female. 33.06% &#177; 12.34% hatch rate</td></tr></table>
ca2c7b7c1d7a681c553b2c6791d70ad388908ed81c29a98e3fdb3cf22196670a.png
complex
<table><tr><td rowspan="2">Indicator <sup>a,b</sup></td><td colspan="2">Overall Diet</td><td colspan="5">Quintiles of the Contribution of Ultra-Processed Foods to Total Energy Intake</td><td colspan="2">Standardized Regression Coefficient</td></tr><tr><td><i>Mean</i></td><td><i>SE</i></td><td>Q1</td><td>Q2</td><td>Q3</td><td>Q4</td><td>Q5</td><td>Crude</td><td>Adjusted <sup>c</sup></td></tr><tr><td>Energy intake (kcal/d)</td><td>1764.71</td><td>8.55</td><td>1732.00</td><td>1766.35</td><td>1784.89</td><td>1776.38</td><td>1763.96</td><td>0.02</td><td>0.03</td></tr><tr><td>Percentage of energy intake from:</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Proteins</td><td>15.77</td><td>0.06</td><td>17.24</td><td>16.57</td><td>16.00</td><td>15.19</td><td>13.84</td><td>-0.32 *</td><td>-0.30 *</td></tr><tr><td>Carbohydrates</td><td>48.65</td><td>0.12</td><td>45.45</td><td>47.27</td><td>48.61</td><td>50.07</td><td>51.84</td><td>0.30 *</td><td>0.26 *</td></tr><tr><td>Free sugars</td><td>12.44</td><td>0.10</td><td>9.94</td><td>11.34</td><td>12.16</td><td>13.38</td><td>15.41</td><td>0.29 *</td><td>0.23 *</td></tr><tr><td>Fats</td><td>32.18</td><td>0.09</td><td>31.37</td><td>31.93</td><td>32.12</td><td>32.47</td><td>33.04</td><td>0.09 *</td><td>0.11 *</td></tr><tr><td>Saturated fats</td><td>12.10</td><td>0.05</td><td>11.67</td><td>12.19</td><td>12.24</td><td>12.18</td><td>12.19</td><td>0.04 *</td><td>0.03</td></tr><tr><td>Dietary fibre density (g/1000 kcal)</td><td>7.70</td><td>0.04</td><td>8.36</td><td>8.04</td><td>7.81</td><td>7.46</td><td>6.86</td><td>-0.20 *</td><td>-0.13 *</td></tr><tr><td>Sodium density (g/1000 kcal)</td><td>1213.91</td><td>5.11</td><td>1072.57</td><td>1204.21</td><td>1228.75</td><td>1245.29</td><td>1318.85</td><td>0.23 *</td><td>0.22 *</td></tr><tr><td>Potassium density (mg/1000 kcal)</td><td>1547.86</td><td>5.94</td><td>1735.20</td><td>1635.79</td><td>1571.38</td><td>1470.65</td><td>1326.19</td><td>-0.37 *</td><td>-0.31 *</td></tr></table>
8f7ba5c6aed4718cdef53b8e5938335ef01f46d7370c6416af8bebf04950da98.png
simple
<table><tr><td>Type of services</td><td>Quantitative indicators (Survey of female workers)</td><td>Qualitative indicators</td></tr><tr><td>Hotline</td><td>&#8226; Frequency of services&#8226; Ranking frequent topic of call&#8226; Number of calls over time&#8226; % of women ever heard about the services&#8226; % of women ever used services&#8226; Ranking about quality/importance of services</td><td>&#8226; In-depth information about issues when implementing services from service provider (hotline expert)&#8226; In-depth information about relevance, quality and usefulness of services from female workers</td></tr><tr><td>Map of health care services providers</td><td>&#8226; Number of health services provided surveyed and presented in map&#8226; % of women ever received map&#8226; % of women ever used map to find health care providers&#8226; Ranking about quality/importance of services</td><td>&#8226; In-depth information about relevance, quality and usefulness of services from female workers</td></tr><tr><td>SMS</td><td>&#8226; Frequency of services&#8226; Number of SMS developed&#8226; Number of SMS sent over time&#8226; Major topic of SMS sent&#8226; % of women ever heard about the services&#8226; % of women ever used services&#8226; Ranking about quality/importance of services</td><td>&#8226; In-depth information about relevance, quality and usefulness of services from female workers</td></tr></table>
a633f28d8d4ae3aff2fb3dda73539d0100e20dfda44b8bdcad4c9c28c422e27b.png
simple
<table><tr><td>Author (Year)</td><td>Number of patients with seminoma</td><td>Residual disease</td><td>Necrosis/scar</td></tr><tr><td>Chong <i>et al</i> (1986) [8]</td><td>5</td><td>1 (20%)</td><td>4 (80%)</td></tr><tr><td>Greist <i>et al</i> (1984) [7]<sup>a</sup></td><td>1</td><td>NA</td><td>NA</td></tr><tr><td>Ng (1997) [12]</td><td>1<sup>b</sup></td><td>0</td><td>1b</td></tr><tr><td>Geldart <i>et al</i> (2002) [13]</td><td>18</td><td>3 (16.7%)</td><td>15 (83.3%)</td></tr><tr><td>Ramani <i>et al</i> (2008) [16]</td><td>13</td><td>0</td><td>13 (100%)</td></tr><tr><td>Miller <i>et al</i> (2012) [17]<sup>c</sup></td><td>6</td><td>4</td><td>2 (33.3%)</td></tr><tr><td>Total</td><td>43(44)<sup>d</sup></td><td>8 (18.6%)</td><td>35 (81.3%)</td></tr></table>
33964d8871a959e4b92b53a685bd835d3dfc995209f3145fd2327324f9038846.png
simple
<table><tr><td></td><td>All tumors</td><td>TC</td><td>AC</td><td>LCNEC</td></tr><tr><td>Clinical status at last f/u</td><td></td><td></td><td></td><td></td></tr><tr><td><i>Alive without recurrence</i></td><td>35</td><td>30</td><td>5</td><td>0</td></tr><tr><td><i>Alive with recurrence</i></td><td>2</td><td>0</td><td>1</td><td>1</td></tr><tr><td><i>Alive, unknown</i></td><td>7</td><td>6</td><td>0</td><td>1</td></tr><tr><td><i>Died with disease</i></td><td>8</td><td>0</td><td>1</td><td>7</td></tr><tr><td><i>Died of other causes</i></td><td>2</td><td>2</td><td>0</td><td>0</td></tr><tr><td><i>Died, unknown cause</i></td><td>1</td><td>1</td><td>0</td><td>0</td></tr><tr><td>Median disease free survival (months)<sup>&#8224;</sup></td><td>NR</td><td>NR</td><td>35.5</td><td>10.1</td></tr><tr><td>Hazard ratio</td><td></td><td>&lt;0.01</td><td>0.10</td><td>1.00</td></tr><tr><td>Confidence interval (95%)</td><td></td><td>-</td><td>0.01-0.57</td><td>-</td></tr><tr><td><i>P-value</i></td><td><i>-</i></td><td>&lt;0.0001</td><td>0.0063</td><td>-</td></tr><tr><td><i>Mean DFS follow-up (months)</i></td><td>20.2</td><td>21.9</td><td>21.9</td><td>12.0</td></tr><tr><td>Median survival (months)</td><td>NR</td><td>NR</td><td>NR</td><td>19.7</td></tr><tr><td>Hazard ratio</td><td></td><td>0.06</td><td>0.08</td><td>1.00</td></tr><tr><td>Confidence interval (95%)</td><td></td><td>0.01-0.24</td><td>0.00-0.54</td><td>-</td></tr><tr><td><i>P-value</i></td><td><i>-</i></td><td>&lt;0.0001</td><td>0.0070</td><td>-</td></tr><tr><td><i>Mean OS follow-up (months)</i></td><td>29.6</td><td>31.4</td><td>34.3</td><td>18.3</td></tr></table>
e15ffeca0c73ea41a6819de0bc0872ef8fb5520175dad31e1a61731188763293.png
complex
<table><tr><td>CO initial liquid conc. (mM) (headspace, atm)</td><td><i>t</i><sub>max</sub> (d)<sup>*</sup></td><td>CO specific activity (mmol CO/g VSS.d)</td><td>Relative CO conversion rate (%)<sup>&#167;</sup></td><td>CH<sub>4</sub> specific activity (mmol CO/g VSS.d)</td><td>Relative CH<sub>4</sub> conversion rate (%)<sup>&#167;</sup></td><td colspan="3">Products formed (% of the stoichiometric yield)<sup>&#8225;</sup></td><td>H<sub>2</sub> at maximum (atm.10<sup>&#8722;3</sup>)</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td>CH<sub>4</sub></td><td>Acetate</td><td>Propionate</td><td></td></tr><tr><td colspan="10">VANCOMYCIN</td></tr><tr><td>0.09 (0.1)</td><td><sup>**</sup></td><td>0.26 &#177; 0.03</td><td>15 &#177; 2</td><td>0.15 &#177; 0.03</td><td>13 &#177; 3</td><td>154 &#177; 6</td><td>13 &#177; 3</td><td>30 &#177; 10</td><td>0.4 &#177; 0.01</td></tr><tr><td>0.17 (0.2)</td><td><sup>**</sup></td><td>0.36 &#177; 0.05</td><td>7 &#177; 1</td><td>0.14 &#177; 0.01</td><td>14 &#177; 1</td><td>130 &#177; 4</td><td>21 &#177; 15</td><td>17 &#177; 0.0</td><td>0.3 &#177; 0.01</td></tr><tr><td>0.26 (0.3)</td><td>20</td><td>0.53 &#177; 0.08</td><td>7 &#177; 1</td><td>0.17 &#177; 0.0</td><td>31</td><td>113 &#177; 3</td><td>3 &#177; 1</td><td>12 &#177; 0</td><td>0.4 &#177; 0.005</td></tr><tr><td>0.44 (0.5)</td><td>44</td><td>0.99 &#177; 0.06</td><td>11 &#177; 1</td><td>0.26 &#177; 0.04</td><td>58 &#177; 18</td><td>89 &#177; 8</td><td>8</td><td>7</td><td>1.2 &#177; 0.2</td></tr><tr><td>0.87 (1.0)</td><td>40</td><td>2.11 &#177; 0.32</td><td>30 &#177; 5</td><td>0.74 &#177; 0.06</td><td>1480 &#177; 60</td><td>89 &#177; 0.2</td><td>2.6</td><td>3.5</td><td>85</td></tr><tr><td>1.31 (1.5)</td><td>55</td><td>1.38 &#177; 0.05</td><td>19 &#177; 1</td><td>0.31 &#177; 0.06</td><td>&#8734;</td><td>66 &#177; 22</td><td>7 &#177; 0.1</td><td>5.4 &#177; 1.9</td><td>72 &#177; 1.2</td></tr><tr><td colspan="10">BES</td></tr><tr><td>0.09 (0.1)</td><td>5</td><td>2.10 &#177; 0.14</td><td>119 &#177; 8</td><td>0.05 &#177; 0.0</td><td>4</td><td>28 &#177; 0.2</td><td>67 &#177; 2</td><td>18 &#177; 3</td><td>3.3 &#177; 0.01</td></tr><tr><td>0.17 (0.2)</td><td>4</td><td>2.39 &#177; 0.46</td><td>45 &#177; 9</td><td>0.01 &#177; 0.0</td><td>1</td><td>9 &#177; 0.3</td><td>51 &#177; 8</td><td>7 &#177; 0.4</td><td>5.6 &#177; 2.3</td></tr><tr><td>0.26 (0.3)</td><td>5</td><td>2.14 &#177; 0.11</td><td>30 &#177; 2</td><td>0.03 &#177; 0.01</td><td>6 &#177; 2</td><td>12 &#177; 3</td><td>82 &#177; 4</td><td>17 &#177; 1</td><td>28 &#177; 14</td></tr><tr><td>0.44 (0.5)</td><td>8</td><td>4.64 &#177; 0.30</td><td>54 &#177; 3</td><td>0.00 &#177; 0.0</td><td>0</td><td>2 &#177; 0</td><td>54 &#177; 3</td><td>10 &#177; 1</td><td>22 &#177; 5</td></tr><tr><td>0.87 (1.0)</td><td>21</td><td>6.30 &#177; 0.28</td><td>82 &#177; 12</td><td>0.001 &#177; 0.00</td><td>2</td><td>0.4 &#177; 0.0</td><td>57 &#177; 14</td><td>16 &#177; 8</td><td>37 &#177; 5</td></tr><tr><td>1.31 (1.5)</td><td>31</td><td>2.92 &#177; 0.61</td><td>41 &#177; 9</td><td>0.000 &#177; 0.00</td><td>0</td><td>0.1 &#177; 0.1</td><td>45 &#177; 7</td><td>11 &#177; 1</td><td>37 &#177; 12</td></tr></table>
77b6d15404fb82f729c49358c1f9afb8d314e482f45cd843c60ac62d6285a559.png
simple
<table><tr><td>SEQUENCE</td><td>ENERGY</td><td>SEQUENCE</td><td>ENERGY</td></tr><tr><td>AAA</td><td>-0.65821</td><td>AAAAA</td><td>-2.84828</td></tr><tr><td>AAB</td><td>0.03223</td><td>AAAAB</td><td>-1.58944</td></tr><tr><td>ABA</td><td>-0.65821</td><td>AAABA</td><td>-2.44493</td></tr><tr><td>ABB</td><td>0.03223</td><td>AAABB</td><td>-0.54688</td></tr><tr><td>BAB</td><td>-0.03027</td><td>AABAA</td><td>-2.53170</td></tr><tr><td>BBB</td><td>-0.03027</td><td>AABAB</td><td>-1.34774</td></tr><tr><td></td><td></td><td>AABBA</td><td>-0.92662</td></tr><tr><td>AAAA</td><td>-1.67633</td><td>AABBB</td><td>0.04017</td></tr><tr><td>AAAB</td><td>-0.58527</td><td>ABAAB</td><td>-1.37647</td></tr><tr><td>AABA</td><td>-1.45098</td><td>ABABA</td><td>-2.22020</td></tr><tr><td>AABB</td><td>0.06720</td><td>ABABB</td><td>-0.61680</td></tr><tr><td>ABAB</td><td>0.64938</td><td>ABBAB</td><td>-0.00565</td></tr><tr><td>ABBA</td><td>-0.03617</td><td>ABBBA</td><td>-0.39804</td></tr><tr><td>ABBB</td><td>0.00470</td><td>ABBBB</td><td>-0.06596</td></tr><tr><td>BAAB</td><td>0.06172</td><td>BAAAB</td><td>-0.52108</td></tr><tr><td>BABB</td><td>-0.00078</td><td>BAABB</td><td>0.09621</td></tr><tr><td>BBBB</td><td>0.13974</td><td>BABAB</td><td>-0.64803</td></tr><tr><td></td><td></td><td>BABBB</td><td>-0.18266</td></tr><tr><td></td><td></td><td>BBABB</td><td>-0.24020</td></tr><tr><td></td><td></td><td>BBBBB</td><td>-0.45266</td></tr></table>
80e4263354c45d8b07bb9c4a313028e0836657d1da8d129cf85ef2123e43277c.png
simple
<table><tr><td>Drug</td><td>Route</td><td>IC<sub>50</sub>(&#956;M)</td><td>Max serum level (&#956;M)</td><td>Elimination half life</td><td>Efficacy</td><td>Mode of action</td></tr><tr><td><i>Aclarubicin</i></td><td>IV</td><td>0.94</td><td>0.34</td><td>13.3 hrs</td><td>-122.30</td><td>Topoisomerase I and II inhibitor</td></tr><tr><td><i>Actinomycin D</i></td><td>IV</td><td>0.38</td><td>0.02-0.08</td><td>36 hrs</td><td>-112.51</td><td>Inhibitors of DNA synthesis</td></tr><tr><td><i>Bortezomib</i></td><td>IV</td><td>0.34</td><td>0.16-0.31</td><td>9-15 hrs</td><td>-77.11</td><td>Proteasome inhibitor;</td></tr><tr><td><i>Carboquone</i></td><td>PO/IV</td><td>0.75</td><td>0.62-0.74 (200-240 ng/mL)</td><td>0.5 hrs</td><td>-119.79</td><td>Alkylating agents</td></tr><tr><td><i>Ciclopirox</i></td><td>Topical</td><td>0.64</td><td>N/A - topical only</td><td>2.2 hrs in rabbits</td><td>-61.11</td><td>Chelation of polyvalent metal cations</td></tr><tr><td><i>Deslanoside</i></td><td> </td><td>0.34</td><td>0.16</td><td>51 hrs</td><td>-110.35</td><td>Na+/K + ATPase inhibition;</td></tr><tr><td><i>Digitoxin</i></td><td>IV</td><td>0.08</td><td>0.05-0.2</td><td>4-9 days</td><td>-109.13</td><td>Na+/K + ATPase inhibition;</td></tr><tr><td><i>Digoxin</i></td><td>PO/IV</td><td>0.19</td><td>0.003</td><td>36-48 hrs</td><td>-111.40</td><td>Na+/K + ATPase inhibition;</td></tr><tr><td><i>Ecteinascidin</i></td><td>IV</td><td>0.01</td><td>Up to 0.05</td><td>50-180 hrs</td><td>-116.82</td><td>Disruption of DNA strand</td></tr><tr><td><i>Homoharringtonine</i></td><td>SQ</td><td>0.21</td><td>0.176</td><td>9.3 hrs</td><td>-125.33</td><td>Protein synthesis inhibitor</td></tr><tr><td><i>Lanatoside A</i></td><td>IV/PO</td><td>0.19</td><td>N/A</td><td>N/A</td><td>-114.10</td><td>Na+/K + ATPase inhibition;</td></tr><tr><td><i>Lanatoside C</i></td><td>IV/PO</td><td>0.3</td><td>N/A</td><td>N/A</td><td>-117.82</td><td>Na+/K + ATPase inhibition;</td></tr><tr><td><i>Methotrexate</i></td><td>PO/IV</td><td>0.02</td><td>10-100</td><td>8-15 hrs</td><td>-74.91</td><td>DHFR inhibitor</td></tr><tr><td><i>Metildigoxin</i></td><td>PO/IV</td><td>0.24</td><td>N/A</td><td>N/A</td><td>-110.90</td><td>Na+/K + ATPase inhibition;</td></tr><tr><td><i>Niclosamide</i></td><td>PO/IV</td><td>0.27</td><td>N/A</td><td>N/A</td><td>-94.29</td><td>Uncouple oxidative phosphorylation</td></tr><tr><td><i>Ouabain</i></td><td>IV</td><td>0.08</td><td>0.128</td><td>18 hrs</td><td>-110.64</td><td>Na+/K + ATPase inhibition;</td></tr><tr><td><i>Plicamycin</i></td><td>IV</td><td>0.94</td><td>0.6 &#956;M</td><td>10.5 hrs</td><td>-117.62</td><td>RNA synthesis inhibitor;</td></tr><tr><td><i>Proscillaridin A</i></td><td>IV/PO</td><td>0.01</td><td>0.019 (IV); 0.0019 (PO)</td><td>23-33 hrs</td><td>-110.55</td><td>Na+/K + ATPase inhibition;</td></tr><tr><td><i>Pyrimethamine</i></td><td>PO/IV</td><td>0.75</td><td>8.04</td><td>140-190 hrs</td><td>-81.43</td><td>DHFR inhibitor</td></tr><tr><td><i>Rotenone</i></td><td>N/A</td><td>0.75</td><td>N/A</td><td>N/A</td><td>-69.22</td><td>Electron transport chain in mitochondria interference</td></tr><tr><td><i>Trimetrexate glucuronate</i></td><td>IV</td><td>0.01</td><td>N/A</td><td>11-16 hrs</td><td>-80.39</td><td>DHFR inhibitor</td></tr></table>
9662066eea85145b8d7cba0dab26a253c37081100d74b68bb2d16fb17e9d28af.png
complex
<table><tr><td rowspan="2">Results</td><td colspan="8">Data Frequency (Hz)</td></tr><tr><td>10</td><td>4</td><td>2</td><td>1</td><td>0.5</td><td>0.33</td><td>0.25</td><td>0.2</td></tr><tr><td>Training instances</td><td>729,097</td><td>364,588</td><td>184,297</td><td>98,301</td><td>50,805</td><td>34,291</td><td>25,527</td><td>20,566</td></tr><tr><td>Test instances</td><td>6,561,871</td><td>3,281,290</td><td>1,658,673</td><td>884,709</td><td>457,244</td><td>308,623</td><td>229,746</td><td>185,092</td></tr><tr><td>Overall accuracy (%)</td><td>99.963</td><td>99.883</td><td>99.690</td><td>99.131</td><td>98.012</td><td>96.731</td><td>95.415</td><td>94.477</td></tr><tr><td>Time (s)</td><td>304.86</td><td>102.09</td><td>42.05</td><td>19.37</td><td>9.45</td><td>6.02</td><td>5.35</td><td>3.53</td></tr></table>
af5d917e1cc2d04dc87a91f778f1649b49a199c899832d6dea1687c5d1aa965a.png
simple
<table><tr><td>Dataset</td><td>Description</td><td>Updated</td><td>Genes</td><td>Reference</td></tr><tr><td>hg18rpa</td><td>Protein-coding genes on autosomal chromosomes (based on human genome hg18 and RefSeq genes)</td><td>2011</td><td>18,166</td><td>[35]</td></tr><tr><td>HI</td><td>Recombination hotspots intersected genes</td><td>2010</td><td>1,156</td><td>-</td></tr><tr><td>MI</td><td>Recombination middle spots intersected genes</td><td>2010</td><td>1,481</td><td>-</td></tr><tr><td>CI</td><td>Recombination cold spots intersected genes</td><td>2010</td><td>1,594</td><td>-</td></tr><tr><td>HK</td><td>Housekeeping genes</td><td>2011</td><td>1,974</td><td>[36]</td></tr><tr><td>SPD</td><td>Genes encoding secreted proteins</td><td>2010</td><td>1,667</td><td>[37]</td></tr><tr><td>TiGER</td><td>Tissue-specific genes</td><td>2008</td><td>4,710</td><td>[38]</td></tr><tr><td>DGD</td><td>Duplicated genes</td><td>2012</td><td>4,393</td><td>[16]</td></tr><tr><td>AGE</td><td>Genes classified by different evolutionary age</td><td>2011</td><td>16,418</td><td>[17]</td></tr><tr><td>OMIM</td><td>Mendelian disorder associated genes in human</td><td>2012</td><td>2,624</td><td>[39]</td></tr><tr><td>MD</td><td>Mendelian Disease Genes (at least one mutation in the particular gene is causative of the disease)</td><td>2011</td><td>1,629</td><td>[21]</td></tr><tr><td>CGC</td><td>Genes with mutations have been causally implicated in cancer</td><td>2011</td><td>424</td><td>[23]</td></tr><tr><td>TICdb</td><td>Reciprocal translocation associated genes in human tumours</td><td>2008</td><td>240</td><td>[40]</td></tr><tr><td>dbCRID</td><td>Chromosomal rearrangement associated genes in human diseases</td><td>2010</td><td>401</td><td>[22]</td></tr><tr><td>InteCR</td><td>Integrated chromosomal rearrangement associated genes in human diseases (Combined of dbCRID, TICdb and CGC genes)</td><td>2012</td><td>614</td><td>-</td></tr></table>
c5744d69d5359a6a006f9f069112e0834b5c51c11ef434f226e2c5e2b4358a6a.png
simple
<table><tr><td></td><td>Inoculated andContacts vs.Controls</td><td>Inoculated vs.Contacts</td><td>Carriers vs.Non-Carriers</td></tr><tr><td>SAA</td><td>&lt;0.0001***</td><td>0.61</td><td>0.49</td></tr><tr><td>IFN</td><td>&lt;0.0001***</td><td>0.43</td><td>0.27</td></tr><tr><td>Haptoglobin</td><td>&lt;0.0001***</td><td>0.04*</td><td>0.015*</td></tr></table>
dc43f74e41a2b584143d5c9f8a82e06c50f0893698dcaf2e0e58e4fe1ce4971b.png
simple
<table><tr><td>Gene name</td><td>Sequence (5&#8217;&#8211;3&#8217;)</td></tr><tr><td>&#946;<i>-actin</i></td><td>Sense: TCTTGGGTATGGAGTCCTGAntisense: TAGAAGCATTTGCGGTGG</td></tr><tr><td><i>FGA</i></td><td>Sense: GCAGAACAGCATCCAGGAGCAGGAntisense: TCCACCTGGTAATCAAAACTTCTAGCAC</td></tr><tr><td><i>CA2</i></td><td>Sense: CACTGGCACGAGCACTTCAntisense: ACTTCACGCCATCCACAGT</td></tr><tr><td><i>KRT7</i></td><td>Sense: CTGGACGGGTTGTTAAATAntisense: TCCGCTTCGTAGAGAGAT</td></tr><tr><td><i>GRTP1</i></td><td>Sense: GGCTGCTCCAACGCCCACTTAntisense: CGCAACGCCTTCTGCTCTTT</td></tr><tr><td><i>MnSOD</i></td><td>Sense: CTGACCTGCCCTACGACTAntisense: TGGTATGATTGATATGACCC</td></tr><tr><td><i>LOC429524</i></td><td>Sense: GGAGGAAATGCGGCGCTTAGAntisense: GGCTGGACGAGACGCTGTTGA</td></tr><tr><td><i>ATP5A1</i></td><td>Sense: CAGTTTGGGTCTGATTTGGAntisense: AGCTTAGCTTCCGTCTGG</td></tr><tr><td><i>FKBP4</i></td><td>Sense: TACCTCCCAATGCTACGCAntisense: CCTTCGCCTTTCTTACGG</td></tr><tr><td><i>GOT1</i></td><td>Sense: GCACAGACCCTACTCCAGACAntisense: AAGCCCTCGGAGACAAAG</td></tr><tr><td><i>LMNA</i></td><td>Sense: GGGGAACTGGCAGGTGAAGCAntisense: CCTCGTCGTCGTCGTTGATG</td></tr><tr><td><i>PTGDS</i></td><td>Sense: CCGAGGTCTTTTGTTTGAntisense: AGGAGGGGGACTTTGATG</td></tr><tr><td><i>HSP</i>&#946;<i>1</i></td><td>Sense: CAAACACGAGGAGAAACAAntisense: CGTTTATTCAAGGCACTG</td></tr><tr><td><i>Apo A-I</i></td><td>Sense: TCCGCTTCGTAGAGAGATGTGAntisense: TCAGCGTGTCCAGGTTGTC</td></tr></table>
85da63a3f5d330f08ebaa9207ea49942f33d4f208821e52c40f61dd0d9a324a7.png
complex
<table><tr><td></td><td colspan="3">Independently (N = 372)</td><td colspan="3">Long-term care facility (N = 107)</td></tr><tr><td></td><td>N</td><td>HR (95%CI)</td><td><i>P-</i>value</td><td>N</td><td>HR (95%CI)</td><td><i>P-</i>value</td></tr><tr><td><i>Socio-demographic factors</i></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Female</td><td>242</td><td>1.4 (0.9, 2.3)</td><td>0.127</td><td>80</td><td>2.1 (0.9, 4.9)</td><td>0.098</td></tr><tr><td>Low income</td><td>170</td><td>1.0 (0.7, 1.5)</td><td>0.914</td><td>68</td><td>0.9 (0.5, 1.6)</td><td>0.650</td></tr><tr><td>Primary school only</td><td>221</td><td>1.2 (0.8, 1.9)</td><td>0.452</td><td>75</td><td>2.3 (1.1, 4.9)</td><td>0.036</td></tr><tr><td>Smoking (current)</td><td>55</td><td>1.1 (0.6, 1.9)</td><td>0.817</td><td>15</td><td>1.4 (0.6, 3.1)</td><td>0.443</td></tr><tr><td>Body Mass Index &#8805;27</td><td>171</td><td>1.2 (0.8, 1.8)</td><td>0.329</td><td>41</td><td>0.9 (0.4, 1.7)</td><td>0.655</td></tr><tr><td><i>Functioning</i></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Severe cognitive impairment(MMSE &lt; 19)</td><td>36</td><td>1.9 (1.1, 3.4)</td><td>0.030</td><td>54</td><td>2.3 (1.2, 4.4)</td><td>0.009</td></tr><tr><td>Depressive symptoms (GDS-15 &gt; 4)</td><td>46</td><td>1.2 (0.6, 2.2)</td><td>0.578</td><td>12</td><td>0.2 (0.0, 1.7)</td><td>0.146</td></tr><tr><td>Disability in daily living &#8224;</td><td>191</td><td>1.9 (1.3, 2.9)</td><td>0.002</td><td>92</td><td>3.6 (1.1, 11.7)</td><td>0.033</td></tr><tr><td><i>Co-morbidities</i></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Diabetes mellitus</td><td>53</td><td>0.8 (0.4, 1.5)</td><td>0.536</td><td>23</td><td>1.1 (0.5, 2.6)</td><td>0.759</td></tr><tr><td>Stroke</td><td>31</td><td>1.4 (0.8, 2.8)</td><td>0.269</td><td>29</td><td>1.6 (0.9, 3.1)</td><td>0.143</td></tr><tr><td>Cancer</td><td>80</td><td>1.1 (0.6, 1.8)</td><td>0.845</td><td>17</td><td>1.0 (0.4, 2.4)</td><td>0.963</td></tr><tr><td>Benign Prostatic Hyperplasia(IPSS score &#8805;8)</td><td>49</td><td>1.3 (0.6, 2.9)</td><td>0.521</td><td>4</td><td>NA</td><td>NA</td></tr><tr><td>UTI between the ages of 85 and 86 years</td><td>41</td><td>3.3 (2.1, 5.3)</td><td>&lt; 0.001</td><td>31</td><td>4.1 (2.2, 7.5)</td><td>&lt; 0.001</td></tr><tr><td>Unintentional loss of faeces</td><td>35</td><td>2.7 (1.6, 4.8)</td><td>&lt; 0.001</td><td>30</td><td>2.5 (1.3, 4.6)</td><td>0.004</td></tr><tr><td>Self-reported urine incontinence</td><td>143</td><td>1.7 (1.2, 2.6)</td><td>0.007</td><td>69</td><td>1.9 (0.9, 4.0)</td><td>0.071</td></tr><tr><td>Medical diagnosis incontinence</td><td>69</td><td>1.3 (0.8, 2.2)</td><td>0.260</td><td>26</td><td>1.7 (0.9, 3.4)</td><td>0.110</td></tr><tr><td>PRAFAB score &#8805;11</td><td>76</td><td>0.7 (0.3, 1.7)</td><td>0.462</td><td>24</td><td>NA</td><td>NA</td></tr><tr><td>PRAFAB: Pad use</td><td>69</td><td>1.0 (0.4, 2.2)</td><td>0.949</td><td>22</td><td>1.9 (0.3, 15.1)</td><td>0.530</td></tr><tr><td>Creatinine clearance &lt; 30 mL/minute</td><td>29</td><td>0.8 (0.4, 1.6)</td><td>0.487</td><td>14</td><td>1.8 (0.5, 5.8)</td><td>0.337</td></tr><tr><td>CRP &gt; 5 mg/L</td><td>116</td><td>1.2 (0.8, 1.8)</td><td>0.425</td><td>43</td><td>1.1 (0.6, 2.1)</td><td>0.664</td></tr></table>
db3d5648e5afaccf5b5db9636a913435120db766ff7a9f2f65ed562a47d75630.png
complex
<table><tr><td rowspan="3">Variable</td><td colspan="3">Unadjusted</td><td colspan="3">Adjusted</td></tr><tr><td>OR</td><td>95%CI</td><td>p</td><td>OR</td><td>95%CI</td><td>p</td></tr><tr><td colspan="7">Level 1<sup>a</sup> &#8211; Demographic characteristics</td></tr><tr><td>Education level</td><td> </td><td> </td><td>&lt; 0.001</td><td> </td><td> </td><td>0.024</td></tr><tr><td>High school and university (C/I)</td><td>1.00</td><td> </td><td> </td><td>1.00</td><td> </td><td> </td></tr><tr><td>Basic education (C)</td><td>1.71</td><td>1.09&#8211;2.67</td><td> </td><td>1.27</td><td>0.73&#8211;2.19</td><td> </td></tr><tr><td>Basic education (I)/Illiterate</td><td>3.10</td><td>1.99&#8211;4.82</td><td> </td><td>2.02</td><td>1.17&#8211;3.47</td><td> </td></tr><tr><td>Access to telephone</td><td> </td><td> </td><td>0.001</td><td> </td><td> </td><td>0.006</td></tr><tr><td>Yes</td><td>1.00</td><td> </td><td> </td><td>1.00</td><td> </td><td> </td></tr><tr><td>No</td><td>2.95</td><td>1.58&#8211;5.52</td><td> </td><td>2.45</td><td>1.28&#8211;4.70</td><td> </td></tr><tr><td colspan="7">Level 2<sup>b</sup> &#8211; Behavioral characteristics</td></tr><tr><td>Religion</td><td> </td><td> </td><td>0.044</td><td> </td><td> </td><td>0.012</td></tr><tr><td>No religion</td><td>1.00</td><td> </td><td> </td><td>1.00</td><td> </td><td> </td></tr><tr><td>Catholic</td><td>1.16</td><td>0.77&#8211;1.74</td><td> </td><td>1.70</td><td>1.07&#8211;2.68</td><td> </td></tr><tr><td>Evangelical</td><td>0.68</td><td>0.45&#8211;1.03</td><td> </td><td>0.86</td><td>0.53&#8211;1.39</td><td> </td></tr><tr><td colspan="2">Number of pregnancies including current one</td><td> </td><td>0.002</td><td> </td><td> </td><td>0.008</td></tr><tr><td>1</td><td>1.00</td><td> </td><td> </td><td>1.00</td><td> </td><td> </td></tr><tr><td>2&#8211;3</td><td>1.64</td><td>1.11&#8211;2.43</td><td> </td><td>1.77</td><td>1.12&#8211;2.79</td><td> </td></tr><tr><td>&#8805; 4</td><td>2.23</td><td>1.39&#8211;3.58</td><td> </td><td>2.27</td><td>1.30&#8211;3.95</td><td> </td></tr><tr><td colspan="3">Number of sex partners in the last 12 months</td><td>&lt; 0.001</td><td> </td><td> </td><td>0.004</td></tr><tr><td>1</td><td>1.00</td><td> </td><td> </td><td>1.00</td><td> </td><td> </td></tr><tr><td>2</td><td>1.93</td><td>1.18&#8211;3.17</td><td> </td><td>1.66</td><td>0.93&#8211;2.97</td><td> </td></tr><tr><td>&#8805; 3</td><td>4.60</td><td>2.42&#8211;8.75</td><td> </td><td>3.15</td><td>1.51&#8211;6.53</td><td> </td></tr><tr><td colspan="2">Age at which started using drugs (years)</td><td> </td><td>&lt; 0.001</td><td> </td><td> </td><td>0.003</td></tr><tr><td>Does not use</td><td>1.00</td><td> </td><td> </td><td>1.00</td><td> </td><td> </td></tr><tr><td>&#8805; 18</td><td>1.83</td><td>0.73&#8211;4.60</td><td> </td><td>0.50</td><td>0.16&#8211;1.53</td><td> </td></tr><tr><td>&#8804; 17</td><td>5.66</td><td>3.03&#8211;10.56</td><td> </td><td>3.04</td><td>1.45&#8211; 6.40</td><td> </td></tr><tr><td>Current partner uses drugs</td><td> </td><td> </td><td>&lt;0.001</td><td> </td><td> </td><td>0.026</td></tr><tr><td>No</td><td>1.00</td><td> </td><td> </td><td>1.00</td><td> </td><td> </td></tr><tr><td>Yes</td><td>2.26</td><td>1.47&#8211;3.47</td><td> </td><td>1.78</td><td>1.07&#8211;2.98</td><td> </td></tr><tr><td colspan="7">Level 3<sup>c</sup> &#8211; Clinical, obstetric, and health care history in prenatal care and maternity hospital</td></tr><tr><td colspan="3">Number of appointments in the prenatal care</td><td>&lt; 0.001</td><td> </td><td> </td><td>&lt; 0.001</td></tr><tr><td>&#8805; 7</td><td>1.00</td><td> </td><td> </td><td>1.00</td><td> </td><td> </td></tr><tr><td>6&#8211;4</td><td>1.31</td><td>0.86&#8211;2.00</td><td> </td><td>1.48</td><td>0.88&#8211;2.49</td><td> </td></tr><tr><td>3&#8211;1</td><td>3.60</td><td>2.17&#8211;5.98</td><td> </td><td>3.53</td><td>1.86&#8211;6.69</td><td> </td></tr><tr><td>No prenatal care</td><td>4.47</td><td>2.53&#8211;7.90</td><td> </td><td>3.20</td><td>1.36&#8211;7.54</td><td> </td></tr><tr><td>History of previous STI</td><td> </td><td> </td><td>&lt; 0.001</td><td> </td><td> </td><td>&lt; 0.001</td></tr><tr><td>No</td><td>1.00</td><td> </td><td> </td><td>1.00</td><td> </td><td> </td></tr><tr><td>Yes</td><td>10.68</td><td>6.46&#8211;17.66</td><td> </td><td>9.70</td><td>5.46&#8211;17.24</td><td> </td></tr></table>
f0a8d8e19ed7a8193062690428363f9510370c519c1e63c70c4d609992aa54f1.png
simple
<table><tr><td>Setting</td><td>Number of hours</td><td>Number of days</td><td>Time period</td></tr><tr><td>999</td><td>170</td><td>41</td><td>Nov 2008 &#8211; Jul 2010</td></tr><tr><td>SPA</td><td>172</td><td>33</td><td>Oct 2009 &#8211; July 2010</td></tr><tr><td>OOH</td><td>149</td><td>27</td><td>Sept 2009 &#8211; Aug 2010</td></tr><tr><td>Total</td><td>491</td><td>101</td><td>Nov 2008 &#8211; Aug 2010</td></tr></table>
303c5e08da5f2914b64f837abec4818034c28abec1a4281141d4177c55c33643.png
simple
<table><tr><td></td><td>Control</td><td>Cold</td><td>Fold increase</td></tr><tr><td><i>Col-0</i></td><td>2.1 , 0.7</td><td>6.0 , 1.1</td><td>2.9</td></tr><tr><td><i>dgk1-1</i></td><td>2.2 , 0.5</td><td>5.1 , 0.4</td><td>2.3</td></tr><tr><td><i>dgk2-1</i></td><td>2.2 , 0.6</td><td>6.7 , 1.7</td><td>3.1</td></tr><tr><td><i>dgk2-2</i></td><td>1.9 , 0.3</td><td>6.5 , 1.8</td><td>3.3</td></tr><tr><td><i>dgk4-1</i></td><td>1.9 , 0.4</td><td>5.9 , 0.9</td><td>3.2</td></tr><tr><td><i>dgk4-2</i></td><td>2.0 , 0.3</td><td>7.2 , 1.0</td><td>3.7</td></tr><tr><td><i>dgk5-1</i></td><td>3.3 , 0.3</td><td>8.4 , 0.4</td><td>2.6</td></tr><tr><td><i>dgk6-1</i></td><td>2.6 , 0.2</td><td>9.7 , 0.6<sup>*</sup></td><td>3.7</td></tr><tr><td><i>dgk7-1</i></td><td>2.0 , 0.4</td><td>9.4 , 1.4<sup>*</sup></td><td>4.6</td></tr><tr><td><i>dgk7-2</i></td><td>2.3 , 0.5</td><td>10.3 , 1.0<sup>**</sup></td><td>4.5</td></tr><tr><td><i>dgk7-3</i></td><td>1.8 , 0.2</td><td>8.7 , 0.5</td><td>4.9</td></tr></table>
af594ade52b03681f8655cd296edd04e1f20e2b833e1d98e71174d8e77c43b5d.png
simple
<table><tr><td>Substance</td><td>Mechanism</td><td>Cancer Type</td><td>Reference</td></tr><tr><td>&#946;-asarone</td><td>p53/Bcl-2/Bclin-1 and p53/AMPK/mTOR pathways</td><td>Glioma cell line (U251)</td><td>[161]</td></tr><tr><td>Walsuronoid B</td><td>ROS-formation and activation of p53/PI3K/Akt/mTOR signaling pathway</td><td>Liver cancer (HepG2 and Bel-7402)</td><td>[166]</td></tr><tr><td>Sulforaphane</td><td>Reduction of phosphorylation of Akt and mTOR</td><td>Malignant mesothelioma (H-28)</td><td>[167]</td></tr><tr><td>Physapubescin B</td><td>(ROS)-mediated suppression of mTORC1</td><td>Colon cancer (HCT116) and cervical cancer (HeLa)</td><td>[168]</td></tr><tr><td>Fluvastatin</td><td>p53/AMPK/mTOR pathway</td><td>Lung adenocarcinoma (A549 and SPC-A-1)</td><td>[169]</td></tr><tr><td>Trichostatin A and Valproic Acid</td><td>ROS formation</td><td>Pancreatic cancer (Panc1 and PaCa44)</td><td>[170]</td></tr><tr><td>Cobalt chloride</td><td>p53/Bcl-2/Beclin-1 pathway</td><td>Malignant glioma (U87-MG)</td><td>[162]</td></tr><tr><td>Oridonin</td><td>AMPK deactivation-mediated GLUT1 downregulation in p53-mutated cells</td><td>p53-mutated colorectal cancer cells (HCT-15, COLO205, HCT116, RKO, SW480, and SW620)</td><td>[171]</td></tr><tr><td>Astemizole-Histamine</td><td>ROS formation and p53 phosphorylation, which increased p53-p62 interactions to enhance Beclin-1-independent autophagy</td><td>breast cancer (MCF-7)</td><td>[172]</td></tr><tr><td>Polygonatum odoratum lectin</td><td>Up-regulation of miR-15a-3p, which mediated ROS-p53 pathway</td><td>human lung adenocarcinoma (A549)</td><td>[173]</td></tr><tr><td>Trichosanthin</td><td>ROS-formation and activation of p53/PI3K/Akt/mTOR signaling pathway,</td><td>gastric cancer (MKN-45)</td><td>[174]</td></tr><tr><td>Honokiol</td><td>ROS-formation and activation of p53/PI3K/Akt/mTOR signaling pathway</td><td>Glioma (U87 MG)</td><td>[175]</td></tr></table>
cdc37017844a9236fd79462865831700c28387074e74974453e93c48538ad992.png
complex
<table><tr><td></td><td colspan="6">Practice (n=number of participating GPs at commencement)</td></tr><tr><td>Organisational Characteristics</td><td>Eastvale (n = 5)</td><td>Gibson (n = 1)</td><td>Frank (n = 4)</td><td>Southville (n = 7)</td><td>Coopers (n = 7)</td><td>West Sanders (n = 9)</td></tr><tr><td>Funding Structure</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Privately owned primary care sites</td><td>Y</td><td>Y</td><td>Y</td><td>Y</td><td></td><td></td></tr><tr><td> Corporatised primary care site</td><td></td><td></td><td></td><td></td><td></td><td>Y</td></tr><tr><td> Publicly funded community health centre</td><td></td><td></td><td></td><td></td><td>Y</td><td></td></tr><tr><td>Location</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Urban</td><td>Y</td><td>Y</td><td></td><td></td><td>Y</td><td>Y</td></tr><tr><td> Outer Urban</td><td></td><td></td><td></td><td>Y</td><td></td><td></td></tr><tr><td> Regional</td><td></td><td></td><td>Y</td><td></td><td></td><td></td></tr><tr><td>Personnel employed in the practice (in total)</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> GP(s)</td><td>6</td><td>2</td><td>4</td><td>8</td><td>8</td><td>14</td></tr><tr><td> Practice nurse(s)</td><td>2</td><td>3</td><td>2</td><td>4</td><td>2</td><td>3</td></tr><tr><td> Registrar(s)</td><td>1</td><td>0</td><td>0</td><td>0</td><td>0</td><td>1</td></tr><tr><td> Psychologist(s)</td><td>1</td><td>1</td><td>0</td><td>2</td><td>1</td><td>1</td></tr><tr><td> Practice manager(s)</td><td>1</td><td>0</td><td>1</td><td>1</td><td>1</td><td>1</td></tr><tr><td> Receptionist(s)</td><td>6</td><td>2</td><td>3</td><td>10</td><td>5</td><td>7</td></tr><tr><td> Other</td><td>2</td><td>0</td><td>2</td><td>7</td><td>10</td><td>0</td></tr></table>
0ba763416376590f4ed8150b5ae116d605ed1a7ba2602f48e5dfd6f105bb6cc7.png
complex
<table><tr><td>Variables</td><td>Adjusted odds ratio</td><td>95% confidence interval</td><td><i>p</i>-value</td></tr><tr><td>Therapeutic Self-Care</td><td>0.74</td><td>0.56, 0.96</td><td>0.03</td></tr><tr><td>Over age 75</td><td>1.01</td><td>0.77, 1.34</td><td>0.93</td></tr><tr><td>Female</td><td>0.77</td><td>0.63, 0.96</td><td>0.02</td></tr><tr><td>Polypharmacy</td><td>1.11</td><td>0.87, 1.44</td><td>0.40</td></tr><tr><td>Polypharmacy*Therapeutic Self-Care</td><td>1.48</td><td>1.10, 2.02</td><td>0.01</td></tr><tr><td>CHESS Scores</td><td>1.42</td><td>1.14, 1.76</td><td>&lt;0.01</td></tr><tr><td>Congestive Heart Failure</td><td>1.66</td><td>1.20, 2.30</td><td>&lt;0.01</td></tr><tr><td>Alzheimer&#8217;s Disease</td><td>1.31</td><td>1.01, 1.70</td><td>0.02</td></tr><tr><td>Model Fit Assessment</td><td>Chi-Square</td><td>DF</td><td>p-value</td></tr><tr><td>Likelihood Ratio</td><td>68.28</td><td>10</td><td>&lt;0.01</td></tr><tr><td>Model Fit Assessment</td><td colspan="2">Association of Predicted Probabilities and Observed Responses</td><td></td></tr><tr><td>C-index</td><td colspan="3">0.62</td></tr></table>
c7b4748972613a4524969d60916dfac6f1cc2b5a840cf52bbe887cd282612112.png
simple
<table><tr><td>Methods</td><td>EdgeC ount</td><td>TP</td><td>FP</td><td>TN</td><td>FN</td><td>FP to TP</td><td>TN to FN</td><td>AURO C</td><td>AUPR</td></tr><tr><td>Gold</td><td>2194</td><td>2194</td><td>0</td><td>400396</td><td>0</td><td>0</td><td>0</td><td>1</td><td>1</td></tr><tr><td>ALL</td><td>5440</td><td>94</td><td>5346</td><td>395050</td><td>2100</td><td>4623</td><td>2150</td><td>0.7530</td><td>0.4614</td></tr><tr><td>SAMBA</td><td>1611</td><td>46</td><td>1565</td><td>398831</td><td>2148</td><td>1340</td><td>2501</td><td>0.6958</td><td>0.3644</td></tr><tr><td>ISA</td><td>2558</td><td>56</td><td>2502</td><td>397894</td><td>2138</td><td>2141</td><td>1151</td><td>0.8451</td><td>0.6306</td></tr><tr><td>OPSM</td><td>220</td><td>12</td><td>208</td><td>400188</td><td>2182</td><td>190</td><td>2453</td><td>0.5423</td><td>0.089</td></tr><tr><td>Friedman</td><td>947</td><td>22</td><td>925</td><td>399471</td><td>2172</td><td>794</td><td>2700</td><td>0.6364</td><td>0.2491</td></tr><tr><td>CMSBE</td><td>735</td><td>20</td><td>715</td><td>399681</td><td>2174</td><td>653</td><td>2750</td><td>0.6181</td><td>0.2333</td></tr><tr><td>K-means</td><td>380</td><td>13</td><td>367</td><td>400029</td><td>2181</td><td>323</td><td>3100</td><td>0.5667</td><td>0.1307</td></tr><tr><td>Bivisu</td><td>1515</td><td>13</td><td>1502</td><td>398894</td><td>2181</td><td>1265</td><td>2610</td><td>0.6845</td><td>0.3326</td></tr><tr><td>CC</td><td>590</td><td>3</td><td>587</td><td>399809</td><td>2191</td><td>507</td><td>2800</td><td>0.5943</td><td>0.1788</td></tr></table>
92b293669f254b0e6cf693fa6ced8d278b2ccbe0e91dfe767a0d684446bb5d15.png
simple
<table><tr><td>microRNA</td><td><i>p</i>-value</td><td>Fold change (NB vs CB)</td></tr><tr><td>hsa-miR-222</td><td>0.001</td><td>2.24</td></tr><tr><td>hsa-miR-1292</td><td>0.020</td><td>1.27</td></tr><tr><td>hsa-miR-23a-star</td><td>0.022</td><td>1.27</td></tr><tr><td>hsa-miR-140-5p</td><td>0.009</td><td>1.21</td></tr><tr><td>hsa-miR-1273d</td><td>0.022</td><td>1.16</td></tr><tr><td>hsa-miR-539</td><td>0.044</td><td>1.14</td></tr><tr><td>hsa-miR-145-star</td><td>0.049</td><td>1.14</td></tr><tr><td>hsa-miR-30c-1-star</td><td>0.039</td><td>1.14</td></tr><tr><td>hsa-miR-3194</td><td>0.039</td><td>1.13</td></tr><tr><td>hsa-miR-545-star</td><td>0.004</td><td>1.13</td></tr><tr><td>hsa-miR-593-star</td><td>0.041</td><td>1.12</td></tr><tr><td>hsa-miR-2114</td><td>0.010</td><td>1.12</td></tr><tr><td>hsa-miR-27b-star</td><td>0.038</td><td>1.11</td></tr><tr><td>hsa-miR-215</td><td>0.020</td><td>1.10</td></tr><tr><td>hsa-miR-129-3p</td><td>0.029</td><td>1.10</td></tr><tr><td>hsa-miR-549</td><td>0.011</td><td>1.09</td></tr><tr><td>hsa-miR-23b-star</td><td>0.004</td><td>1.08</td></tr><tr><td>hsa-miR-92a-2-star</td><td>0.044</td><td>1.07</td></tr><tr><td>hsa-miR-2117</td><td>0.042</td><td>&#8211;1.08</td></tr><tr><td>hsa-miR-146b-3p</td><td>0.017</td><td>&#8211;1.08</td></tr><tr><td>hsa-miR-4330</td><td>0.036</td><td>&#8211;1.09</td></tr><tr><td>hsa-miR-454</td><td>0.020</td><td>&#8211;1.09</td></tr><tr><td>hsa-miR-338-5p</td><td>0.049</td><td>&#8211;1.10</td></tr><tr><td>hsa-miR-1303</td><td>0.044</td><td>&#8211;1.10</td></tr><tr><td>hsa-miR-548a-5p</td><td>0.036</td><td>&#8211;1.10</td></tr><tr><td>hsa-miR-326</td><td>0.025</td><td>&#8211;1.11</td></tr><tr><td>hsa-miR-369-3p</td><td>0.020</td><td>&#8211;1.12</td></tr><tr><td>hsa-miR-4325</td><td>0.007</td><td>&#8211;1.12</td></tr><tr><td>hsa-miR-519e</td><td>0.023</td><td>&#8211;1.13</td></tr><tr><td>hsa-miR-1244</td><td>0.041</td><td>&#8211;1.13</td></tr><tr><td>hsa-miR-586</td><td>0.024</td><td>&#8211;1.14</td></tr><tr><td>hsa-miR-562</td><td>0.016</td><td>&#8211;1.15</td></tr><tr><td>hsa-miR-590-5p</td><td>0.016</td><td>&#8211;1.17</td></tr></table>
055ccb5a7a235eaf1e58efe09051ede3bc726a205ff864c57b329faa966975a4.png
complex
<table><tr><td rowspan="3"></td><td colspan="2">Whole SAMPLE</td><td colspan="2">8 year&#8211;old group</td><td colspan="2">9 year&#8211;old group</td><td colspan="2">10 year&#8211;old group</td><td colspan="2">11&#8211;12 year&#8211;old group</td></tr><tr><td rowspan="2">Prevalencen. (%)</td><td>M</td><td rowspan="2">Prevalencen. (%)</td><td>M</td><td rowspan="2">Prevalencen. (%)</td><td>M</td><td rowspan="2">Prevalencen. (%)</td><td>M</td><td rowspan="2">Prevalence n. (%)</td><td>M</td></tr><tr><td>F</td><td>F</td><td>F</td><td>F</td><td>F</td></tr><tr><td rowspan="2">DMC</td><td rowspan="2">352 (7.5%)</td><td>M = 173</td><td rowspan="2">116 (6.3%)</td><td>M = 62</td><td rowspan="2">89 (7.8%)</td><td>M = 46</td><td rowspan="2">79 (8.8%)</td><td>M = 35</td><td rowspan="2">68 (8.3%)</td><td>M = 30</td></tr><tr><td>F = 179</td><td>F = 54</td><td>F = 43</td><td>F = 44</td><td>F = 38</td></tr><tr><td rowspan="2">H</td><td rowspan="2">335 (7.1%)</td><td>M = 168</td><td rowspan="2">118 (6.4%)</td><td>M = 59</td><td rowspan="2">96 (8.4%)</td><td>M = 51</td><td rowspan="2">54 (6,0%)</td><td>M = 28</td><td rowspan="2">67 (8.2%)</td><td>M = 30</td></tr><tr><td>F = 167</td><td>F = 59</td><td>F = 45</td><td>F = 26</td><td>F = 37</td></tr><tr><td rowspan="2">IT</td><td rowspan="2">185 (3.9%)</td><td>M = 87</td><td rowspan="2">72 (3.9%)</td><td>M = 35</td><td rowspan="2">40 (3.5%)</td><td>M = 19</td><td rowspan="2">39 (4.4%)</td><td>M = 17</td><td rowspan="2">34 (4.2%)</td><td>M = 16</td></tr><tr><td>F = 98</td><td>F = 37</td><td>F = 21</td><td>F = 22</td><td>F = 18</td></tr><tr><td rowspan="2">TA</td><td rowspan="2">131 (2.8%)</td><td>M = 79</td><td rowspan="2">49 (2.6%)</td><td>M = 32</td><td rowspan="2">31 (2.7%)</td><td>M = 19</td><td rowspan="2">24 (2.7%)</td><td>M = 12</td><td rowspan="2">27 (3.3%)</td><td>M = 16</td></tr><tr><td>F = 52</td><td>F = 17</td><td>F = 12</td><td>F = 12</td><td>F = 11</td></tr><tr><td rowspan="2">TT</td><td rowspan="2">67 (1.4%)</td><td>M = 39</td><td rowspan="2">34 (1.8%)</td><td>M = 19</td><td rowspan="2">12 (1.1%)</td><td>M = 7</td><td rowspan="2">8 (0.9%)</td><td>M = 4</td><td rowspan="2">13 (1.6%)</td><td>M = 9</td></tr><tr><td>F = 28</td><td>F = 15</td><td>F = 5</td><td>F = 4</td><td>F = 4</td></tr><tr><td rowspan="2">ST</td><td rowspan="2">43 (0.9%)</td><td>M = 25</td><td rowspan="2">13 (0.7%)</td><td>M = 6</td><td rowspan="2">13 (1.1%)</td><td>M = 8</td><td rowspan="2">8 (0.9%)</td><td>M = 4</td><td rowspan="2">9 (1.1%)</td><td>M = 7</td></tr><tr><td>F = 18</td><td>F = 7</td><td>F = 5</td><td>F = 4</td><td>F = 2</td></tr><tr><td rowspan="2">O</td><td rowspan="2">30 (0.6%)</td><td>M = 13</td><td rowspan="2">13 (0.7%)</td><td>M = 7</td><td rowspan="2">7 (0.6%)</td><td>M = 2</td><td rowspan="2">5 (0.6%)</td><td>M = 2</td><td rowspan="2">5 (0.6%)</td><td>M = 2</td></tr><tr><td>F = 17</td><td>F = 6</td><td>F = 5</td><td>F = 3</td><td>F = 3</td></tr><tr><td rowspan="2">T</td><td rowspan="2">2 (0.04%)</td><td>M = 1</td><td rowspan="2">1 (0.1%)</td><td>M = 1</td><td rowspan="2">0</td><td>M = 0</td><td rowspan="2">0</td><td>M = 0</td><td rowspan="2">1 (0.1%)</td><td>M = 0</td></tr><tr><td>F = 1</td><td>F = 0</td><td>F = 0</td><td>F = 0</td><td>F = 1</td></tr></table>
ab68ab796a6f2b9ee646ceb77230303c692f08ce8eb564aad2bc04fbe3beab25.png
complex
<table><tr><td></td><td></td><td></td><td colspan="2">Fold change</td></tr><tr><td>SAGE tag</td><td>RefSeq accession</td><td>Gene ID</td><td>Caudal/rostral (SAGE)</td><td>Caudal/rostral (RT-qPCR)</td></tr><tr><td>gttgttcttccagtcgg</td><td>NM_016916</td><td>bladder cancer associated protein homolog (human), <i>Blcap</i></td><td>2.68</td><td>1.43</td></tr><tr><td>gtcatagctgttctgtg</td><td>BC025816</td><td>EST sequence BC025816</td><td><i>Cs</i></td><td>1.31 (NS)</td></tr><tr><td>aagcttgacatttggaa</td><td>NM_026187</td><td>ankyrin repeat and zinc finger domain containing 1, <i>Ankzf1</i></td><td><i>Rs</i></td><td>1.17<sup>&#8224; </sup>(NS)</td></tr><tr><td>gatacttggaatgacta</td><td>NM_007393</td><td>actin, beta, cytoplasmic, <i>Actb</i></td><td>-2.63</td><td>-1.32</td></tr><tr><td>ttggtgaaggaaaaaac</td><td>NM_021278</td><td>thymosin, beta 4, X chromosome, <i>Tmsb4x</i></td><td>-2.33</td><td>-2.13 (NS)</td></tr></table>
c171becdf65cda83387bead85430db6ab253713080bfa07d90aebd831ca73d44.png
simple
<table><tr><td></td><td>Prescription</td><td>Market</td><td>Patient</td><td>Physician</td></tr><tr><td>TotalVPC (in %)</td><td>42.3[39.0; 45.6]</td><td>50.3[46.4; 54.2]</td><td>4.9[4.5; 5.3]</td><td>2.1[1.9; 2.3]</td></tr><tr><td>Residualvariance (in %)</td><td>34.8[34.7 34.9]</td><td>38.7[33.2; 45.3]</td><td>2.6[2.6; 2.7]</td><td>1.2[1.2; 1.3]</td></tr></table>
c7da9f8b7b1cddff4b50e0e52c592f5b399b3b7c56b12b3a1123eee9b548a769.png
complex
<table><tr><td></td><td>OHIP-14 Subscales Characteristics</td><td colspan="3">DMFT category</td><td rowspan="2">Statistics Spearman Ranks (rs) correlation<sup>a</sup></td></tr><tr><td></td><td></td><td>Acceptable DMFT &lt;3 <i>N</i> = 341% = 48.7Mean subscale (S.D)</td><td>Average DMFT 4&#8211;10<i>N</i> = 220% = 31.4Mean subscale (S.D)</td><td>Poor DMFT &gt; 10<i>N</i> = 139% = 19.9Mean subscale (S.D)</td></tr><tr><td>1.</td><td>Functional Limitation</td><td>2.1056 (1.95252)</td><td>2.8545 (1.93660)</td><td>3.1871 (2.05563)</td><td>0.234</td></tr><tr><td>2.</td><td>Physical pain</td><td>0.5073 (.96289)</td><td>0.7545 (0.99484)</td><td>0.8489 (1.10934)</td><td>0.160</td></tr><tr><td>3.</td><td>Psychological discomfort</td><td>3.3842 (2.39034)</td><td>4.1136 (1.95633)</td><td>4.6403 (1.89968)</td><td>0.221</td></tr><tr><td>4.</td><td>Physical disability</td><td>3.8358 (2.87525)</td><td>4.7273 (2.70771)</td><td>5.5540 (2.73775)</td><td>0.230</td></tr><tr><td>5.</td><td>Psychological disability</td><td>3.1554 (2.73042)</td><td>3.6591 (1.85973)</td><td>4.1727 (1.84520)</td><td>0.220</td></tr><tr><td>6.</td><td>Social disability</td><td>5.6452 (3.33611)</td><td>6.3545 (2.82224)</td><td>7.3165 (2.63487)</td><td>0.194</td></tr><tr><td>7.</td><td>Handicap</td><td>1.2669 (1.41496)</td><td>1.4727 (1.32216)</td><td>1.7914 (1.24222)</td><td>0.172</td></tr></table>
c616e366ed42e4a06e17c9739307229e9975d8fd4b2c2a0b4f9cd64c7db81c4f.png
complex
<table><tr><td rowspan="2">Target gene</td><td rowspan="2">Primer name</td><td rowspan="2">Nucleotide sequence (5'&#8211;3')</td><td rowspan="2">Product size (bp)</td><td colspan="4">PCR profile (&#176;C/s)</td><td rowspan="2">Reference</td></tr><tr><td>Denaturation</td><td>Annealing</td><td>Extension</td><td>Cycles</td></tr><tr><td rowspan="4">17 kDa</td><td>Rr17k. 1p</td><td>TTTACAAAATTCTAAAAACCAT</td><td rowspan="2">539</td><td rowspan="2">95/30</td><td rowspan="2">57/60</td><td rowspan="2">72/120</td><td rowspan="2">35</td><td rowspan="4">[23]</td></tr><tr><td>Rr17k. 539n</td><td>TCAATTCACAACTTGCCATT</td></tr><tr><td>Rr17k. 90p</td><td>GCTCTTGCAACTTCTATGTT</td><td rowspan="2">450</td><td rowspan="2">95/30</td><td rowspan="2">57/60</td><td rowspan="2">72/120</td><td rowspan="2">35</td></tr><tr><td>Rr17k. 539n</td><td>TCAATTCACAACTTGCCATT</td></tr><tr><td rowspan="4"><i>ompA</i></td><td>Rr190k. 71p</td><td>TGGCGAATATTTCTCCAAAA</td><td rowspan="2">650</td><td rowspan="2">95/30</td><td rowspan="2">42/35</td><td rowspan="2">60/120</td><td rowspan="2">35</td><td rowspan="4">[23]</td></tr><tr><td>Rr190k. 720n</td><td>TGCATTTGTATTACCTATTGT</td></tr><tr><td>Rr190k. 71p</td><td>TGGCGAATATTTCTCCAAAA</td><td rowspan="2">532</td><td rowspan="2">95/30</td><td rowspan="2">48/60</td><td rowspan="2">65/120</td><td rowspan="2">35</td></tr><tr><td>Rr190k. 602n</td><td>AGTGCAGCATTCGCTCCCCCT</td></tr></table>
54cd7c76d1961159af41125213050a81dece91adf034037b8dad95b6948fc358.png
complex
<table><tr><td rowspan="2"> Type</td><td colspan="4">Number of cases</td></tr><tr><td>Detected</td><td>Misreported</td><td>Under-reported</td><td>Total</td></tr><tr><td>Probe</td><td>226</td><td>4</td><td>7</td><td>233</td></tr><tr><td>DoS</td><td>131</td><td>14</td><td>23</td><td>155</td></tr><tr><td>R2L</td><td>77</td><td>12</td><td>12</td><td>89</td></tr><tr><td>U2R</td><td>29</td><td>12</td><td>8</td><td>36</td></tr></table>
8b5b215135164034de260ca7f42960f2d2f6fc1694bea171a666bb3318affe47.png
complex
<table><tr><td></td><td colspan="6">N (Percentage)</td></tr><tr><td>Characteristic</td><td>Quintile 1</td><td>Quintile 2</td><td>Quintile 3</td><td>Quintile 4</td><td>Quintile 5</td><td>p value</td></tr><tr><td>Median z score</td><td>-6.11</td><td>-3.21</td><td>-0.55</td><td>2.58</td><td>7.67</td><td></td></tr><tr><td>Age (mean, SD)</td><td>64.5 &#177; 9.5</td><td>64.1 &#177; 9.3</td><td>64.4 &#177; 9.4</td><td>64.8 &#177; 9.4</td><td>64.9 &#177; 9.4</td><td>.004</td></tr><tr><td>Black</td><td>2706 (72)</td><td>1904 (51)</td><td>1397 (37)</td><td>1022 (27)</td><td>438 (12)</td><td>&lt;.001</td></tr><tr><td>Female</td><td>2309 (62)</td><td>2191 (58)</td><td>2036 (54</td><td>1961 (52)</td><td>1838 (49)</td><td>&lt;.001</td></tr><tr><td>Residing in Southeast</td><td>2631 (70)</td><td>2591 (69)</td><td>2404 (64)</td><td>2074 (55)</td><td>1928 (51)</td><td>&lt;.001</td></tr><tr><td><sup>a</sup>History of cardiovascular disease</td><td>898 (24)</td><td>832 (22)</td><td>790 (21)</td><td>723 (19)</td><td>698 (19)</td><td>&lt;.001</td></tr><tr><td>Obese (BMI &gt; =30)</td><td>1749 (47)</td><td>1642 (44)</td><td>1449 (39)</td><td>1292 (34)</td><td>1052 (28)</td><td>&lt;.001</td></tr><tr><td>High waist circumference (&gt;102 cm (&gt;40 in) for men; &gt; 88 cm (&gt;35 in) for women</td><td>2116 (56)</td><td>2023 (54)</td><td>1875 (50)</td><td>1700 (45)</td><td>1396 (37)</td><td>&lt;.001</td></tr><tr><td>High triglycerides (&gt;150 mg/dL)</td><td>875 (23)</td><td>1025 (28)</td><td>1118 (30)</td><td>1066 (28)</td><td>1021 (27)</td><td>&lt;.001</td></tr><tr><td>Low HDL cholesterol (for men &lt;40 mg/dL, for women &lt; 50 mg/dL or on lipid lowering medication)</td><td>1413 (38)</td><td>1433 (38)</td><td>1415 (38)</td><td>1354 (36)</td><td>1112 (30)</td><td>&lt;.001</td></tr><tr><td>Blood pressure &gt; 130/&gt; 85 mm Hg or on antihypertensive medications</td><td>2574 (69)</td><td>2410 (64)</td><td>2210 (59)</td><td>2069 (55)</td><td>1724 (46)</td><td>&lt;.001</td></tr><tr><td>Fasting glucose &gt; 110 mg/dL or on antidiabetic medications</td><td>1070 (29)</td><td>912 (24)</td><td>772 (21)</td><td>585 (16)</td><td>444 (12)</td><td>&lt;.001</td></tr><tr><td>Metabolic syndrome</td><td>992 (26)</td><td>958 (25)</td><td>911 (24)</td><td>785 (21)</td><td>598 (16)</td><td>&lt;.001</td></tr><tr><td>Inflammation (CRP &#8805; 3 mg/L)</td><td>1853 (49)</td><td>1701 (45)</td><td>1505 (40)</td><td>1392 (37)</td><td>1115 (30)</td><td>&lt;.001</td></tr><tr><td>Metabolic syndrome + inflammation</td><td>1722 (24)</td><td>1615 (23)</td><td>1482 (21)</td><td>1323 (19)</td><td>1003 (14)</td><td>&lt;.0001</td></tr><tr><td>Current smoking</td><td>751 (20)</td><td>676 (18)</td><td>534 (14)</td><td>445 (12)</td><td>316 (8.5)</td><td>&lt;.001</td></tr><tr><td>Income</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>less than $20 K</td><td>1281 (34)</td><td>874 (23)</td><td>579 (16)</td><td>344 (9.2)</td><td>145 (3.9)</td><td></td></tr><tr><td>$20 K&#8211;$34 K</td><td>1079 (29)</td><td>1064 (28)</td><td>1001 (27)</td><td>853 (23)</td><td>514 (14)</td><td></td></tr><tr><td>$35 K&#8211;74 K</td><td>710 (19)</td><td>1039 (28)</td><td>1224 (33)</td><td>1422 (38)</td><td>1317 (35)</td><td></td></tr><tr><td>$75+</td><td>171 (4.6)</td><td>340 (9.1)</td><td>487 (13)</td><td>722 (19)</td><td>1337 (36)</td><td></td></tr><tr><td>Refused to report</td><td>510 (14)</td><td>451 (12)</td><td>455 (12)</td><td>417 (11)</td><td>443 (12)</td><td>&lt;.001</td></tr><tr><td>Education</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>&lt;High school</td><td>946 (25)</td><td>597 (16)</td><td>374 (10)</td><td>189 (5.0)</td><td>79 (2.1)</td><td></td></tr><tr><td>High school</td><td>1287 (34)</td><td>1192 (32)</td><td>1061 (29)</td><td>826 (22)</td><td>489 (13)</td><td></td></tr><tr><td>Some college</td><td>869 (23)</td><td>1073 (28)</td><td>1132 (30)</td><td>1140 (30)</td><td>900 (24)</td><td></td></tr><tr><td>College</td><td>649 (17)</td><td>906 (24)</td><td>1179 (31)</td><td>1603 (43)</td><td>2288 (61)</td><td>&lt;.001</td></tr></table>
b5ba89bcc34b91142c70886954135d437d76dc0ec48eac8c2728f4c201481c93.png
complex
<table><tr><td>Feature of presenting complaint</td><td>Study participants (<i>n</i> = 30)</td></tr><tr><td colspan="2">Trauma (%)</td></tr><tr><td> Yes</td><td>16 (53.3)</td></tr><tr><td> No</td><td>14 (46.7)</td></tr><tr><td colspan="2">Weight-bearing (%)</td></tr><tr><td> Yes</td><td>17 (56.7)</td></tr><tr><td> No</td><td>13 (43.3)</td></tr><tr><td colspan="2">Side affected (%)</td></tr><tr><td> Right</td><td>11 (36.7)</td></tr><tr><td> Left</td><td>18 (60.0)</td></tr><tr><td> Both</td><td>1 (3.3)</td></tr><tr><td colspan="2">Region affected (%)</td></tr><tr><td> Hip</td><td>5 (16.7)</td></tr><tr><td> Thigh</td><td>8 (26.7)</td></tr><tr><td> Knee</td><td>6 (20.0)</td></tr><tr><td> Lower leg</td><td>8 (26.7)</td></tr><tr><td> Ankle</td><td>3 (10.0)</td></tr><tr><td colspan="2">Diagnosis (%)</td></tr><tr><td> Soft tissue injury</td><td>13 (43.3)</td></tr><tr><td> Irritable hip</td><td>9 (30.0)</td></tr><tr><td> Toddler&#8217;s fracture</td><td>3 (10.0)</td></tr><tr><td> Other</td><td>4 (13.3)</td></tr><tr><td> Unknown diagnosis</td><td>1 (3.3)</td></tr></table>
722886f8e661ceb31fd6dc823fc9e3ac642533050022459dcf5ab8cc21f9bade.png
complex
<table><tr><td>Evaluation</td><td colspan="2">Any Difference(Mack Skillings Test)</td><td colspan="2">Paired Comparisons*(Signed Rank Test)</td></tr><tr><td></td><td>Raw P Value</td><td>Adjusted P Value</td><td>P Value of Cycle 1 Comparisons</td><td>P Value of Cycle 2 Comparisons</td></tr><tr><td>CD4+</td><td>0.0203</td><td>0.1827</td><td>-</td><td>-</td></tr><tr><td>CD8+</td><td>0.0207</td><td>0.1827</td><td>-</td><td>-</td></tr><tr><td>CD56+</td><td>-</td><td>-</td><td>0.1250</td><td>-</td></tr><tr><td>CD16+/CD56+</td><td>-</td><td>-</td><td>1.0</td><td>-</td></tr><tr><td>CD25+</td><td>0.3192</td><td>1.0</td><td>-</td><td>-</td></tr><tr><td>CD27+</td><td>0.0709</td><td>0.4254</td><td>-</td><td>-</td></tr><tr><td>NK+ granzyme B+</td><td>0.2623</td><td>1.0</td><td>-</td><td>-</td></tr><tr><td>CD8+ granzyme B+</td><td>0.0948</td><td>0.4740</td><td>-</td><td>-</td></tr><tr><td>NK activity</td><td>0.0207</td><td>0.1827</td><td>-</td><td>-</td></tr><tr><td>ADCC w/IL2</td><td>0.2818</td><td>1.0</td><td>-</td><td>-</td></tr><tr><td>ADCC</td><td>0.5095</td><td>1.0</td><td>-</td><td>-</td></tr><tr><td>S100</td><td>-</td><td>-</td><td>0.3621</td><td>-</td></tr><tr><td>IL6</td><td>0.0366</td><td>0.0732</td><td>-</td><td>-</td></tr><tr><td>sIL2R</td><td>&lt;0.0001</td><td>&lt;0.0001</td><td>0.0156</td><td>0.0156</td></tr><tr><td>TNF</td><td>0.1948</td><td>0.1948</td><td>-</td><td>-</td></tr><tr><td>IL10</td><td>0.0115</td><td>0.0345</td><td>0.0769</td><td>0.250</td></tr><tr><td>Neopterin</td><td>&lt;0.0001</td><td>&lt;0.0003</td><td>0.0156</td><td>0.0222</td></tr></table>
e647741d2ab0d600b40d9dece1725ef0bbb4b98ae582fd3aaf5c924897e8ee02.png
simple
<table><tr><td>Month(s)</td><td>NT-proBNP (fmol/ml)</td><td>IL-6 (pg/ml)</td><td>Adiponectin (ng/ml)</td></tr><tr><td>1</td><td>172.79&#177;4.32</td><td>13.24&#177;1.25</td><td>15.19&#177;0.86</td></tr><tr><td>3</td><td>292.43&#177;7.59**</td><td>116.09&#177;8.78**</td><td>12.54&#177;1.61*</td></tr><tr><td>6</td><td>339.43&#177;12.59**</td><td>181.29&#177;16.45**</td><td>12.25&#177;0.29*</td></tr><tr><td>9</td><td>348.53&#177;15.85 **</td><td>223.61&#177;12.43**</td><td>11.64&#177;0.95*</td></tr><tr><td>12</td><td>379.18&#177;19.37 **</td><td>236.15&#177;6.05 **</td><td>9.64&#177;0.85**</td></tr><tr><td>15</td><td>386.52&#177;19.69 **</td><td>260.05&#177;9.90** &#8224;</td><td>10.45&#177;1.52*&#8224;</td></tr><tr><td>18</td><td>407.97&#177;18.23 **&#8224;&#8224;</td><td>421.45&#177;19.49** &#8224;&#8224;</td><td>11.01&#177;1.81*&#8224;</td></tr></table>
ef16de2e9d53a92eb91391b9187da534ae8ba1aa7adc374287f4d168bec8cfc3.png
simple
<table><tr><td></td><td>p-value </td><td>Pearson correlations </td></tr><tr><td>Infant age (month) </td><td>0.002 </td><td>-0.270 </td></tr><tr><td>Height at birth (cm) </td><td>0.010 </td><td>0.237 </td></tr><tr><td>Weight at birth (kg) </td><td>0.940 </td><td>-0.007 </td></tr><tr><td>Head circumference at birth (cm) </td><td>0.251 </td><td>0.157 </td></tr></table>
a238c1e47a0e25f9efff5e40190d3d4f02711048332b4540fc57b733bc74958e.png
simple
<table><tr><td>Annotation category</td><td>Number of annotations</td></tr><tr><td>Natural antisense lncRNA</td><td>64</td></tr><tr><td>Pseudogene</td><td>75</td></tr><tr><td>Transposable element gene</td><td>10</td></tr><tr><td>Transposase</td><td>46</td></tr><tr><td>miRNA primary transcript</td><td>4</td></tr><tr><td>Hypothetical protein</td><td>5</td></tr><tr><td>Protein</td><td>8</td></tr><tr><td>Other</td><td>8</td></tr></table>
1bb2f6f3bd1ddab8a81aa640a92c9a7ac5fec8c10681e292f717f2847d047e4f.png
complex
<table><tr><td>Sharing platform</td><td colspan="2">Current users, <i>n</i> = 200<i>n</i> (%)</td></tr><tr><td>Do not share data</td><td>130</td><td>(65.0%)</td></tr><tr><td>Tracker support software</td><td>70</td><td>(35.0%)</td></tr><tr><td>Strava</td><td>9</td><td>(4.5%)</td></tr><tr><td>Facebook</td><td>7</td><td>(3.5%)</td></tr><tr><td>Instagram</td><td>2</td><td>(1.0%)</td></tr><tr><td>In person</td><td>2</td><td>(1.0%)</td></tr><tr><td>Twitter</td><td>1</td><td>(0.5%)</td></tr><tr><td>Other</td><td>3</td><td>(1.5%)</td></tr><tr><td colspan="3">Reasons for sharing on social media</td></tr><tr><td>Do not share data on social media</td><td>154</td><td>(77.0%)</td></tr><tr><td>To compete with friends</td><td>33</td><td>(16.5%)</td></tr><tr><td>To share progress</td><td>18</td><td>(9.0%)</td></tr><tr><td>To motivate others</td><td>17</td><td>(8.5%)</td></tr><tr><td>To get encouragement from others</td><td>13</td><td>(6.5%)</td></tr><tr><td>Other</td><td>4</td><td>(2.0%)</td></tr></table>